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Abstract 
 
Activation  Induced  Deaminase  (AID)  belongs  to  the  protein  family  of  DNA 
deaminases, which catalyse the deamination of the cytosine residues in single 
stranded  DNA,  resulting  in  the  formation  of  deoxy-uracils.  The  enzymatic 
activity of AID is required for the immunoglobulin gene modifications by class 
switch recombination (CSR), somatic hypermutation (SHM) and gene conversion 
(iGC). While being essential for antibody diversification, the activity of AID can 
be harmful for the organism due to its direct mutagenic activities and induction of 
genomic instability. 
This thesis investigates AID regulation both, on the level of gene expression 
and  its  interaction  partners,  and the DNA repair pathways triggered by  AID-
mediated DNA deamination. Firstly, I have identified estrogen and progesterone 
as regulators of AID expression. This is achieved via direct binding of estrogen 
and progesterone receptors to AID promoter. Estrogen leads to an induction of 
AID expression and increase in AID-mediated downstream pathways – SHM, 
CSR as well as oncogenic translocations between Ig and c-myc loci. In contrast, 
progesterone results in a decrease in AID expression and an attenuation of its 
downstream  pathways.  Secondly,  by  generating  DT40  cell  lines  with 
endogenously tagged AID, we used co-immunoprecipitation and subsequent mass 
spectrometry  for  identifying  proteins  that  form  a  complex  with  AID  in  the 
cytoplasm,  nucleoplasm  and  chromatin.  The  results  of  this  approach  gave  us 
possible insight into the mechanistic process of AID-mediated DNA deamination 
in  vivo,  suggesting  that  chromatin  bound  AID  resides  in  a  complex  with 
elongating  RNA  polymerase  II.  Thirdly,  by  expressing  AID  in  meiotic 
recombination deficient fission yeast and nematode, we have established that a 
meiotic  cell  can  process  a  base  mismatch,  using  the  base  excision  repair 
machinery, to give rise to meiotic recombination. This suggests that meiotic cells 
can process lesions other than Spo-11 induced DSBs for recombination.  
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1.1 Immune cells and immune responses.  
The immune system consists of an innate (non-specific) and adaptive (specific) 
immune system, which forms an integral network composed of cellular and non-
cellular components.  The  predominant cellular  components  of the  nonspecific 
immune  system  are  macrophages  and  of  the  specific  immune  system  are 
lymphocytes. Lymphocytes can be divided into B-cells and T-cells. In general, B-
cells  have  the  function  of  making  immunoglobulins,  whereas  T-cells  have 
distinctive functions [Reviewed in (Allen et al., 2007)]. Immunity mediated by 
antibodies is known as humoral immunity, and immunity that is due to cytotoxic 
T-cells and/or T helper cells is known as cell-mediated immunity (Abbas, 2007). 
Cytotoxic T-cells kill cells infected with viruses or other pathogens, whereas a 
subclass  of  T-cells  named  T  helpers  are  essential  for  shaping  the  immune 
responses via regulating the activation of B-cells and other cells of the immune 
system by secreting cytokines [Reviewed in (Felix and Allen, 2007)]. A subclass 
of  T  helpers  recognizes  the  antigenic  peptide  and  major  histocompatibility 
(MHC) complex on B-cells and activates them to proliferate and differentiate into 
antibody producing plasma cells [Reviewed in (Dorner and Radbruch, 2007)]. 
This interaction between T helpers and B-cells is required for the initiation of 
antibody diversification and subsequent antibody production by plasma cells. The 
antibodies secreted by the plasma cell bind to extracellular pathogens and toxins, 
making  them  prone  to  phagocytosis  by  macrophages,  and  promote  their 
destruction by other effector cells or by the complement system (Abbas, 2007). In 
addition to B-cells and T-cells, other cells are involved in innate and adaptive 
immune responses. Macrophages and dentritic cells engulf and destroy pathogens 
by phagocytosis. Dendritic cells are phagocytic when they are immature and take 
up pathogens, however after maturing they initiate adaptive immune responses by 
acting  as  antigen-presenting  cells  to  T-cells.  Basophils  and  mast  cells  act 
primarily as secretory cells during adaptive immune responses, releasing their 
histamine  and  proteoglycan  containing  granules  upon  activation  by  antibody 
(Abbas, 2007). 
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1.2 Antibodies. 
Antibodies produced by B-cells play a central part in the immune responses of 
mammals.  The  antibody  molecules  consist  of  four  polypeptide  chains  –  two 
heavy chains and two light chains. The two heavy chains are linked to each other 
by disulfide bonds and each heavy chain is linked to a light chain by a disulfide 
bond (Figure 1). In all immunoglobulin molecules, the two heavy chains and the 
two light chains are identical, giving an antibody molecule two identical antigen-
binding sites. Two types of light chain, termed lambda (λ) and kappa (κ), are 
found in antibodies. Either type of light chain may be found in antibodies of any 
five major classes (IgM, IgD, IgG, IgA and IgE), but a given immunoglobulin 
either has lambda or kappa chains (Abbas, 2007). The class, and thus the effector 
function of an antibody, is defined by the structure of its heavy chain (µ, δ, γ, α, 
ε), in IgM, IgD, IgG, IgA and IgE, respectively (Abbas, 2007). Each of the four 
Ig chains has a variable (V) region at its amino terminus, which contributes to the 
antigen-binding site, and a constant (C) region, which determines the isotype. Ig 
isotypes have different functions in the immune system. IgM plays an important 
role  in  the  activation  of  the  complement  system.  IgG  isotypes  are  primarily 
involved in opsonisation, neutralization and activation of the complement system, 
as well as the sensitization for killing by natural killer cells. IgA is involved in 
neutralization, and IgE is important for sensitizing mast cells (Abbas, 2007). 
The diversity of the immunoglobulin repertoire in humans is generated by 
several processes (Abbas, 2007). Firstly, the multiple inherited gene segments V, 
D  and  J  that  form  the  Ig  V  region,  can  be  used  in  different  combinations. 
Secondly,  variable  addition  and  substraction  of  nucleotides  at  the  junctions 
between  gene  segments  increase  diversity.  Thirdly,  different  possible 
combinations  of  a  heavy  and  light  chain  are  used  in  the  complete 
immunoglobulins. Fourthly, V regions are mutated in mature B-cells through the 
process  of  somatic  hypermutation.  Somatic  hypermutation  is  triggered  by 
enzymatic deamination of cytosines in the immunoglobulin locus. The enzyme 
Activation Induced Deaminase that catalyzes this process, and is the main subject 
of this thesis, will be described in detail below. 
   17
 
 
Figure 1. Antibody heavy and light chains are constructed from gene segments. Light-chain 
V-region genes are constructed from two segments (left pannel). A variable (V) and a joining (J) 
gene segment in the genomic DNA are joined to form a complete light-chain V-region. A leader 
peptide (L) directs the protein into the cell’s secretory pathways and is then cleaved. The light-
chain C region is joined to the V-region by splicing of the light-chain RNA to remove the L-to-V 
and  J-to-C  introns.  Heavy-chain  V  regions  are constructed  from  three  gene  segments  (centre 
panel). First, the diversity (D) and J gene segments join, followed by the joining of V segment 
with DJ the combined DJ sequence, forming a complete VH. The C-region, which consists of 
several segments, is spliced to the V-domain sequence together with the leader sequence. The 
leader sequence is removed after translation and the disulfide bonds (black lines) that link the 
polypeptide chains are formed. The hinge region is shown in purple. Adapted from (Janeway, 
2001). 
 
 
 
1.3 Activation Induced Deaminase. 
Activation  Induced  Deaminase  is  a  24  kDa  protein  that  is  a  member  of  the 
AID/APOBEC  family  of  proteins  (Figure  2)  [Reviewed  in  (Petersen-Mahrt, 
2005)].  AID  is  produced by  mature  vertebrate B-lymphocytes  that  have  been 
activated to undergo somatic hypermutation and class switch recombination. It is 
also found in immature B-cells of birds and some mammalian species undergoing 
gene conversion of Ig genes [Reviewed in (Di Noia and Neuberger, 2007)]. AID 
enzymatic activity is essential for these processes, indicated by the hyper IgM 
syndrome  in  human  patients  lacking  AID  and  in  AID  knock-out  mice   18
(Muramatsu  et  al.,  2000;  Revy  et  al.,  2000).  It  has  been  shown  in  vitro 
(Bransteitter et al., 2003; Chaudhuri et al., 2003; Dickerson et al., 2003) and in E. 
coli (Petersen-Mahrt et al., 2002), that AID initiates these events by deaminating 
cytosines in DNA into uracils (U). AID preferentially targets WRC motifs (A/T-
A/G-C) in ssDNA in vitro (Yu et al., 2004a), in yeast (Mayorov et al., 2005) and 
reveals hotspots for nucleotide mutations during somatic hypermutation and in 
immunoglobulin  switch  regions  (Larijani  et  al.,  2005;  Shapiro  and  Wysocki, 
2002). Not much is known about the mechanisms of AID’s targeting to the Ig 
locus and the molecular reasons for its selective activity on these loci. There are a 
number of genes that are mutated by AID such as BCL6, CD95/FAS, c-myc, 
RHO/TTF, PAX-5, PIM1, Igα, Igβ, B29 and MB1 (Gordon et al., 2003; Kuppers 
and Dalla-Favera, 2001; Liu et al., 2008; Muschen et al., 2000; Pasqualucci et al., 
1998;  Pasqualucci  et  al.,  2001;  Shen  et  al.,  1998).  The  difference  in  AID-
mediated mutations in various loci appears to be in part due to regulated targeting 
of  AID,  as  overexpression  of  AID  causes  mutation  of  several  genes  that  in 
normal B-cells are  not subject to somatic hypermutation (Martin et al., 2002; 
Figure 2. Activation induced deaminase (AID). (A) The structural domains of AID. NLS – 
nuclear localization signal, NES – nuclear export signal. Numbers indicate the corresponding 
amino acids. (B) The catalytic activity of AID in ssDNA produces a uracil from a cytosine by 
deamination. This results in a U:G mismatch in DNA. Modified from (Durandy et al., 2006; 
Neuberger et al., 2003). 
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Okazaki et al., 2003; Yoshikawa et al., 2002). In addition to specific targeting of 
AID to certain loci, a balance between high fidelity DNA repair and error-prone 
repair  seems  to  determine  whether  a  gene  will  accumulate  AID-induced 
mutations or not (Liu et al., 2008). 
Cis  elements,  including  enhancers,  have  been  suggested  to  affect  AID 
targeting  to  certain  loci.  The  presence  of  two additional  E2A protein-binding 
sequences CAGGTG has been shown to increase V region mutation frequencies 
(Michael et al., 2003). The oncogene c-myc, that also contains this relatively 
frequently occurring cis element, is expressed and mutated in B-cell lymphomas 
(Klein et al., 2003; Pasqualucci et al., 2001). Somatic hypermutation of Igκ is 
also  affected  by  intronic  or  3’  enhancers,  but  this  is  probably  not  the  only 
determinant for the efficiency of mutations, because it occurs in mice that lack 
the intronic enhancer (Betz et al., 1994; Perlot et al., 2005; van der Stoep et al., 
1998). 
Most of AID protein is localized in the cytoplasm of B-cells (Ito et al., 
2004; McBride et al., 2006). AID has an N-terminal nuclear import signal as well 
as  a  C-terminal  nuclear  export  signal  and  accumulates  in  the  nucleus  after 
overexpression in cells where nuclear export is inhibited (McBride et al., 2006). 
The half-life of AID protein is shorter in the nucleus compared to the cytoplasm, 
due to its polyubiquitinylation and faster degradation in the nucleus (Aoufouchi 
et al., 2008).  In addition, the  localization  and  activity  of  AID are potentially 
regulated by post-translational modifications. AID has been shown to associate 
with  PKA  in  a  cAMP  dependent  manner  in  the  cytoplasm  of  Ramos  cells 
(Pasqualucci et al., 2006), and its phosporylation has been correlated with AID 
localization  to  the  nucleus.  Purified  AID  from  activated  mouse  B-cells  is 
phosphorylated at serine 38 (S38), tyrosine 184 (Y184) (Basu et al., 2005), and 
threonine 140 (T140) (McBride et al., 2008). Threonine 140 and serine 38 can 
also be phosphorylated in vitro by various PKC isoforms, and the mutation of 
these residues in AID protein leads to a decrease in somatic hypermutation and 
also in Ig class switching (McBride et al., 2008). AID purified from HEK293 
non-lymphoid  cells  is  not  as  highly  phosphorylated  and  lacks  substantial 
interaction with RPA (Chaudhuri et al., 2004), a protein that has been identified 
to  bind  AID.  However,  phosphorylation  of  AID  in  vitro  renders  the  protein 
capable of interacting with RPA (Basu et al., 2005). In addition to RPA, AID   20
may  interact  with Mdm2  (MacDuff et  al.,  2006), the  transcription  machinery 
(Nambu et al., 2003), and CTNNBL1 [a nuclear protein that interacts with the 
spliceosome  (Conticello  et  al.,  2008)].  AID  mutants  that  are  unable  to  bind 
CTNNBL1 yield severely diminished hypermutation and class switching and the 
absence  of  CTNNBL1  in  DT40  results  in  abrogated  Ig  V  diversification 
(Conticello et al., 2008).  
The regulation of AID expression in B-cells is mediated by both stimulatory 
and  inhibitory  factors.  AID  expression  is  induced  by  CD40,  bacterial 
lipopolysaccharides  and  interleukin-4  (IL-4)  (produced  by  CD4+  T-cells) 
(Muramatsu et al., 1999). These signals are mediated by  various transcription 
factors such as Pax5, E47, Stat6, NFκB, Irf8 and Hox4C, all of which function in 
a cooperative manner with negative regulators of AID such as id3 or Blimp1 – 
classical B-cell specific transcription factors (Dedeoglu et al., 2004; Gonda et al., 
2003; Lee et al., 2006; Sayegh et al., 2003; Shapiro-Shelef et al., 2005; Xu et al., 
2007). Furthermore, AID is negatively regulated by microRNA-155 as well as 
microRNA-181b in a posttransciptional manner (de Yebenes et al., 2008; Dorsett 
et al., 2008; Teng et al., 2008). 
  
 
1.4 Somatic hypermutation. 
Somatic hypermutation introduces point mutations in rearranged V region genes, 
generating antibodies with higher affinity to antigens (Figure 3) (Weigert et al., 
1970; Neuberger et al., 2003). AID induced mutant immunoglobulin molecules 
that  bind  antigen  better  than  the  original  B-cell  receptors  are  preferentially 
selected to mature into antibody-secreting cells. This process is called antibody 
affinity maturation. The mutations introduced by SHM are predominately point 
mutations, although insertions and deletions are occasionally observed (Goossens 
et al., 1998).  
The  U:G  mismatches  due  to  AID  have  several  possible  fates  in  SHM 
(Neuberger et al., 2003; Odegard and Schatz, 2006). If a lesion is not repaired 
before the start of DNA replication, DNA polymerases will insert an A nucleotide 
opposite the U nucleotide creating C to T (G to A) transition mutations. If the U 
nucleotide  is  removed  by  uracil-DNA  glycosylase  (UNG),  an  abasic  site  is   21
created, replication of which should give rise to both transition (purine to another 
purine)  and  transversion  (purine  to  pyrimidine)  mutations.  In  addition  to 
activating UNG-dependent base-excision repair (BER), a U:G mismatch can also 
recruit  the  mismatch  repair  (MMR)  machinery  (Wilson  et  al.,  2005),  which 
allows for mutations at A:T near the initiating U:G lesion through an error-prone 
patch repair process by DNA polymerase eta (Polη) (Delbos et al., 2007; Delbos 
et al., 2005). 
 
 
 
Figure  3.  Schematic  drawing  of  somatic  hypermutation  during  affinity  maturation  of 
antibodies. A rearranged Ig gene as would be present in mature naive B-cells is depicted at the 
top.  The  V  segment  encodes  the  Ig  variable  region  whereas  the  C  regions  encode  constant 
regions. S denotes switch regions. The arrow preceding the V segment represents a promoter.  
SHM  introduces  non-templated  point  mutations  in  V  genes.  Mutations  are  shown  as  yellow 
vertical lines in the V segment.  
 
 
Transcription of the immunoglobulin locus is essential for SHM, as loss of 
transcription abolishes the  frequency of mutations, and the mutation rate of a 
reporter immunoglobulin gene is proportional to the rate of transcription through 
that locus (Bachl et al., 2001; Fukita et al., 1998). Mutations are confined to a 1–
2 kilobase (kb) region in rearranged immunoglobulin genes, beginning about 150 
base pairs (bp) downstream of the transcription start site and the frequency of 
mutations decreases exponentially with increasing distance from the transcription 
start site {Lebecque, 1990 #678}(Rada and Milstein, 2001). 
U nucleotides are generated during normal cell growth due to spontaneous 
deamination of cytosines and are misincorporated into DNA during replication   22
(Krokan et al., 2002). These U nucleotides are efficiently and accurately repaired, 
predominately  by  BER  pathways  that  depend  on  the  activity  of  uracil-DNA 
glycosylases. During SHM, however, the uracil lesion is repaired in an error-
prone manner, resulting in an approximate mutation rate of 2x10
-3 mutations per 
base  pair  per  cell  division,  which  is  10
6-fold  higher  than  the  spontaneous 
mutation rate in somatic cells (Odegard and Schatz, 2006). One mechanism by 
which  error-free  repair  might  be  disrupted,  involves  MRE11  (meiotic 
recombination 11 homologue)–RAD50 complex, which is able to cleave DNA at 
abasic sites, generating a 3' end that cannot be extended by DNA polymerases 
(Larson  et  al.,  2005a).  Another  study,  in  chicken  DT40  cells,  indicated  the 
importance of PCNA ubiquitinylation in somatic hypermutation, presumably by 
recruiting error-prone DNA polymerases (Arakawa et al., 2006). 
 
 
1.5 Class switch recombination. 
Class switch recombination detaches an expressed heavy chain variable (VDJ) 
region from one constant (C) region and joins it to another downstream C region, 
deleting  the  DNA  in  between  (Figure  4)  [Reviewed  in  (Chaudhuri  and  Alt, 
2004)].  Switch  recombination  rejoins  the  chromosome  and  generates  switch 
circles carrying the excised fragment. The ectopic expression of AID is sufficient 
to induce switch recombination (Okazaki et al., 2002) and somatic hypermutation 
(Yoshikawa  et  al.,  2002)  in  engineered  minigenes  in  mammalian  fibroblasts, 
Figure 4. A schematic drawing  of class switch recombination. CSR occurs between a S  
region and a S region located upstream of another C region, such as Sε, which will result in the 
switching  from  IgM  to  IgE.  The  intervening  DNA  sequence  is  predominantly  released  as  a 
circular episome called a switch circle.   23
indicating that downstream steps in the AID-initiated pathways can be carried out 
by non-B-cell specific factors. Recombination is region-specific, not sequence-
specific, and produces junctions at heterogeneous sites and sequences within the 
switch (S) regions, which are repetitive and degenerate guanine-rich regions 2–10 
kb in length (Dunnick et al., 1993). Extracellular signals delivered by T-cells and 
cytokines, which activate S region transcription via an enhancer and promoter in 
the intron upstream of each S region, regulate the production of specific classes 
of Ig. Thus, the critical signal for recombination is transcription of the S regions 
targeted for recombination (Shinkura et al., 2003). Recently switch regions (not 
constant regions) have been  reported to be  transcribed  in anti-sense  direction 
(similarly  to  V region),  but the exact  role  of  this unusual transcription  event 
remains unclear (Perlot et al., 2008). 
CSR depends upon a 10 amino acid region at the very C terminus of AID, a 
region  unnecessary  for  cytosine  deamination,  gene  conversion  or  somatic 
hypermutation  (Barreto  et  al.,  2003;  Shinkura  et  al.,  2004;  Ta  et  al.,  2003). 
Targeted  disruption  of  ung,  Msh2,  Msh6,  and  Exo1  in  mice  decrease  switch 
recombination, indicating the involvement of these proteins in the process (Rada 
et  al.,  2004;  Rada  et  al.,  2002).  CSR  also  depends  upon  factors  involved  in 
nonhomologous end-joining, including Ku and DNA-PKcs (Casellas et al., 1998). 
Furthermore, CSR requires four factors involved in the DNA damage response: 
the cell cycle regulator ATM (Lumsden et al., 2004; Reina-San-Martin et al., 
2004);  the  phosphorylated  variant  histone  γ-H2AX  (Reina-San-Martin  et  al., 
2003); NBS1, the regulatory component of the MRE11/RAD50/NBS1 (MRN) 
complex (Manis et al., 2004); and the p53-binding protein 1, 53BP1 (Reina-San-
Martin et al., 2004; Reina-San-Martin et al., 2003; Ward et al., 2004). These 
factors  act  as  early  sensors  of  AID-mediated  DNA  lesions  and  coordinate 
downstream DNA repair pathways leading to class switch recombination. 
 
 
1.6 Gene conversion. 
Gene conversion (GC) mediates the transfer of genetic information from intact 
homologous  sequences  to  the  region  that  contains  a  DSB  –  this  can  occur 
between sister chromatids, homologous chromosomes or homologous sequences   24
on either the same chromatid or different chromosomes [Reviewed in (Chen et 
al.,  2007)].  Immunoglobulin  GC  (iGC)  is  the  process  through  which 
immunoglobulins are diversified  in chicken, rabbit, cattle and pigs (Figure 5) 
(Arakawa and Buerstedde, 2004; Reynaud et al., 1985; Reynaud et al., 1987). 
This  process  introduces  sequences  from  adjacent  V  pseudogenes  into  the 
expressed  V  gene,  creating  diversity  in  the  receptors  (Reynaud  et  al.,  1985; 
Reynaud  et  al.,  1987).  In  chicken,  all  B-cells  express  the  same  surface 
immunoglobulin (sIg) initially; there are several D segments but only one active 
V and J gene segment for the chicken heavy-chain gene and one active V and J 
gene segment for each of the light-chain genes. Gene rearrangement in chicken 
can  thus  produce  only  a  single  receptor  specificity  (Reynaud  et  al.,  1985; 
Reynaud et al., 1987). 
The chicken DT40 cell line has been a useful tool for studying iGC and the 
factors involved in this process. iGC is initiated by deamination of cytosines by 
AID, followed by base removal by UNG, which creates an abasic site that is 
prone to cleavage (Arakawa et al., 2002; Arakawa et al., 2004; Harris et al., 
2002b). The resulting DNA 3' end undergoes homologous repair, promoted by 
RAD51  paralogs  XRCC2,  XRCC3  or  RAD51B  and  BRCA2,  copying  new 
sequence  information  from  an  upstream  donor  pseudogene  (Krogh  and 
Symington, 2004; Sale et al., 2001). It has also been suggested that single-strand 
lesions lead to gene conversion via Nbs1-mediated homologous recombination 
(Nakahara et al., 2009). 
 
 
 
Figure 5. A schematic drawing of gene conversion. Gene conversion introduces mutations in V 
genes by shuffling sequences from the upstream pseudogenes (ψV, coloured boxes) with similar 
sequences in the functional V region. The ψV gene acting as a template is shown in orange. 
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In summary, AID-mediated deamination of cytosines to uracils is the first 
step that can trigger a number of downstream DNA repair pathways, which can 
result  in  the  simple  repair  of  the  lesion,  mutations  in  or  near  the  lesion  or 
recombinational events such as gene conversion or class switch recombination 
(Figure 6). 
 
 
Figure 6. Differential processing of AID-induced lesions leads to SHM, iGC or CSR. AID 
deaminates cytosines in the Ig locus leading to U:G mismatches that can be processed by Uracil-
DNA  glycosylase (UNG)  or  mismatch  repair  proteins  MSH2/6.  These  DNA  repair  pathways 
cooperate with distinct sets of DNA repair factors that are involved in processing AID-induced 
lesions into  mutations  for SHM, V-pseudogene templated gene conversion  or DSB repair for 
CSR. SHM process can be divided into several phases (Phase 1A, 1B or Phase 2), depending on 
the mechanism of the mutation generation process. Modified from (Neuberger et al., 2003). 
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1.7 APOBEC family members. 
In  addition  to  AID,  the  AID/APOBEC  family  (comprising  of  APOBEC1, 
APOBEC2, APOBEC3(s) and APOBEC4) contains members that can deaminate 
cytosine
  in  DNA  and/or  RNA  and  exhibit  diverse  physiological  functions 
[Reviewed in (Chiu and Greene, 2008; Harris and Liddament, 2004)]. APOBEC1 
is an RNA cytidine deaminase, which edits apolipoprotein B RNA, deaminating
 
C
6666 to U, thereby creating a premature stop codon and potentiating
 the tissue-
specific production of a truncated apolipoprotein
 B involved in lipid metabolism 
(Navaratnam  et  al.,  1993;  Teng  et  al.,  1993). On  the  other  hand,  APOBEC2 
protein  shows  a  muscle  specific  expression,  but  its  function,  similarly  to 
APOBEC4, remains unknown (Liao et al., 1999; Rogozin et al., 2005). However, 
Apobec2 and Apobec3 double knock-out mice reveal  no obvious phenotypes, 
suggesting that these genes are not essential for the viability or fertility of the 
organism (Mikl et al., 2005), although Apobec3 has been shown to inhibit the 
movement of retrotransposable elements (Chiu and Greene, 2008). 
APOBEC3 subgroup of the family has undergone a significant expansion in 
higher  mammals,  especially  in  primates  (Figure  7)  (Conticello  et  al.,  2005). 
Mouse has only one Apobec3 gene, whereas the human genome encodes at least 
eight APOBEC3 members, named APOBEC3A-H [Reviewed in (Holmes et al., 
2007b)]. Several APOBEC3 proteins have been shown to function as cellular 
factors for restricting retroviral infection. APOBEC3G protein is included during 
the packaging of the HIV virion and carried with newly produced viral particles 
to  a  new  target  cell  (Sheehy  et  al.,  2002).  Upon  infection  of  the  new  cell, 
APOBEC3 protein triggers the deamination of cytosine residues to uracils in the 
first cDNA strand of the replicating retroviral genome (Harris et al., 2003). One 
function of the uracils is as a template for the incorporation of second-strand 
adenines, thereby fixing the lesions as G to A hypermutations. This process leads 
to a detrimental level of mutations in the viral genome, decreasing the viability of 
the virus. In addition, APOBEC proteins can inhibit retroviral infections by a 
deamination independent mechanism that likely involves the direct inhibition of 
the  viral  reverse  transcriptase  (Bishop  et  al.,  2006;  Chiu  and  Greene,  2008; 
Newman et al., 2005). Besides APOBEC3G, anti-retroviral (e.g HIV) functions 
have also been attributed to several other APOBEC3 proteins, such as human   27
APOBEC3B  and  APOBEC3F  and  non-human  APOBEC  proteins  like  rat 
Apobec1 and mouse Apobec3 (Holmes et al., 2007a). APOBEC3G is in a large 
complex with ribonucleoproteins, found in cytoplasmic structures called P-bodies 
and stress granules (Chiu et al., 2006; Gallois-Montbrun et al., 2007; Kozak et al., 
2006).  The  importance  of  APOBEC3  mediated  retroviral  restriction  is 
substantiated  by  the  presence  of  Vif  (virion  infectivity  factor)  gene  in  the 
genomes of human and rodent immunodeficiency viruses. VIF protein leads to 
the degradation of APOBEC3 protein, thereby decreasing the pool of this protein 
(Sheehy et al., 2002). This disables the cellular defence mechanisms against viral 
infections (Yu et al., 2003). 
 
 
 
Figure 7. Phylogenetic relationship of the APOBEC gene family. AID and APOBEC2 are the 
ancestral members of the family, found in primates, birds as well as bony fish. APOBEC1 and the 
APOBEC3 subfamily (APOBEC3A to 3H) have later evolved from AID via gene duplications in 
mammals. This has culminated in primates and human, which have at least 12 APOBEC family 
members. APOBEC3A-H inhibit retroviral infection and the spreading of transposable elements. 
AID  is required  for  somatic  hypermutation,  class  switch  recombination  and  gene  conversion. 
Additionally, it may also limit the propagation of transposable elements. APOBEC1 is involved in 
lipid metabolism. The origin and function of APOBEC2 and APOBEC4 is unknown. Adapted 
from (Conticello et al., 2007). 
 
 
In  addition  to  fighting  off  exogenous  retroviral  infections,  APOBEC3 
proteins also block the movement of endogenous retrotransposable elements such 
as long interspersed nuclear element 1, short interspersed nuclear elements and   28
Alu  sequences  (Muckenfuss  et  al.,  2006;  Stenglein  and  Harris,  2006). 
Retroelements have a common step in their life cycle, the self-replication via an 
RNA transcript that is copied into single-stranded DNA by reverse transcription, 
which become the target for APOBEC3 proteins (Esnault et al., 2005). 
Evolutionarily, AID/APOBEC family is found in vertebrates with homologs 
of  AID  and  of  APOBEC2  identifiable  in  bony  fish,  birds,  amphibians,
  and 
mammals  (Figure 7)  (Conticello  et al., 2005). Thus,  AID and  APOBEC2  are 
likely  to  be  the  ancestral
  members  of  the  AID/APOBEC  family  and  both 
APOBEC1  and APOBEC3  are  mammal-specific derivatives  of  AID.  Whether 
AID stems from APOBEC2 or vice versa, is still unknown. 
 
1.8 DNA deamination and cancer. 
The spontaneous deamination of cytosine (as well as of 5-methyl cytosine) in the 
genome can contribute to both somatic and germline mutations [Reviewed  in 
(Lindahl,  1993)].  A  similar  danger  of  mutations  arises  from  the  enzymatic 
activities of DNA deaminases. Indeed, mistargeted SHM by AID has been shown 
to contribute to lymphomagenesis, by mutating regulatory and coding sequences 
in proto-oncogenes and tumor suppressor genes, and by promoting chromosomal 
translocations  (Pasqualucci  et  al.,  2001;  Ramiro  et  al.,  2004).  Many  B-cell 
malignancies harbor chromosomal translocations in which proto-oncogenes are 
rearranged into the Ig  loci.  In a  high  proportion  of  Burkitt's  lymphomas,  the 
breakpoints of translocations in the Ig heavy chain locus occur within one of the 
switch regions, which strongly suggests, that they are the products of aberrant 
switch  recombination  (Rabbitts  et  al.,  1984).  For  instance,  the  c-myc  proto-
oncogene  undergoes  both  aberrant  hypermutation  and  translocation  in  B-cell 
tumors  (Pasqualucci  et  al.,  2001).  Moreover,  AID  is  required  for  c-myc 
translocation leading to tumorigenesis in a murine model for Burkitt's lymphoma 
(Ramiro et al., 2004; Robbiani et al., 2008). Even though electron microscopic 
imaging has revealed that G-loops form within the transcribed c-myc gene, with 
structures similar to those that form in transcribed S regions (Duquette et al., 
2005), and that these G-loops can act as targets for AID (Duquette et al., 2005), 
the mechanism for AID-induced translocation in vivo is unknown. In addition to   29
c-myc, a small subset of other non-Ig genes undergo aberrant hypermutation or 
translocation in B-cells, including the BCL6, CD95/FAS, RHO/TTF, PAX-5, and 
PIM1 proto-oncogenes (Kuppers and Dalla-Favera, 2001; Muschen et al., 2000; 
Pasqualucci et al., 2001); and two non-oncogenic B-cell receptor genes B29 and 
MB1  (Gordon  et  al.,  2003).  The  mutation  frequency  of  non-immunoglobulin 
genes is ~50–1000 fold lower than that of hypermutated variable regions, with 
the reason for this difference remaining elusive. The acquired mutations resemble 
those  introduced  by  SHM  in  rearranged  variable  regions,  as  they  are 
predominately  transition  mutations  and  are  biased  to  WRC  hotspots. 
Furthermore, the mutation distribution in non-immunoglobulin genes is similar to 
that in hypermutated variable regions (Gordon et al., 2003; Kuppers and Dalla-
Favera, 2001; Muschen et al., 2000; Pasqualucci et al., 2001). 
Artificial retroviral substrates lacking any immunoglobulin element mutate 
when integrated at many positions in the genome of hypermutating B-cell lines 
(Wang  et  al.,  2004)  or  in  Ramos  (Parsa  et  al.,  2007).  Some  insertion  sites 
revealed a high mutation rate compared to others that had a low mutation rate. 
This  would  suggest,  that  AID-mediated  SHM  can  occur  in  many  genomic 
locations,  and  that  targeting  of  SHM  to  immunoglobulin  loci  might  be  less 
specific than previously thought. This is supported by the finding that a balance 
between high fidelity DNA repair and error-prone repair determines whether a 
gene will accumulate AID-induced mutations or not (Liu et al., 2008).  
Interestingly, in addition to B-cell lymphoma (Pasqualucci et al., 2008) and 
multiple myeloma (Chesi et al., 2008), unregulated expression of AID can induce 
various non-B-cell cancers, such as lung and T-cell (Okazaki et al., 2003), liver 
(Endo et al., 2007) and gastric cancer (Matsumoto et al., 2007). These gastric 
cancers have been reported to be triggered by Helicobacter pylori infections and 
are mediated by NFκB dependent upregulation of AID (Matsumoto et al., 2007). 
It  is  possible  that  tissues  or  cell  types  other  than  B-cells,  might  be  more 
susceptible  to  AID  induced  oncogenesis  compared  to  B-cells,  in  which  AID 
expression is naturally high. If AID is transiently expressed in these tissues, it 
may result in translocations and mutations that could give rise to uncontrolled 
proliferation and survival of the cells. Thus, AID might be involved in various 
different malignancies besides lymphocytes, and the mechanisms are just starting 
to be elucidated.   30
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2.1 AIMS. 
AID is essential for normal humoral immune responses via initiating antibody 
diversification. By deaminating cytosines in ssDNA at the immunoglobulin loci, 
AID  triggers  somatic  hypermutation,  class  switch  recombination  or  gene 
conversion. On the other hand, if mis-regulated, AID can contribute to some B-
cell mediated autoimmune diseases or promote cancer.  
 
In order to investigate how AID is regulated in the cell, both on the level of gene 
expression as well as its potential interaction partners, I used three approaches: 
 
1. Since humoral immune responses are a target for hormonal regulation, and 
AID expression has been found in some hormone responsive tissues, I examined 
the possibility that AID expression could be affected by hormones estrogen and 
progesterone.  
 
2. In order to glean insight to the network of proteins that form a complex with 
AID,  and  therefore  modulate  its  function  in  B-cells,  I  aimed  to  study  AID 
localization and to identify AID-interacting proteins in an unbiased manner using 
endogenously tagged AID.  
 
3. To set up a system for investigating DNA repair pathways that are utilized by 
the cell to fix dU lesions, I aimed to study the consequences of AID activity in 
two model organisms - the  fission  yeast and the nematode. To analyse  DNA 
repair  events  initiated  from  AID-induced  dU  lesions,  I  aimed  to  use  AID 
expressing fission yeast and nematode compromised for meiotic recombination. 
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Chapter 3 
 
MATERIALS AND METHODS 
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3.1 Materials. 
 
- All chemicals in materials section are from Sigma except where indicated. 
- All media or buffers marked with “*” were prepared by CRUK media kitchen. 
 
 
3.1.1 ChIP dilution buffer - 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 
16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl. 
 
3.1.2 Coupling buffer - 0.1M NaHCO3 (pH 8.3), 0.5 M NaCl. 
 
3.1.3 De-staining solution - 10% acetic acid, 40% ethanol.  
 
3.1.4 Dilution and Equilibration Buffer - 20 mM HEPES (pH 7.7), with 1.5 
mM MgCl2, 0.2 mM EDTA, 10 mM KCl and 25% Glycerol. 
 
3.1.5 DT40 Lysis Buffer - 50 mM TrisHCl (pH 7.5), 100 mM NaCl, 50 mM 
KCl, 2 mM MgCl2, 1mM EDTA, 10% Glycerol, 1 tablet of Complete Protease 
Inhibitors  (Roche,  UK)  per  50  ml,  1  Phosphatase  Inhibitor  Cocktail  Tablet 
(Roche, UK) per 10 ml.  
 
3.1.6 DT40 Lysis Buffer+T - DT40 lysis buffer + 0.3% Triton X-100. 
 
3.1.7  DT40  Lysis  Buffer+TB  -  DT40  lysis  buffer+T  +  50  U/ml  Benzonase 
(VWR International, UK). 
 
3.1.8  DT40  Lysis  Buffer+TD  -  DT40  lysis  buffer+T  +  25  U/ml  DNAse  I 
(Roche, UK). 
 
3.1.9 DT40 Lysis Buffer+TDR - DT40 lysis buffer+TD + 0.5 mg/ml RNase A 
(Sigma, UK). 
 
3.1.10 Elution buffer - DT40 Lysis Buffer + 500  g/ml 3xFLAG peptide.  
   34
3.1.11  EMM:  Edinburgh  minimal  medium*  -  3  g/l  potassium  hydrogen 
phthalate  (final  concentration  14.7  mM),  2.2  g/l  Na2HPO4  (15.5  mM),  5  g/l 
NH4Cl  (93.5  mM),  20  g/l  glucose  (2%);  20  ml/l  salt  solution  [52.5  g/l 
MgCl2*6H2O (0.26 M), 0.735 g/l CaCl2*2H2O (4.99 mM), 50 g/l KCl (0.67 M), 
2 g/l Na2SO4 (14.l mM)]; 1 ml/l vitamins [1 g/l pantothenic acid (4.20 mM), 10 
g/l nicotinic acid (8l.2 mM), 10 g/l inositol (55.5 mM), 10 mg/l biotin (40.8 
 M)]; 0.1 ml/l minerals [5 g/l boric acid (80.9 mM), 4 g/l MnSO4 (23.7 mM), 4 
g/l ZnSO4.7H2O (13.9 mM), 2 g/l FeCl2*6H2O (7.40 mM), 0.4 g/l molybdic acid 
(2.47 mM), 1 g/l KI (6.02 mM), 0.4 g/l CuSO4*5H2O (1.60 mM), 10 g/l citric 
acid  (47.6  mM)].  The  media  was  supplemented  with  225  mg/l  amino  acids 
(adenine,  leucine,  histidine,  lysine,  uracil)  according  to  the  experimental 
requirements. Solid media was made by adding 2% Difco Bacto Agar.  
 
3.1.12 EMSA binding buffer - 20 mM HEPES (pH 7.8), 50 mM KCl, 10% 
glycerol, 0.25 mM DTT, 0.1 mM EDTA, 0.55 µg of poly(dI-dC) (GE Healthcare, 
UK) and 0.25 pmol of labeled oligonucleotides. 
 
3.1.13 Extraction buffer - 20 mM HEPES (pH 7.7), 1.5 mM MgCl2, 0.42 M 
NaCl,  0.2  mM  NaCl,  0.2  mM  EDTA  and  25%  glycerol  supplemented  with 
Complete Protease Inhibitors and 1 mM DTT. 
 
3.1.14 High salt immune complex wash buffer - 0.1% SDS, 1% Triton X-100, 
2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 500 mM NaCl. 
 
3.1.15 Isotonic lysis buffer - 10 mM TrisHCl (pH 7.5), 2 mM MgCl2, 3 mM 
CaCl2,  and  0.32  M  sucrose  supplemented  with  1  Protease  Inhibitor  Cocktail 
Tablet per 50 ml. 
 
3.1.16 5xKCM - 500 mM KCl, 150 mM CaCl2, 250 mM MgCl2. 
 
3.1.17  LB-agar  plates* - 1% peptone, 0.5%  yeast  extract,  0.5%  NaCl,  1.2% 
bacto agar, 50 mg/L selection marker (pH 7.0). 
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3.1.18 LiCl immune complex wash buffer - 0.25M LiCl, 1% IGEPAL CA630, 
1% deoxycholic acid, 1 mM EDTA, 10 mM Tris-HCl (pH 8.1), TE buffer [10 
mM Tris-HCl (pH 8.0), 1 mM EDTA]. 
 
3.1.19 Low salt immune complex wash buffer - 0.1% SDS, 1% Triton X-100, 2 
mM EDTA, 20 mM Tris-HCl (pH 8.1), 150 mM NaCl. 
 
3.1.20 Lysis buffer for single worm PCR - 50 mM KCl, 10 mM Tris pH 8.3, 
2.5 mM MgCl2, 0.45% IGEPAL CA 630, 0.45% Tween-20, 0.01% Gelatin with 
proteinase K (1 mg/ml). 
 
3.1.21 6 x loading dye - 1.3 mM bromophenol blue, 1.7 mM xylene cyanol FF, 
60% glycerol, 5 mM EDTA. 
 
3.1.22 Myo B medium* - 500 g Bactotryptone was mixed with 217 g NaCl, 60 g 
TrisHCl, 26 g Tris (base) and 6.9 g Cholesterol. 7.2 g from the mixture was used 
per 1 liter of medium, supplemented with 20 g agar.  
 
3.1.23  NGM  Classic  -  NGM  Classic  Agarose  plates  seeded  with  RNAi 
expressing  bacteria  were  used  for  RNA  interference  (RNAi)  experiments  for 
nematode. 12 g NaCl, 64 g Agar (Difco Bacto-Agar) and 10 g Bacto-peptone 
were dissolved in 4 L of water, followed by autoclaving. This was allowed to 
cool down to 60 ºC and then, 4 ml cholesterol (5 mg/ml in 95% ethanol), 4 ml 
1M  MgSO4,  4  ml  1M  CaCl2,  100  ml  HPO4  (pH  6.0),  Isopropyl  β-D-1-
thiogalactopyranoside (IPTG; final concentration 6 mM) and plasmid antibiotics 
(ampicillin 25  g/ml) were added to the solution and mixed. Approximately 10 
ml NGM Classic media was poured into each Petri dish and stored at 4 ºC 1-3 
days prior to seeding with RNAi expressing bacteria. 
 
3.1.24 PBS buffer* - 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM 
NaCl (pH 7.4). 
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3.1.25 5 x SDS sample buffer - 2% SDS, 50% glycerol, 0.2% bromophenol blue, 
40 mM DTT, 250 mM Tris (pH 6.8). 
 
3.1.26 SDS lysis buffer for ChIP - SDS 1%, 10 mM EDTA, 50 mM Tris-HCl 
(pH 8.1). 
 
3.1.27  Staining  solution  -  Coomassie  Brilliant  Blue,  25%  isopropanol,  10% 
acetic acid. 
 
3.1.28 Southern blot denaturing buffer - 0.5 M NaOH + 1.5 M NaCl. 
 
3.1.29 Southern blot SSC wash buffer - 0.1x SSC + 0.1% SDS. 
 
3.1.30  Southern  blot  transfer  buffer  -  20x  SSC  stock*:  3  M  NaCl,  0.3  M 
N3citrate∗2H2O. pH adjusted to 7.0 (with 1 M HCl). 
 
3.1.31 TBE electrophoresis buffer - A 10x TBE stock was made and diluted as 
necessary, 109 g of Tris base, 55 g Boric acid and 4.65 g EDTA was diluted in 1 
litre dH2O and pH was adjusted to 8.3. The final concentration of TBE buffer was 
89 mM Tris, 89 mM boric acid, 1.25 mM EDTA (pH 8.3). 
 
3.1.32 TBS buffer - 140 mM NaCl, 25 mM Tris, 2.7 mM KCl, (pH 7.4).  
 
3.1.33 TBS-T buffer - 140 mM NaCl, 25 mM Tris, 2.7 mM KCl, 0.05% Tween-
20 (pH 7.4). 
 
3.1.34 TE buffer* - 1 mM EDTA, 10 mM Tris (pH 7.5). 
 
3.1.35 TSB solution - LB (pH 6.1) (adjusted with HCl), 10% PEG-3350, 5% 
DMSO, 10 mM MgCl2, 10 mM MgSO4.  
 
3.1.36 2xTY* - 16 g/l Bacto-tryptone (Difco, UK), 10 g/l Bacto-yeast extract 
(Difco, UK), 5 g/l NaCl. Autoclaved.    37
 
3.1.37 Tris-glycine Transfer Buffer for western blot - 40 ml of 25x transfer 
buffer stock [12 mM Tris-base, 96 mM Glycine (pH 8.3)]. 
 
3.1.38 YE5S*: Yeast Extract with supplements - 5 g/l  yeast extract, 30 g/l 
glucose, supplemented with 225 mg/l of adenine, histidine, leucine, uracil and 
lysine hydrochloride. Solid YE5S media was obtained by adding 2% Difco Bacto 
Agar  to  the  solution.  YES  +  5  mg/l  phloxin  B  (Sigma,  UK)  was  used  for 
investigating the ploidy of the cells. Phloxin B was added from a 5 g/l stock 
solution in sterile distilled water, when the medium had cooled below 60 ºC.  
 
3.1.39 Western blot blocking solution - 4% milk powder in TBS-0.05% Tween 
20. 
 
3.1.40 Western blot washing buffer - TBS-0.05% Tween 20. 
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3.2 Methods. 
 
 
3.2.1 Molecular biology based methods. 
 
3.2.1.1 Bacterial transformation. 
Conventional E. coli chemical transformation was carried out as follows: 2-3  l 
of plasmid was added to 100  l competent DH5α strain or Stbl cells (Invitrogen 
Ltd, UK) and mixed gently. Bacteria were incubated on ice for 20-30 minutes and 
heat shocked at 42 ºC for 90 seconds. Bacteria were then kept on ice for 1-3 min. 
1 ml of LB medium was added to bacteria and incubated 30-50 min at 37 ºC. 50 
 l of cell solution was spread streaked on LB plates with appropriate antibiotics 
and grown at 37 ºC. 
 
For TOP10 strain transformation, 3  l DNA was added to a vial of TOP10 cells 
(Invitrogen Ltd, UK), incubated for 20 min on ice and then heat shocked at 42 ºC 
for 30 seconds and placed on ice for 2 min. The cells were incubated in 200  l 
SOC media at 37 ºC for 50 min and then plated on LB plates with appropriate 
antibiotics and grown at 37 ºC.  
 
Transformation of MAX Efficiency Stbl2 Competent Cells (Invitrogen Ltd, UK) 
was carried out according to manufacturer’s instructions. Briefly, 3  l DNA was 
added to 100  l of competent cells, incubated on ice for 30 min, heat shocked at 
42 ºC for 25 seconds and placed on ice for 2 min. The cells were incubated in 900 
 l  SOC  medium  at  30  ºC  for  60  min,  plated  on  LB  plates  with  appropriate 
antibiotics and incubated at 30 ºC.  
 
3.2.1.2 DNA digestion with restriction enzymes. 
Samples were prepared in a total reaction volume of 30  l by mixing 1  g of 
DNA with 0.3  l 100 x BSA, 10 U restriction enzymes and 3  l of 10 x buffer 
compatible for enzymes that were being used. The sample was then  vortexed 
briefly, centrifuged for 3 seconds at 13,000 rpm and incubated at 37 ºC for 3   39
hours (if the samples were incubated overnight then 5 U of restriction enzyme 
was used). After incubation the enzymes were heat inactivated at 65 ºC for 20 
minutes. All enzymes were from NEB, USA. 
 
3.2.1.3 Phosphorylation of the 5’ termini of DNA. 
Approximately 500 pmol of DNA was mixed with 2  l of 10 x T4 ligase (NEB, 
USA) buffer, 10 U of T4 Polynucleotide Kinase (NEB, USA) and dH2O to give a 
20  l final volume. After incubating the reaction for 1 hour at 37 ºC, the enzyme 
was heat inactivated by incubating the sample at 65 ºC for 20 minutes or DNA 
purified by gel extraction (see 3.2.1.8). 
 
3.2.1.4 De-phosphorylation of the 5’ termini of DNA. 
Approximately 500 ng of DNA was mixed with 2  l of 10 x NEBuffer, 10 U of 
Calf Intestinal Alkaline Phosphatase (CIP) (NEB, USA) and dH2O to give a 20  l 
final volume. The sample was then incubated for 1 hour at 37 ºC and the DNA 
purified by PCR purification (see 3.2.1.15) or gel extraction. 
 
3.2.1.5 DNA ligation. 
Ligation reaction was performed in 20  l by mixing 2  l 10 x T4 DNA ligase 
buffer (containing 10 mM ATP), approximately 100 ng of digested backbone and 
DNA  insertion  fragment  in  a  molar  excess  of  3-10  times  compared  to  the 
backbone (for two insert ligations into the backbone 4 times molar excess was 
used for inserts compared to the backbone). 400 U of T4 DNA ligase (NEB, 
USA)  was  added  to  the  reaction,  sample  was  mixed  and  incubated  at  16  ºC 
overnight.   
 
3.2.1.6 Colony PCR. 
A single bacterial colony was suspended in 50  l LB medium. The PCR reaction 
was set up as follows: 1  l of bacterial suspension in LB was added to a 29  l 
PCR reaction that included the primers at 1.34  M, 3 l 10x Taq buffer, 1.5 mM 
MgCl2, dNTP’s each at 0.125 mM and 2.5 U of Platinum Taq DNA polymerase   40
(Stratagen, UK). The reaction was initially denatured at 95 ºC for 2 min, followed 
by 36 cycles of denaturation at 94 ºC for 30 seconds, annealing at 58 ºC for 1 
min, extension at 72 ºC for 2 min before a final extension at 72 ºC for 8 min to 
generate the PCR product. The acquired PCR product was run on a 1% or 1.5% 
agarose gel for verification purposes. 
 
3.2.1.7 Agarose gel electrophoresis. 
Agarose was dissolved in TBE buffer, allowed to cool down to approximately 60 
ºC, and ethidium bromide was added to 10  g/ml. The gel was run in 1 x TBE 
buffer  with  0.5   g  of  DNA  ladder  (1  kb  DNA  ladder  or  λ  phage  ladder; 
Invitrogen, UK). Analysis was carried out using Gel Doc 2000 camera and Gel 
Doc software (Bio-Rad, UK) by exposing the gel to ultra violet light.  
 
For DNA gel isolation, the agarose gel was prepared without ethidium bromide, 
and post run stained with DNA SYBR Green (1:10,000) in TBE for 15 minutes at 
RT. DNA was visualized with UV/BLUE converter plate, cut out with a scalpel 
and subjected to gel extraction.  
 
3.2.1.8 Gel extraction of DNA. 
DNA was then extracted from the gel slice using a QIAquick Gel Extraction kit 
(Qiagen,  Germany)  with  a  microcentrifuge  according  to  the  manufacturer’s 
instructions. DNA was then eluted in either 50  l or 30  l of elution buffer EB, 
depending on the concentration of the original plasmid. 
 
3.2.1.9 DNA sequencing. 
0.5   l  ready  Reaction  Premix  (ABI,  USA)  was  mixed  with  4   l  of  ABI 
sequencing buffer (5x) and 3.5  l ddH2O per sequencing reaction and kept on ice. 
This was mixed with 12  l of room temperature ddH2O containing 3.2 pmol of 
primers and 150 ng of plasmid DNA. The reaction was initially denatured at 96 
ºC for 1 min, followed by 25 cycles of denaturation at 96 ºC for 30 seconds, 
primer annealing at 50 ºC for 20 seconds and extension at 60 ºC for 4 min before   41
a final extension at 60 ºC for 7 min. The reaction tubes or plate was briefly 
centrifuged and 5  l of 125 mM EDTA was added. Thereafter, 60  l of 100% 
ethanol was mixed with the reaction and left for 15 min at RT. Samples were 
centrifuged  at  3,250  rpm  for  30  min  at  RT  or at  13,000  rpm  in  a  benchtop 
centrifuge.  Samples  were  inverted  to  remove  the  supernatant.  70   l  of  70% 
ethanol was added and centrifuged at 13,000 rpm for 15 min. The supernatant 
was removed and DNA dried at RT for 30 min.  
 
3.2.1.10 Mini-preparation and sequencing in 96-well plates.  
Individual bacterial colonies from LB plates with antibiotics were picked into 
individual wells  of  the  96-well  plates  containing  1.2 ml  of  LB  medium.  The 
plates were covered with an adhesive sealing film (ThermalSeal, Sigma, UK) 
with aeration holes and incubated overnight at 37 ºC with constant rocking at 
1300  rpm.  The  bacteria  were  then  pelleted  at  3,000  rpm  for  15  min,  the 
supernatant decanted and plates stored at -80 ºC until mini-preparation. Mini-
preparation  and  sequencing  in  96-well  plates  were  performed  at  the  LRI 
sequencing facility. 
 
3.2.1.11 Mini-preparation of plasmid DNA. 
3 ml of LB medium with ampicillin (50 mg/l) or kanamycin (50 mg/l) was placed 
in a 5 ml polystyrene round-bottom tube (BD Falcon
TM) and inoculated with a 
single transformed E. coli colony. The culture was incubated overnight, shaking 
(225 rpm) at 37 ºC. 2 ml bacteria were harvested at 10,000 rpm for 3 minutes in a 
microcentrifuge. Isolation of plasmid DNA was then carried out using QIAprep 
Spin  Miniprep  Kit  (Qiagen,  Germany)  according  to  the  manufacturer’s 
instructions. DNA was eluted with 50  l Buffer EB (10 mM Tris-Cl, pH 8.5) or 
water, incubating it for 1 minute before centrifuging for 1 minute at 13,000 rpm. 
Plasmid DNA was stored at -20 ºC. 
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3.2.1.12 Midi-preparation of plasmid DNA. 
Single  bacterial  colony  was  inoculated  into  50  ml  LB  medium  containing 
antibiotics (50 mg/l) and incubated for 24 hours at 37 ºC with shaking (225 rpm). 
Isolation  of  plasmid  DNA  was  then  carried  out  using  PureYield  Plasmid 
Midiprep System (Promega, UK) according to the manufacturer’s instructions. 
The  DNA  was  eluted  with 600   l  of  nuclease-free  water by adding  it  to  the 
column and centrifuging it for 5 min at 1,600 rpm. Plasmid DNA was stored at -
20 ºC.   
       
3.2.1.13 Maxi-preparation of plasmid DNA. 
A single bacterial colony was inoculated as a starter culture into 3 ml LB medium 
containing antibiotics (50 mg/l). The starter culture was incubated for 8 hours at 
37 ºC with shaking (225 rpm) and then used for inoculating 100 ml medium. 
Bacteria were grown at 37 ºC for 12-16 hours with shaking (225 rpm). Bacterial 
cells were harvested by centrifugation at 6,000 x g in a Sorval GSA rotor for 15 
min at 4 ºC and supernatant removed by inverting the centrifuge tube. Isolation of 
plasmid DNA was then carried out using QIAGEN Plasmid Maxi Kit (Qiagen, 
Germany) according to the manufacturer’s instructions. DNA pellet was air-dried 
for 10 min and re-dissolved in 0.5 ml TE buffer, pH 8.0. Plasmid DNA was 
stored at -20 ºC.   
 
3.2.1.14 General PCR.  
The general PCR procedure was as follows: 1  l of DNA was added to a 49  l 
PCR reaction that included primers at 0.5  M, 5  l 10x Pfu buffer, 5  l 10x PCR 
enhance, dNTP’s each at 0.4 mM and 2.5 U of Pfu Turbo R°DNA polymerase 
(Stratagene, UK). The reaction was initially at 94 ºC for 2 min, followed by 9 
cycles of 94 ºC for 30 seconds, decreasing “touchdown” 63 ºC by 1 ºC every 
cycle and at 72 ºC for 2 min. Then, 30 cycles at 94 ºC for 30 seconds, at 55 ºC for 
30 seconds and at 72 ºC for 3 min, was applied. PCR was carried out using an 
Eppendorf Mastercycler gradient PCR machine.   43
 
3.2.1.15 PCR purification.  
For purifying PCR products from enzyme, nucleotides and primers, QIAquick 
PCR purification kit (Qiagen, Germany) was used according to manufacturer’s 
instructions. 50  l of Buffer EB or water was used to elute DNA. Alternatively, 
30  l of Buffer EB or water was used to elute DNA in order to increase the 
concentration of the DNA. 
 
 
3.2.2 Methods related to mammalian or chicken cell experiments. 
 
3.2.2.1 Reagents. 
25 µg/ml  lipopolysaccharide  (LPS,  Sigma,  UK),  50 ng/ml  mouse  IL4  (R&D 
Systems Europe Ltd, UK) and 20 ng/ml human transforming growth factor (TGF) 
β1  (R&D  Systems  Europe  Ltd,  UK).  The  concentrations  of  estrogen  [17-β-
estradiol  (Sigma,  UK)],  progesterone  (Sigma,  UK)  are  indicated  in  figure 
legends. Tamoxifen  (Sigma,  UK) was used at  50 nM  unless  stated;  the  final 
concentration  for  cycloheximide  (Sigma,  UK)  was  10  µg/ml,  20  nM  for 
actinomycin  D  (CalBioChem,  USA),  4  µg/ml  for  α-amanitin  (CalBioChem, 
USA) and 10 µM for MG-132 (Sigma, UK). Hormone stocks were prepared in 
DMSO at a concentration of 100 mM, this was then diluted in DMSO to give 
1000 x stock solutions, and final dilutions were made in media (final DMSO 
concentration was less than 0.1 %). Hormone stocks were kept at -80 ºC, other 
reagents at either -20 ºC or 4 ºC according to manufacturer’s guidance. 
 
3.2.2.2 Mammalian cells lines. 
Human cell lines Jurkat, SiHa, T47D, Ramos HS13 (derivate of Ramos), JAR 
and  mouse  B-cells  and  mouse  B-cell  lines  were  cultivated  in  RPMI 
1640+GlutaMax medium (Invitrogen Ltd, UK), cell lines MCF7, JAMA2, HeLa 
and  HepG2  in  E4  medium  and  PC3  in  HAMS  F12  medium.  Media  was   44
supplemented with 10% FCS, 100 U / ml penicillin and 100 µg / ml streptomycin 
(Invitrogen Ltd, UK) and cells grown at 37 ºC with 5% CO2.  
 
3.2.2.3 Chicken DT40 cell line. 
Chicken B-cell derived DT40 cell  line was cultured at 39 ºC with 10% CO2. 
Between 5 x 10
5 and 2 x 10
6 cells / ml were maintained in RPMI 1640+Glutamax 
media  with  heat  inactivated  (30  min  at  55  ºC)  10%  fetal  calf  serum,  heat 
inactivated (30 min at 55 ºC) 1% chicken serum, 50  M β-mercapthoethanol 
(Sigma, UK) and 10 U penicillin / streptomycin. 
 
3.2.2.4 Mouse tissue. 
Mouse tissue samples were derived from freshly sacrificed 8-12 week old female 
unplugged  BALB/c  mice.  Mouse  tissue  was  dissected  (from  2  animals)  and 
passed through cell strainers. Cells were incubated for 6 h in hormone-depleted 
media prior to estrogen treatment for 4 h.  
 
3.2.2.5 Thawing cells. 
A cryotube with cells was thawn and cells immediately transferred to a 15 ml 
falcon tube with 13 ml warm culture medium in it. Cells were centrifuged at 
1,200 rpm for 8 min and the supernatant aspirated, leaving 100  l of media on the 
pellet. The cells were resuspended by tapping the tube gently and transferred to a 
small sized flask with 6 ml culture medium. 
 
3.2.2.6 Freezing cells. 
Cell were grown to approximately 10
6 cells / ml. 5 x 10
6 cells were aliquoted into 
15 ml falcon tubes, centrifuged at 1000 rpm for 5-7 minutes and the supernatant 
aspirated. Cells were gently resuspended in 1 ml ice cold freezing medium (10% 
DMSO in FCS) and transferred into a cryotube. The cells were placed into a 
NALGENE Cryo Freezing Container containing isopropanol, and stored at -80 ºC 
for 72 hours before transferring the vials into liquid nitrogen. 
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3.2.2.7 Culturing cells in suspension. 
Cells were monitored on a daily basis. The requirement for feeding the cells was 
estimated according to cell density, cell morphology and the color of the culture 
medium  from  red  to  orange/yellow.  Cells  were  counted  by  using  the 
haemocytometer.  
Culture media was warmed up at 37 ºC prior to adding it to the cells. For 
chicken  DT40  cells,  2.5  x  volumes  of  media  were  added  each  day.  For 
mammalian cells lines in cell suspension, approximately 2 x volumes of media 
were added each day. For adherent cells, the culture media was aspirated, cells 
rinsed with PBS and cells detached from the surface by trypsin treatment. Cells 
were then counted by haemocytometer and transferred to a new flask with fresh 
culture medium.  
 
3.2.2.8 Hormone depletion from cells. 
Cells were treated for 24 - 72 h (see 3.2.2.25) in hormone-depleted serum: Opti-
MeM Reduced Serum Medium (Invitrogen Ltd, UK) supplemented with 10% 
Charcoal Stripped Fetal Bovine Serum (Invitrogen Ltd, UK), prior to hormone 
treatments.  Opti-MeM  Reduced  Serum  Medium  was  supplemented  with: 
Charcoal  Stripped  Fetal  Bovine  Serum  (Invitrogen  Ltd,  UK);  Non-essential 
amino acids (final concentration and Sigma, UK catalog number): L-Alanine (8.9 
mg/ml - A7469); L-Asparagine (15.0 mg/ml - A4159); L-Aspartic Acid (13.3 
mg/ml - A4534); L-Glutamic Acid (14.7 mg/ml - G8415); Glycine (7.5 mg/ml - 
G7126); Proline (11.5 mg/ml - P5607; L-Serine (10.5 mg/ml - S2600). 
 
3.2.2.9 Isolation of mouse splenic B-cells. 
Mouse splenic B-cells were isolated with Mouse B-cell Negative Isolation Kit 
(Dynal  Biotech,  Norway)  according  to  manufacturer's  instructions.  Mouse 
spleens were transferred to a tube containing 30 ml of RPMI 1640+Glutamax 
with 10% FCS preheated to 18-25 ºC. Spleens were sterilized by placing it twice 
into 70 % ethanol for 1 second and then into media. Tissues were then transferred 
to a wet 70  m cell strainer on top of a 50 ml tube. Cells were macerated through 
the filter using the back of a syringe plunger. After this, the filter was rinsed   46
twice with 5 ml RPMI 1640 10% FCS solution. The tube was filled with cold 
RPMI  1640  10%  FCS  and  centrifuged  at  800  rpm  at  4  ºC  for  10  minutes. 
Supernatant was discarded and cells resuspended in 5 ml room temperature RPMI 
1640 1% FCS. The cells suspension was carefully pipetted on 7 ml Lympholyte 
M (Cedarlane Laboratories Limited, Canada) in a 15 ml tube. The sample was 
then  centrifuged  at  800  rpm  for  20-30  minutes  to  remove  erythrocytes.  The 
interphase with B-cells was collected into a fresh tube. After filling the tube with 
RPMI 1640 1% FCS, cells were centrifuged at 800 rpm for 10 minutes and the 
supernatant removed, leaving 2-3 ml of media on the cells. 120 U of DNAse I 
(Roche, UK) was added per 1 ml cell suspension, mixed gently and incubated on 
a rotator for 15 minutes at RT. The suspension was filtered through a 70  m cell 
strainer and counted for leucocytes. Thereafter, tube was filled with cold RPMI 
1640 1% FCS and centrifuged at 800 rpm at 4 ºC for 10 minutes. Leucocytes 
were suspended in PBS with 0.1% BSA (1 x 10
7 per 100  l) and transferred to a 
15 ml tube. 20  l heat inactivated FCS per 1 x 10
7 leucocytes was added followed 
by  the  addition  of  20   l  of  Antibody  Mix  per  1  x  10
7  cells.  The  mix  was 
incubated for 20 min at 4 ºC. Cells were then washed in 2ml PBS 0.1% BSA per 
1 x 10
7 leucocytes and centrifuged at 800 rpm at 4 ºC for 10 minutes. Supernatant 
was  removed  and  cells  resuspended  in  800   l  PBS  0.1%  BSA  per  1  x  10
7 
leucocytes. Mouse Depletion Dynabeads were washed in PBS 0.1% BSA before 
adding 200  l per 1 x 10
7 leucocytes. Cells were incubated for 15 min at RT with 
gentle rotation. Bead-captured cells were resuspended and 1 ml PBS 0.1% BSA 
added  per  1  x  10
7  leucocytes.  The  tube  was  placed  in  the  magnet  for 
approximately 2 minutes before transferring the supernatant with isolated mouse 
B-cells into a new tube. Cells were diluted in appropriate volume of RPMI 1640 
with 10% FCS and grown at 37 ºC with 5% CO2. 
  
3.2.2.10 Total RNA extraction from cell lines and mouse tissue derived cells. 
The cells were shaken gently, then approximately 2 x 10
6 cells harvested and 
centrifuged in a Beckman Coulter Allegra
TM Centrifuge at 1,500 rpm for 7 min at 
RT. The supernatant was removed and the pellets frozen at -80 ºC for at least 30 
min to aid homogenization. The cell pellet was resuspended in 500  l RNAWIZ 
buffer (Ambion, UK), homogenate incubated at RT for 5 min before the addition   47
of 100  l of chloroform, vortexed for 20 seconds, incubated at RT for 10 min, 
centrifuged at 13,000 rpm in a benchtop centrifuge at 4 ºC for 15 min, and the 
upper aqueous phase was transferred to a new eppendorf tube. 250  l of RNase 
free H2O was added to the aqueous phase, mixed, followed by addition of 500  l 
of isopropanol, mixed thoroughly, incubated at RT for 10 min, centrifuged at 
13,000 rpm at 4 ºC for 15 min, and the supernatant was removed. The pellet 
washed with 500  l of cold 75% ethanol, centrifuged at 13,000 rpm at 4 ºC for 5 
min, the supernatant discarded and the pellet air-dried for 10-15 min before being 
resuspended in 20  l RNase free H2O. All tubes were RNase free and RNase free 
filtered pipette tips were used at all times when preparing and handling RNA. 
RNA samples were stored at -80 ºC. 
Alternatively  RNA  was  extracted  using  the  RNeasy  Mini  kit  (Qiagen, 
Germany)  according  to  manufacturer’s  instructions.  Where  necessary, 
homogenisation of the sample was aided by passing the lysate at least 5 times 
through a 20-gauge needle fitted to an RNase-free suringe. RNA was eluted with 
30   l  of  RNase-free  water  by  centrifuging  the  column  at  13,000  rpm  for  1 
minute. 
 
3.2.2.11 Synthesis of cDNA.  
The  genomic  DNA  was  removed  from  total  RNA  samples  prior  to  cDNA 
synthesis  by  using  Turbo  DNA-free  Kit  (Ambion,  USA)  according  to  the 
manufacturer’s protocol. 2.5  g of total RNA was denatured at 70 ºC for 2 min 
and  then  placed on  ice,  before  adding  5x  first  strand  buffer,  DTT to  a  final 
concentration of 5 mM, dNTPs to a final concentration of 0.4 mM each, 0.1  g 
oligo  dT  primer  (Invitrogen  Ltd,  UK)  and/or  2.5   g  d(N)10  random  primers 
(Promega, UK), 8 U RNase OUT (Invitrogen Ltd, UK), 200 U Superscript III 
reverse transcriptase (Invitrogen Ltd, UK) and the appropriate quantity of RNase 
free H2O to a 20 ul reaction. This was incubated at 37 ºC for 10 min, 50 ºC for 40 
min and then 55 ºC for 10 min. 80 ul of sterile H2O was added to the cDNA 
before incubating at 100 ºC for 2 min. 
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3.2.2.12 Quantitative real time PCR (qRT-PCR). 
The primers for real time PCR were designed by PrimerExpress software, using 
60 ºC as the Tm and 150 bp as the length of the PCR product. Real time PCR 
analysis was carried out using the Abi 7000 Sequence Detection System (Applied 
Biosystems,  UK)  qRT-PCR  machine  and  Abi  software.  Tissue  or  cell  line 
hormone responsiveness was determined by qRT-PCR of GREB1 (gene regulated 
by  breast  cancer  1),  a  known  estrogen-responsive  gene.  The  real  time  PCR 
reaction was as follows: 10  l of SYBRGreen PCR (Qiagen, Germany) reaction 
mixture  was  added  to  9   l  of  RNase  free  water  and  primers  with  a  final 
concentration of 0.5  M. 1  l of cDNA was added to the PCR reaction. First, 
reaction was incubated at 50 ºC for 2 min, then at 95 ºC for 15 min followed by 
40 cycles of melting at 95 ºC for 30 seconds, primer annealing at 56 ºC for 30 
seconds and extention at 72 ºC. Real time PCR primers used in this study are 
listed in Table 1.  
 
Primers SP3029 and SP3030 were used for amplifying
 mouse AID; SP3033 and 
SP3034 for mouse GAPDH; SP3065 and SP3066 for mouse GREB1; SP3067 
and SP3068
 for mouse c-myc. Real time PCR primers used for human AID were 
SP3055 and SP3056; SP3063 and SP3064 for human GAPDH. For amplification 
of  pre-mRNA  of  mouse  AID  the  following  primers  were  used:  SP3069  and 
SP3070 (for amplification of the region 75-226bp), SP3071 and SP3072 (2168-
2318bp),  SP3073  and  SP3074  (4185-4335bp),  SP3075  and  SP3076  (6293-
6443bp),  SP3077  and  SP3078  (7539-7689bp),  SP3079  and  SP3080  (9915-
10065bp).  Human  AID  was  amplified  by  using  SP3055  and  SP3056;  human 
GAPDH  with SP3063 and SP3064. For amplifying AID cDNA  from chicken 
derived  DT40  cells,  oligos  SP3081  and  SP3082  were  used;  for  amplifying 
chicken GADPH, SP3083 and SP3084 were used. 
 
Table 1. Primers used for gene expression analysis by real time PCR. 
Gene  Species  Oligo  Direction  Sequence 
Aid  mouse  SP3029  forward  5’-AACCCAATTTTCAGATCGCG-3’ 
Aid  mouse  SP3030  reverse  5’-AGCGGTTCCTGGCTATGATAAC-3’ 
Gapdh  mouse  SP3033  forward  5’-GCACAGTCAAGGCCGAGAAT-3’ 
Gapdh  mouse  SP3034  reverse  5’-GCCTTCTCCATGGTGGTGAA-3’   49
Greb1  mouse  SP3065  forward  5’-TCCGAGTTCAGAGGTCGGC-3’ 
Greb1  mouse  SP3066  reverse  5’-GTCCTACCTGTTGAGCTCCCACT-3’ 
Aid A  mouse  SP3069  forward  5’-GTCACGCTGGAGACCGATATG-3’ 
Aid A  mouse  SP3070  reverse  5’-AAAGACCTGAGCAGAGGGTGG-3’ 
Aid B  mouse  SP3071  forward 
5’-TTCCCATCTAGGTAACACAGGA 
AGT-3’ 
Aid B  mouse  SP3072  reverse 
5’-TCACCACCACAGTACAGGTA 
AACTC-3’ 
Aid C  mouse  SP3073  forward 
5’-AATAAAA 
TCAACAAAACTGACCCAGC-3’ 
Aid C  mouse  SP3074  reverse  5’-CGAGGGATCAAACTCAAGACATC-3’ 
Aid D  mouse  SP3075  forward  5’-GAGGCCAATGACCGACCAC-3’ 
Aid D  mouse  SP3076  reverse  5’-CCATGGAAGCCAATCTGCA-3’ 
Aid E  mouse  SP3077  forward  5’-GCCACTCAGAGTGAGTGTCAGC-3’ 
Aid E  mouse  SP3078  reverse  5’-GAGGTCGGAGAATTGCAAGTTG-3’ 
Aid F  mouse  SP3087  forward  5’-TCTTGCCTCCTCTTCGCTCA-3’ 
Aid F  mouse  SP3088  reverse  5’-GTCTAAACGAAGTGGGTGGCTC-3’ 
Aid G  mouse  SP3079  forward  5’-GTAAGAGGGTGGCAAAATAGGGA-3’ 
Aid G  mouse  SP3080  reverse  5’-TTTACCAGAACCCAATTCTGGCT-3’ 
Apobec3  mouse  SP3153  forward  5’-TTCCACTGGAAGAGGCCCTT-3’ 
Apobec3  mouse  SP3154  reverse  5'-TCTCCAATCCTTTCCATGGC-3' 
AID  human  SP3055  forward  5’-TCGGCGTGAGACCTACCTGT-3’ 
AID  human  SP3056  reverse  5’-GCCAGGGTCTAGGTCCCAGT-3’ 
GAPDH  human  SP3063  forward  5’-TCACCACCATGGAGAAGGCT-3’ 
GAPDH  human  SP3064  reverse  5’-CAGGAGGCATTGCTGATGATC-3’ 
APOBEC1  human  SP3151  forward  5’-TCCATGAGCTGCTCCATCAC-3’ 
APOBEC1  human  SP3152  reverse  5’-GCCGATTTTGTTGATCCATGT-3' 
APOBEC2  human  SP3134  forward  5'-TGTGGAGCAAGAAGAGGGTGA-3' 
APOBEC2  human  SP3135  reverse  5'-GCTGTCTCTTGGTGGCAGC-3' 
APOBEC3A  human  SP3136  forward  5'-ACACACGTGAGACTGCGCAT-3' 
APOBEC3A  human  SP3137  reverse  5'-GGTCCACAAAGGTGTCCCAG-3' 
APOBEC3B  human  SP3138  forward  5'-GGAGCGGATGTATCGAGACAC-3' 
APOBEC3B  human  SP3139  reverse  5'-CACCTGGCCTCGAAAGACC-3' 
APOBEC3C  human  SP3140  forward  5'-CCAACGATCGGAACGAAACT-3' 
APOBEC3C  human  SP3141  reverse  5'-TCGCAGAACCAAGAGAGGAAG-3' 
APOBEC3D  human  SP3142  forward  5'-TGGCACTGATTGCAACTGACA-3' 
APOBEC3D  human  SP3143  reverse  5'-GGCATGAATGGCTGACCTTC-3' 
APOBEC3F  human  SP3144  forward  5'-ATTCATGCCTTGGTACAAATTCG-3' 
APOBEC3F  human  SP3145  reverse  5'-GCTTTCGTTCCGACCATAGG-3'   50
APOBEC3G  human  SP3146  forward  5'-AAGTGGAGGAAGCTGCATCG-3' 
APOBEC3G  human  SP3147  reverse  5'-AGTAGTAGAGGCGGGCAACG-3' 
APOBEC3H  human  SP3148  forward  5'-CCCGCCTGTACTACCACTGG-3' 
APOBEC3H  human  SP3149  reverse  5'-GGGTTGAAGGAAAGCGGTTT-3' 
AID  chicken  GB3503  forward  5'-GATGCCTTTAAAACTCTGG-3' 
AID  chicken  GB3527  reverse  5'-ATATCCTCCTCGATGTC-3' 
GAPDH  chicken  SP3083  forward  5’-GCACTGTCAAGGCTGAGAACG-3’ 
GAPDH  chicken  SP3084  reverse  5’-GCCTTCTCCATGGTGGTGAA-3’ 
 
 
3.2.2.13 sIgM fluctuation analysis. 
The surface IgM (sIgM) expression was investigated in Ramos HS13 cells (Sale 
and Neuberger, 1998), which contains a stop codon in the lambda locus, with 
reversion mutations resulting in sIgM production. Ramos HS cells were stained 
for cell surface expression of IgM  -chain [(anti-human IgM–FITC (Sigma, UK)] 
and  analysed  with  MoFlo  (Cytomation,  USA)  flow  cytometer.  Single  IgM 
negative cells were sorted into flat-bottom 96-well plates containing 200  l of 
media  and  left  to  grow.  100   l  of  fresh  media  with  appropriate  hormones 
concentrations was substituted for old media every 48 hours. Cells were treated 
with hormones for approximately 20 doublings. Thereafter, cells were once again 
stained for surface expression of IgM  -chain and analysed by flow cytometry. 
 
3.2.2.14 Isolation of genomic DNA. 
Genomic DNA was  isolated from cells using PUREGENE products Genomic 
DNA  Isolation  (Gentra  Systems,  USA)  according  to  manufacturer’s 
recommendations. 50  l of TE (pH 8.0) were added to DNA pellets and left to 
rehydrate overnight at RT. Samples were stored at -20 ºC.  
 
3.2.2.15 PCR amplification of VH, C, CD95/Fas, Sγ γ γ γ3 loci from genomic DNA. 
VH and C regions were cloned and sequenced as published (Sale and Neuberger, 
1998). The amplification of VH and C region from Ramos HS genomic DNA 
was as follows: 50 ng of DNA was added to a 50  l PCR reaction that included   51
the primers VH forward and VH reverse at 20  M, 10x buffer, 10x PCR enhance, 
dNTP’s  each  at  0.4  mM  and  2.5  U  of  Pfu  Turbo  R°DNA  polymerase.  The 
reaction  was  initially  denatured  at 94  ºC for 1 min,  followed by  9  cycles  of 
denaturation at 94 ºC for 30 seconds, decreasing annealing temperature from 68 
ºC by  1 ºC  every  cycle, extension  at  72  ºC for 2 min.  Thereafter, 35  cycles 
denaturation at 94 ºC for 30 seconds, annealing at 63 ºC and extension at 72 ºC 
for 2 min was performed, before a final extension at 72 ºC for 5 min to generate a 
450 bp PCR product. Primer sequences used for VH amplification were VHF (5’-
CCCCAAGCTTCCCAGGTGCAGCTACAGCAG-3’)  and  VHR  (5’-
GCGGTACCTGAGGAGACGGTGACC-3’).  For  amplification  of  Ramos  HS 
genomic  C  region  in  Ig  locus  the  following  primers  were  used:  hCF  (5’-
CCCCAAGCTTCGGGAGTGCATCCGCCCCAACCCTT-3’)  and  hCR  (5’-
CCCCGGTACCAGATGAGCTTGGACTTGCGG-3’).  
 
The human CD95/Fas locus was PCR amplified from isolated genomic DNA as 
published (Muschen et al., 2000). A 750-bp fragment encompassing
 the 5' region 
of  the  CD95/Fas  gene  was  amplified  using  hFas1F  (5'-
ACCACCGGGGCTTTTCGTGA-3')  as  external  forward,  hFas2F  (5'-
TGAGCTCGTCTCTGATCTCG-3')  as  internal  forward,  hFas1R  (5'-
TATCTGTTCTGAAGGCTGCAG-3')  as  external  reverse,  and  hFas2R  (5'-
CGGAGCGGACCTTTGGCT-3')
 as internal reverse primers in a nested PCR at 
an annealing
 temperature of 58 °C. The First PCR reaction contained 20 cycles of 
amplification, followed by 25 cycles during the second PCR reaction. 
 
Genomic DNA was amplified and 750 bp of the Sγ3 region sequenced, using 
previously  published  (Xue  et  al.,  2006)  forward  primer  g3.2F  (5’-
gcgaattcTTGCAACTCC-TAAGAGGAAAGATCCC-3’)  and  reverse  primer 
g3.2R (5’-gcggatcCAGCCTGGTCC-CTACACTCCTAACAAC-3’).  
 
3.2.2.16 c-myc/IgH translocation. 
c-myc/IgH  translocations  were  detected  by  PCR  as  previously  described 
(Kovalchuk et al., 1997; Ramiro et al., 2006), and carried out in collaboration 
with Isora V. Sernández (CNIO, Spain). Briefly, DNA was isolated from p53
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cells after 72 hours of LPS stimulation  in the presence or absence of 50 nM 
estrogen. Two rounds of PCR (primers listed in Table 2) were performed using 
Expand Long Template PCR system (Roche, USA) with primers MycIg1A and 
primers MycIg1B in the first round, and MycIg2A and MycIg2B in the second 
round.  PCR  products  were  separated  on  agarose  gels,  transferred  to  nylon 
membranes and probed with γ-[P
32]-ATP labelled oligonucleotides IgH probe and 
c-myc probe (Table 2). P values were calculated using two-tailed unpaired t test.  
 
Table 2. Primers and probes used in c-myc/IgH tranlocation study. 
MycIg1A  5’-TGAGGACCAGAGAGGGATAAAAGAGAA-3’ 
MycIg1B  5’-GGGGAGGGGGTGTCAAATAATAAGA-3’ 
MycIg2A  5’-CACCCTGCTATTTCCTTGTTGCTAC-3’ 
MycIg2B  5’-GACACCTCCCTTCTACACTCTAAACCG-3’ 
IgH probe  5’-CCTGGTATACAGGACGAAACTGCAGCAG-3’ 
c-myc probe  5’-GCAGCGATTCAGCACTGGGTGCAGG-3’ 
 
 
3.2.2.17 TOPO cloning of PCR products. 
PCR fragments were cloned into TOPO vector using Zero Blunt TOPO PCR 
Cloning Kit (Invitrogen, UK) according to manufacturer’s guidance. Cells were 
plated on LB plates with kanamycin and grown at 37 ºC overnight.  
 
3.2.2.18 Western blot. 
5 x SDS lysis buffer was added to 1 x to protein samples and denatured at 90 ºC 
for 5 minutes. The samples were then left to cool down for 3 minutes, 4 x LDS 
buffer was added to 1 x and the samples incubated at 70 ºC for 10 minutes. 4  l 
of Prestained SDS-PAGE Standand Low Range Ladder (Bio-Rad, UK) or 0.5  l 
of BenchMark Ladder (Invitrogen, UK) was electrophoresed simultaneously with 
the protein samples using either MOPS SDS Running Buffer (Invitrogen, UK) or 
MES SDS Running Buffer (Invitrogen, UK) at 200V for 50 minutes at RT. The 
separated proteins  were  transferred onto  Immobilon-P polyvinylidene  fluoride 
(PVDF)  membrane  (Millipore,  UK)  in  transfer  buffer  in  a  Novex  MiniGel 
transfer apparatus (Invitrogen, UK) at 30 V for 150 minutes on ice. Membranes   53
were blocked with 4% milk in TBS-0.05% Tween 20 (blocking solution) for 30 
min  at  RT  or  overnight  at  4  ºC,  probed  with  primary  antibody  (in  blocking 
solution) for 1 h at RT followed by washing the membrane with TBS-0.05% 
Tween 20 three times for 5 minutes at RT. The membrane was then incubated 
with  HRP-conjugated secondary antibody in blocking  solution for 1 h at RT, 
washed 3 times  with  TBS-0.05% Tween  20 for 5 minutes  at  RT,  and bands 
detected with ECL Plus Western Blotting Detection System (GE Healthcare, UK) 
according to manufacturer’s recommendations. Primary and secondary antibodies 
used for western blotting are listed in Table 3. 
Quantitative  western  blot  was  carried  out  using  the  LI-COR  system, 
according to manufacturer’s instructions. Potein was visualized by IR Dye 680 
and analysed with LI-COR Odyssey Infrared Reader. 
 
Table 3. Antibodies used for western blot.  
Antibody  Concentration / 
dilution 
Mouse monoclonal anti-FLAG M2 (Sigma, F3165)  0.25 µg/ml 
Mouse monoclonal anti-Myc 9E10 (LIF Monoclonal Antibody Service)  0.5 µg/ml 
Mouse monoclonal anti-RACK1 (BD Biosciences, 610177)  0.1 µg/ml 
Rabbit polyclonal anti-PARP1 (Alexis Biochemicals, ALX-210-219-R100)   1/10,000 
Rabbit polyclonal anti-PAR (Trevigen, 4336)   1/1,000 
Mouse monoclonal anti-Tubulin (LIF Monoclonal Antibody Service)  1/10,000 
Goat anti-mouse Ig-HRP conjugate (DakoCytomation, P0449)  1/10,000 
Goat anti-rabbit Ig-HRP conjugate (DakoCytomation, P0448)  1/2,000 
Goat anti-mouse IR Dye 680 (LI-COR Biosciences, 926-32220) 
 
1/15,000 
 
 
3.2.2.19 Circle transcript detection by RT-PCR in mouse B-cells. 
Isolated  splenic  B-cells  were  stimulated  for  up  to  72  h  with  LPS  +  IL4  for 
inducing switching to IgG1 and IgE, LPS + TGF-β for switching to IgA and LPS 
for switching to IgG3. Hormones were added to the cells together with LPS and 
cytokines in fresh media. Primers (Table 4) that were used for detecting IgG1 
(Reina-San-Martin  et  al.,  2003),  IgG3,  IgA  (Kinoshita  et  al.,  2001)  and  IgE 
(Lumsden et al., 2004), have been described previously.  
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Table 4. Primers used for detecting circle transcripts. 
Subclass  Orientation  Sequence 
IgG1  Forward  5’-TCGAGAAGCCTGAGGAATGTG-3’ 
IgG1  reverse  5’-GAAGACATTTGGGAAGGACTGACT-3’ 
IgG3  forward  5'-TGGGCAAGTGGATCTGAACA-3' 
IgG3  reverse  5'-AATGGTGCTGGGCAGGAAGT-3' 
IgA  forward  5'-CCAGGCATGGTTGAGATAGAGATAG-3' 
IgA  reverse  5'-AATGGTGCTGGGCAGGAAGT-3' 
IgE  forward  5'-TTGGACTACTGGGGTCAAGG-3' 
IgE  reverse  5'-CAGTGCCTTTACAGGGCTTC-3' 
 
3.2.2.20 Promoter analysis. 
Bioinformatic  promoter  analysis  was  carried  out  with  the  AliBaba2.1 
transcription  factor  response  element  predicting  program  using  Transfac  4.0 
transcription factor binding site database as a source for constructing matrices. 
Human  AID  promoter  fragments  were  analyzed  using  pE1BLuc  plasmid 
backbone (kindly provided by Göran Akusjärvi, Uppsala University) containing a 
luciferase ORF and a minimal promoter region. Primers (Table 5) approximately 
every 500 base pairs from the human AID transcription start site were used to 
amplify  AID  promoter  regions.  The  PCR  procedure  was  as  follows:  1   l  of 
genomic DNA was added to a 49  l PCR reaction that included primers at 0.5 
 M, 5  l 10x Pfu buffer, 5  l 10x PCR enhance, dNTP’s each at 0.4 mM and 2.5 
U of Pfu Turbo. The reaction was initially at 94 ºC for 2 min, followed by 9 
cycles of 94 ºC for 30 seconds, (decreasing “touchdown” 63 ºC by 1 ºC every 
cycle) and at 72 ºC for 3 min. Then, 30 cycles at 94 ºC for 30 seconds, at 55 ºC 
for 30 seconds and at 72 ºC for 3 min, was applied. Products were cloned into 
pE1BLuc  vector  and  3  µg  DNA  were  transfected  into  SiHa  cells  using 
Lipofectamine 2000 (Invitrogen, UK) according to manufacturer protocols. 24 h 
after transfection, cells were treated with indicated concentrations of hormones or 
TNF-α for 4 h and analyzed thereafter for luciferase signal by using the Dual 
Luciferase  Reporter  Assay  System  (Promega,  UK)  and  Glomax  luminometer 
(Promega, UK). The expression vector containing a dominant negative mutant for 
IκBα (S32A S36A - kindly provided by Felix Randow, MRC-LMB, UK), was 
cotransfected with pE1BLuc constructs where indicated. One 1µg CMV promoter   55
driven Renilla luciferase expression vector (Promega, UK) was included in all 
transfections and used as a control for transfection efficiency. 
 
 
Table 5. Primer sequences for hAID promoter analysis. 
Oligo 
name 
Approximate 
position 
relative to 
transcription 
start 
Direction  Sequence 
SP3089  0bp  forward  5’-CTCGAGGCCAATGCACTGTCAGACTA-3’ 
SP3090  0bp  reverse 
5’-CAGCTGGAAAAATCTCACTTCAATTAATGAT-
GGTTC-3’ 
SP3092  -2000bp  forward  5’-CTCGAGGATGGTGTAAGCCACAACCA -3’ 
SP3093  -1500bp  forward  5’-CTCGAGCAAGAAGAGTAGGTAAGGCAG-3’ 
SP3094  -1000bp  forward  5’-CTCGAGATTTGAAAATCATCAAGGTATAGATG-3’ 
SP3095  -500bp  forward  5’-CTCGAGACTGAGTTCATTTGCTTAACTGCA-3’ 
SP3096  500bp  forward 
5’-CAGCTGTTACAAAATTATTACGAAAATTAGCACT-
ACC-3’ 
SP3099   2000bp  reverse  5’-CAGCTGTCTCTTTGAGGCCCAGTG-3’ 
SP3108  1500bp  forward  5’-CAGCTGTTTCAGGCTTGCAGGCTGACAG-3’ 
SP3101  pE1BLuc  forward  5’-ACATATTGTCGTTAGAACGCGGCTAC-3’ 
SP3102  pE1BLuc  reverse  5’-CCAACAGTACCGGAATGCCAAG-3’ 
 
 
3.2.2.21 Preparation of nuclear extracts. 
For isolating nuclear extracts from 5 x 10
6 Ramos, the Pierce Nuclear Extraction 
Kit  was  used  according  to  manufacturer’s  instructions.  Supernatant  (nuclear 
extract) fractions were stored at -80 ºC.   
 
3.2.2.22 Electro-mobility shift assay (EMSA). 
EMSAs were performed by standard protocol (Ausubel et al., 1987) with minor 
modifications.  Complementary  oligonucleotides  containing  either  NFκB  or 
putative estrogen receptor binding elements (ERE) were annealed to each other 
and  end  labeled  with  [γ-
32P]ATP  by  T4  polynucleotide  kinase  to  a  specific 
activity of ca. 300,000 to 500,000 cpm/ng. Seven µg of nuclear extracts were   56
incubated with the binding mixture containing 20 mM HEPES (pH 7.8), 50 mM 
KCl, 10% glycerol, 0.25 mM DTT (Invitrogen Ltd, UK), 0.1 mM EDTA, 0.55 µg 
of poly(dI-dC) (GE Healthcare, UK) and 0.25 pmol of labeled oligonucleotides 
for 20 min at RT in a total volume of 12 µl. Competition assays included 1-, 3- 
and 10-fold mass excess of unlabeled oligonucleotides. Antibodies to NFκB p65 
(polyclonal - Santa Cruz, USA, sc-109), ERα (monoclonal, Abcam, UK, ab2746) 
or mouse λ (polyclonal, Southern Biotech, USA, 1060-01) were added 10 min 
after starting the reaction (0.2 - 1.8 µg / assay) and incubated for further 20 
minutes at RT. Gels were pre-electrophoresed at 10 mA for 60 min. Samples 
were electrophoresed at 4 ˚C on a pre-run non-denaturing 4.5 % poly-acrylamide 
gels (30:1) in low-ionic-strength TBE buffer (10 mM Tris-borate, pH 7.5; 0.025 
mM EDTA) at 20 mA / gel for 120 min. This was followed by autoradiography 
on  imaging  plates  (FujiFilm,  Japan)  and  analysis  with  a  FLA-5000  Scanner 
(FujiFilm, Japan). 
 
3.2.2.23 Chromatin immunoprecipitation (ChIP). 
Approximately 1 x 10
7 cells were fixed with 1 % formaldehyde in the culture 
media for 10 min at 37 ºC, then quenched with 0.125 M glycine for 5 min at RT. 
Cells  were  pelleted  and  washed  twice  with  cold  PBS.  The  cell  pellet  was 
resuspended in 300 µl SDS lysis buffer [1% SDS, 10 mM EDTA, 50 mM Tris-
HCl (pH 8.1)] and incubated on ice for 10 min. Cell lysates were sonicated for 6 
min with a 30 sec on/off sonication cycle in 1.5 ml eppendorf tubes. Samples 
were centrifuged for 5 minutes at 13,000 rpm at 4 ºC and supernatants diluted to 
1.5 ml with ChIP buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 
mM  Tris-HCl  (pH  8.1),  167  mM  NaCl]  -  an  aliquot  was  kept  as  input 
measurement. Samples were pre-cleared with 60 µl Protein G beads (ProtG - 
Roche, UK) and 1 µg salmon sperm DNA (Invitrogen Ltd, UK) for 45 min at 4 
ºC. Anti-NFκB p65 antibody (Santa Cruz, USA, sc-109), rabbit anti-ERα HC-20 
antibody (Santa Cruz, USA, sc-543x), mouse anti-PR-AB (monoclonal, Abcam, 
UK, ab2764) or goat anti-mouse lambda control antibody (see above) was added 
to the supernatant at a concentration of 2 µg / assay and incubated for 12 h at 4 
ºC. Sixty µl of salmon sperm DNA (1 µg DNA / 20 µl ProtG) was added to the 
samples  and  incubated  for  1  h  while  rotating.  The  ProtG/  antibody/  protein   57
complex was pelleted and washed with the following buffers: 1) low salt wash 
buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 
150 mM NaCl], 2) high salt wash buffer [0.1% SDS, 1% Triton X-100, 2 mM 
EDTA, 20 mM Tris-HCl (pH 8.1), 500 mM NaCl], 3) LiCl wash buffer [0.25 M 
LiCl, 1% IGEPAL CA630, 1% deoxycholic acid, 1 mM EDTA, 10 mM Tris-HCl 
(pH 8.1)], TE buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA], and twice with a 
standard TE buffer. The sample was eluted with 250 µl of elution buffer [1% 
SDS, 0.1 M NaHCO3 (pH 7.5)] and incubated for 15 min at RT with agitation. 
The  beads  were  centrifuged  and  the  elution  was  repeated  once.  Bound 
immunocomplexes  were  then  reverse-crosslinked  with  200  mM  NaCl  by 
incubating it at 65 ºC for 12 h. Ten mM EDTA (pH 8), 40 mM Tris-HCl (pH 6.5) 
and 20 µg of proteinase K was added to the sample and incubated for 1 h at 45 
ºC. DNA was then extracted with phenol/chloroform and precipitated with 130 
mM NaOAc (pH 5.5), 30 µg glycogen (Roche, UK) and 50% ethanol for 2 h at -
20 ºC. The DNA pellet was washed with 70% ethanol, resuspended in 50 µl of 
water  and  subjected  to  qRT-PCR,  using  forward  primer  CHIPEF  (5’-
GCGTGAGCTCTCTCTTGCCT-3’)  and  reverse  primer  CHIPER  (5’-
CACTGCTAATAAAGACATGCCTGAG-3’) for amplifying -1189 to -1039 bp 
of AID promoter region. 
The  following  qRT-PCR  primers  were  used  in  anti-PR  ChIP  studies: 
forward primer CHIP1 and reverse primer CHIP2 for region I, forward primer 
CHIP3  and  reverse  primer  CHIP4  for  region  II,  forward  primer  CHIP5  and 
reverse primer CHIP6 for region III, forward primer CHIP7 and reverse primer 
CHIP8  for region IV,  forward primer CHIP9 and reverse primer CHIP10 for 
region V (Table 6). 
 
Table 6. Primer sequences used for anti-PR ChIP studies. 
CHIP1  forward  5’-GCAGGAAGGCCAGTTGGGAA-3’ 
CHIP2  reverse  5’-GCTCCTCTCTTTCTTTTAAATTCCATGCAC-3’ 
CHIP3  forward  5’-GACAGGCTGGAGGTGCTCAG-3’ 
CHIP4  reverse  5’-GACAGGCTGGAGGTGCTCAG-3’ 
CHIP5  forward  5’-CCACATGTCATGGGAGGGA-3’ 
CHIP6  reverse  5’-GTGGTAGGCAAGAGAGAGCTCAC-3’   58
CHIP7  forward  5’-TCAGGCATGTCTTTATTAGCAGTGT-3’ 
CHIP8  reverse  5’-GATGCAATGCTAAGCAATGCAG-3’ 
CHIP9  forward  5’-GATCTTAGCCTGTTTTCCAAATTCAG-3’ 
CHIP10  reverse  5’-TTTTGCATGAGCCATCTTTTTTAG-3’ 
 
 
3.2.2.24 Lipofectamine transfection of SiHa cells. 
Transfection  of  SiHa  cells  with  Lipofectamine  2000  (Invitrogen,  UK)  was 
performed as suggested by the manufacturer. The day before transfection, cells 
were plated into 96-well plates in a density so that the next day, cells should have 
a  confluency  of  90-95%.  The  media  used  for  Lipofection  was  Opti-MEM 
Reduced Serum Medium. Cells were grown  in Opti-MEM supplemented with 
10%  Charcoal  Treated  Fetal  Bovine  Serum.  Approximately  5  hours  before 
transfection, fresh media with FCS but without antibiotics was added to the cells.  
Lipofectamine was diluted in Opti-MEM medium without serum and incubated 
for 5 min at RT. Plasmid DNA was diluted in Opti-MEM medium without serum 
and combined with Lipofectamine, followed by incubation at RT for 20 min. The 
medium  in  plates  was  substituted  with  serum  free  medium  and  the  DNA-
lipofectamine complexes were added to the wells. The cells were incubated for 6 
hour  at  37  ºC  and  the  medium  was  once  again  substituted  with  medium 
containing 10% FCS. After incubation for 24 hours, fresh media with serum and 
antibiotics were added to the cells. 
 
3.2.2.25 Time and concentration of hormones used during various 
experiments. 
A list of different concentrations of estrogen and progesterone and the time of 
cell treatment for various experiments is indicated in Table 7. 
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Table 7. Treatment of cells with hormones.  
 
Experiment  Cells  Depletion  Hormone  [nM]  h 
AID mRNA  B-cells  24  Estrogen  0.1-1,000  1-8 
      Progesterone  0.1-10,000  1-24 
AID mRNA  Ramos  72  Estrogen  10-100  1-4 
      Progesterone  200-2,000  1-4 
AID mRNA  DT40  48  Estrogen  10-100  1-8 
      Progesterone  200  1-8 
AID pre-mRNA  B-cells  24  Estrogen  1-10  1-8 
      Progesterone  200  1-24 
AID protein  DT40  48  Estrogen  10-100  1-8 
      Progesterone  200  1-8 
AID EMSA  Ramos  72  Estrogen  10  4 
           
AID ChIP  Ramos  72  Estrogen  1-10  4 
      Progesterone  200  4 
SHM  Ramos  72  Estrogen  10-100  3 wks 
      Progesterone  200-2,000  3 wks 
SHM  B-cells  24  Estrogen  10  6 days 
      Progesterone  200  6 days 
CSR (switch circle)  B-cells  24  Estrogen  1-10  48 
      Progesterone  200  48 
CSR FACS  B-cells  24  Progesterone  200  6 days 
           
c-myc/Ig  B-cells  24  Estrogen  50  72 
           
Promoter analysis  SiHa  24  Estrogen  0.1-1,000  4 
      Progesterone  200  4 
Mouse tissues  Various  6  Estrogen  1-10  4 
 
 
3.2.3 Methods for generating endogenously tagged AID DT40 cell 
lines. 
The generation of tagged AID constructs was undertaken in collaboration with 
Gudrun Bachmann. 
 
3.2.3.1 Generating tags. 
Primer  sequences  (Table  8)  for  the  following  tags  were  generated:  3FLAG 
(abbreviated  FLAG),  3Myc  (abbreviated  Myc),  3FLAG-2TEV-3Myc 
(abbreviated FLAG-TEV-Myc) and eGFP (Figure 8).   60
 
Figure 8. A schematic illustration of the tags that were attached to 3’ end of chicken AID. 
The FLAG and Myc epitopes are in three repeats whereas the TEV protease cleavage site is in 
two repeats. The size of each individual tag is shown at the 3’ end of the respective tag. Not 
drawn to scale. 
 
3FLAG: Oligonucleotide F1 and F2 were hybridized and the sample subjected to 
electrophoresis on  a 10% PAGE gel. The gel was stained with SYBR  green, 
visualized with Gel Doc 2000 UV-illuminator and the FLAG fragment cut out of 
the gel. The fragment was melted into a 1.5% agarose gel before being subjected 
to electrophoresis and purification by gel extraction. 
 
3Myc: Oligonucleotide M1 and M2 were hybridized and purified as described for 
3FLAG tag. 
 
3FLAG-2TEV-3Myc: Oligonucleotide FT1, FT2 and FT3 were separately 5’-end 
phosphorylated by T4 polynucleotide kinase (PNK). Thereafter, FT1, FT2 and 
FT3 were hybridized to FT4, FT5 and FT6, respectively, yielding fragment A, B 
and C. Fragment A and B were then ligated by T4 DNA ligase, yielding fragment 
AB. The AB fragment was purified as above. The purified AB fragment was 5’-
end  phosphorylated  and  ligated  to  fragment  C,  yielding  fragment  ABC.  The 
ligation sample was subjected to electrophoresis and purification from the gel. 
The ABC fragment was then ligated to Spe I digested, calf intestinal alkaline 
phosphatase dephosphorylated, gel-purified plasmid containing 3Myc sequence. 
The FLAG-TEV-Myc fragment was amplified by Pfu Turbo°R DNA polymerase 
using forward primer FTM1, reverse primer FTM2 and the ligation sample as the 
template. The PCR parameters were as  follows: denaturation at 94 ºC for 30 
seconds, primer annealing at 53 ºC for 30 seconds and polymerization at 72 ºC   61
for 45 seconds, for 35 cycles. The PCR sample was purified by PCR Purification 
Kit and digested with Spe I and EcoR I. Thereafter, the sample was run on a 1.5% 
agarose gel, followed by purification from the gel. 
 
eGFP: The eGFP open reading frame (ORF) was amplified from a pIRES-eGFP 
vector  by  using  Pfu  Turbo  R°DNA  polymerase,  forward  primer  G1,  reverse 
primer  G2,  and  the  following  PCR  parameters:  denaturation  at  94  ºC  for 30 
seconds, primer annealing at 48 ºC for 30 seconds, polymerization at 72 ºC for 70 
seconds, for 35 cycles. The sample was run on a 1% agarose gel, followed by 
purification from the gel. Thereafter, the fragment was double digested with Spe I 
and EcoR I and purified with the PCR Purification Kit. 
 
Table 8. List of oligos used in generating tags. 
Oligo 
name 
Oligo sequence 
F1  5’-CTAGTGACTACAAGGACCACGATGGCGACTACAAGGAT 
CACGACATCGATTACAAGGACGATGACGACAAGTG-3’ 
F2  5’-AATTCACTTGTCGTCATCGTCCTTGTAATCGATGTCGTGA 
TCCTTGTAGTCGCCATCGTGGTCCTTGTAGTCA-3’ 
M1  5’-CTAGTGAGCAGAAGCTGATCTCCGAGGAAGACCTGGAGCAG-
AAGCTGATCTCCGAGGAAGACCTGGAGCAGAAGCTGATCTCCGA-
GGAAGACCTGTG-3’ 
M2  5’-AATTCACAGGTCTTCCTCGGAGATCAGCTTCTGCTCCAGGTCTT-
CCTCGGAGATCAGCTTCTGCTCCAGGTCTTCCTCGGAGATCAGC-
TTCTGCTCA-3’ 
FT1  5’-TACAAGGACGATGACGAACAAGGATTACGATATCCCAACGAC- 
CGAA-3’ 
FT2  5’-CTTGTAATCGATGTCGTGATCCTTGTAGTCGCCATCGTGGTCCTT-3’ 
FT3  5’-CCTGTATTTTCAGGGCGAAAACCTGTATTTTCAGGGCC-3’ 
FT4  5’-TACAGGTTTTCGGTCGTTGGGATATCGTAATCCTTGTCGTCATCG-3’ 
FT5  5’-CTAGTGACTACAAGGACCACGATGGCGACTACAAGGATCACGACA-3’ 
FT6  5’-CTAGGGCCCTGAAAATACAGGTTTTCGCCCTGAAAA-3’ 
FTM1  5’-CAGGTCGACTCTAGAG-3’ 
FTM2  5’-CTAGGGCCCTGAAAATACA-3’ 
G1  5’-ATGGTGAGCAAGGGC-3’ 
G2  5’-CTTGTACAGCTCGTCC-3’ 
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3.2.3.2 Generating constructs with tagged AID sequence. 
A  part  of  chicken  AID  gene  (Genbank  accession  number  XP_416483)  was 
inserted into a pBluescript plasmid (Figure 9) containing a puromycin resistance 
gene flanked with LoxP sites. The vector was double digested with Spe I and 
EcoR I followed by CIP dephosphorylation, electrophoresis and purification from 
the gel. 
 
 
 
Figure 9. The plasmid containing the chicken AID gene. The pBluescript plasmid contains a 
part of the chicken AID gene and a puromycin (pink) selection cassette. loxP sites, depicted as 
blue triangles, are located at the 5’- and -3’-end of the selection cassette. 5’-arm is 1 kb of the 
intron  between  exon  one  and  exon  two  in  the  chicken  gene,  whereas  -3’arm  stands  for 
approximately 1 kb of the sequence that lies downstream of the AID gene. Exons are depicted as 
light blue, numbered squares. Stop codon is shown as a orange square. ori stands for origin of 
replication and Amp
R for a gene coding for β-lactamase. 
 
 
Next, each tag was ligated into the linearized backbone and transformed 
into bacteria. Clones were cultured and subjected to plasmid purification. The 
purified DNA was verified by Stu I and Nsi I digestion and visualization on an 
agarose  gel  and  also  sequenced  using  the  BigDyer  Terminator  v3.1  Cycle 
Sequencing Kit and primers listed in Table 9. Sequences were analyzed using 
SequencerTM 4.5.  
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Table 9. Primers for sequencing tagged AID constructs. Sequences of HPLC purified primers 
used for sequencing tagged AID constructs. ‘*’ denotes primers used for sequencing construct 
with eGFP tag. 
 
Name  Sequence 
S1  5’-ACCGTTACCTTAAAATACTGC-3’ 
S2  5’-GTCCCTGCTGCTTTAAC-3’ 
S3  5’-GGATATGATGATTTAGTGAGC-3’ 
S4  5’-GATGCCTTTAAAACTCTGG-3’ 
S5  5’-AATTCAGAGGAAGTCATCAG-3’ 
S6  5’-TACAAATGTGGTATGGCTGA-3’ 
S7  5’-ATCTCGGCGAACACC-3’ 
S8  5’-TCACACGCCAGAAGC-3’ 
S9  5’-TGCTCAGCAACTCGG-3’ 
S10  5’-GCGCGCTTCGCTTTT-3’ 
S11  5’-CTATGACAGGTTGAAACTAG-3’ 
S12  5’-TTGGGGTTATGTGAGTTC-3’ 
S13  5’-AAGGGACCCAATCATATCT-3’ 
S14  5’-ACTGTCCACAAAACCAGATA-3’ 
S15  5’-TCAAAAGAACTCACATAACCC-3’ 
S16  5’-GTCTAGTTTCAACCTGTCA-3’ 
S17  5’-TTTCCTTTTATGGCGAGG-3’ 
S18  5’-TCCCCGAGTTGCTGA-3’ 
S19  5’-TTCTCCCTCTCCAGC-3’ 
S20  5’-TGTTCGCCGAGATCG-3’ 
S21  5’-GGATCATAATCAGCCATAC-3’ 
S22  5’-TATTGCTGATGACTTCCTC-3’ 
S23  5’-CTAGTAAGTCCCAGAGTTT-3’ 
S24  5’-TCTCTTCTAGGCTCACTAA-3’ 
S25  5’-CTGAGGTACTGTTAAAGCA-3’ 
S26  5’-GCAGTATTTTAAGGTAACGG-3’ 
S29*  5’-AGGAGGACGGCAACAT-3’ 
S30*  5’-TGTAGTTGTACTCCAGCT-3’ 
m13F  5’-GTTTTCCCAGTCACGAC-3’ 
m13R  5’-GGAAACAGCTATGACCATG-3’ 
 
 
Clones transformed with the  construct containing AID-FLAG-TEV-Myc, 
were picked and resuspended in 2xTY broth. The resuspension was used as a 
template  in  modified  colony  PCR,  using  forward  primer  5’-
CTGCCACTGTATGAAGT-3’, reverse primer 5’-CAGGTCGACTCTAGAG-3’   64
and the following PCR parameters: denaturation at 94 ºC for 30 seconds, primer 
annealing at 50 ºC for 60 seconds, polymerisation at 72 ºC for 45 seconds, for 30 
cycles,  were  applied  after  initial  denaturing  and  lysis  step  at  95  ºC  for  six 
minutes. Positive clones were grown further and used for isolating plasmid and 
sequencing. A similar procedure was carried out for all constructs. Samples were 
sequenced for plasmids and digested with Not I, or Pvu I, followed by ethanol-
precipitation and air drying of the DNA. The DNA pellet was then resuspended 
in sterile PBS buffer.  
 
3.2.3.3 Stable transfection of DT40 cells. 
Newly  thawed  DT40  (CL18
-)  cells  were  incubated  in  filter-sterilized  culture 
medium (10% fetal calf serum, 1% chicken serum, 50-75 µM β-mercaptoethanol, 
0.01% penicillin, 0.01% streptomycin in RPMI 1640+Glutamax media at 39 ºC 
in 10% CO2 for three days. The cells were maintained at a density of 5x10
5-1x10
6 
cells / ml by splitting the culture every day (described above in Cell culturing 
section).  1x10
7  cells  were  then  spun  down  at  90  x  g  for  5-10  minutes  and 
resuspended in RPMI 1640+Glutamax medium (without FCS) to give a 500 µl 
final volume. 25-50 µg of Not I or Pvu I linearized plasmid containing tagged 
AID was added to the culture solution and transferred to a 4 mm electrode gap 
Gene  Pulser  Cuvette.  The  cuvette  was  placed  on  ice  for  10  minutes  and 
electroporated using the following parameters: voltage = 550 V, capacitance = 25 
µF, resistance = ∞, followed by incubating the culture on ice for five minutes. 
The cells were transferred to a flask, containing filter-sterilized culture medium 
with serum and incubated for 8 hours at 39 ºC in 10% CO2. The culture was then 
dispensed into 96 well flat bottom plates and incubated overnight. Puromycin 
was thereafter added to each well, to a final concentration of 50 µM, and the 
plates incubated for 5-7 days. Clones were fed or splitted every day until reaching 
high density. The overall scheme for generating endogenously tagged AID DT40 
cell lines is shown in Figure 10. 
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Figure 10. Endogenous tagging of AID in DT40. Schematic representation of the targeting of 
chicken AID locus with the tagged AID construct (AID-tag). A targeting construct that contains a 
part of chicken AID genomic locus, an in-frame tag (red rectangle) and a puromycin selection 
cassette (white rectangle) between two loxP sites (blue triangles) is targeted into chicken AID 
allele by homologous recombination. After confirming the targeting of the  allele  by southern 
blotting, puromycin cassette is removed by Cre recombinase. 
 
3.2.3.4 Verifying stably transfected DT40 cell lines. 
A southern blotting probe was prepared by PCR amplifying a part of the AID 
gene  using  Pfu  Turbo°R  DNA  polymerase,  forward  primer  Pa1  (5’-
CTTATGACTGTGCCCGACATG-3’),  reverse  primer  Pa2  (5’-
CTGCTCCAGAGAGGACAC-3’) and the generated FLAG-tagged plasmid as a 
template. The PCR parameters were the following: denaturation at 94 ºC for 30 
seconds, primers were annealed at 57 ºC for 30 seconds, polymerization at 72 ºC 
for 60 seconds, for 35 cycles. Genomic DNA from 6-9x10
6 cells was purified 
using the PUREGENE DNA Isolation Kit followed by digestion with Mph1103I 
endonuclease or with Spe I. The digested DNA was subjected to electrophoresis 
on a 0.7% agarose gel. This was followed by incubating the gel in denaturation 
buffer (0.5 M NaOH, 1.5 M NaCl) for 45 min at RT with constant agitation. The 
DNA was then blotted to a Hybond-N+ membrane, the membrane washed in 
2xSSC (30 mM trisodium citrate, 300 mM NaCl) and exposed to 0.12 joules of   66
UV light using an UV-crosslinker. The membrane was placed in a roller bottle, 
65 ºC warm ExpressHyb solution was added to the bottle and incubated at 65 ºC 
for  one  hour.  The  probe  was  [α
32P]  dCTP  labelled  using  RediprimeTM  II 
Random Primer Labelling System. Thereafter, the radioactive probe was mixed 
with 5 ml ExpressHyb solution, added to the roller bottle and incubated at 65 ºC 
for  2  hours.  The  membrane  was  washed  in  wash  buffer  (1.5  mM  trisodium 
citrate, 15 M NaCl, 0.1% SDS) at 65 ºC, followed by exposing the membrane to a 
phosphorimager cassette. The radioactive signal was detected with a FLA 5000 
phosphorimager.  
 
3.2.3.5 Transient transfection of DT40 cells with Cre recombinase. 
3x10
6 cells were centrifuged at 1000 rpm for 5-10 minutes, the medium was 
aspirated and cell pellet resuspended in 100  l supplemented NucleofectorTM 
Solution from the cell line Nucleofector°R kit (Amaxa, UK). This was mixed 
with 4  g of pCMV Cre plasmid, or 2  g pmaxGFP plasmid. The sample was 
transferred  to  an  Amaxa  cuvette,  electroporated  using  B023  NucleofectorTM 
program, the cells transferred to a 6 well plate containing culture medium and 
incubated for 30 hours. The transfection efficiency was then analyzed by GFP 
detection  by  flow  cytometry.  Next,  the  pCMV  Cre  transfected  cells  were 
dispensed into 96-well flat bottom plates, one clone per well, and incubated for 
10 days. Each colony of clones was then divided into two wells and puromycin 
was added (final concentration 50 µM) to one of the duplicates, followed by 
incubation for 2-3 days. The wells that contained puromycin, were investigated 
for cell growth and survival by visual estimation.  
 
3.2.3.6 Verifying puromycin sensitive clones by southern blot. 
A southern blot probe was amplified from the FLAG-tagged plasmid with Pfu 
Turbo  R°  DNA  polymerase,  using  forward  primer  Cre1  (5’-
GGGAACGCACTTTCACAG-3’),  reverse  primer  Cre2  (5’-
CATCTACAAGCTGTACAGCTTC-3’)  and  the  following  PCR  parameters: 
denaturation at 94 ºC for 30 seconds, primer annealing at 55 ºC for 30 seconds, 
polymerization at 72 ºC for 60 seconds, for 35 cycles. The PCR product was   67
verified on a 2% agarose gel and purified with the QIAquick PCR Purification 
Kit. The probe was verified by cutting with BsmA I. Genomic DNA from 6-
9x10
6 cells was then digested with Kpn I or Mfe I and analyzed with southern 
blotting as previously described.  
 
3.2.3.7 Investigating Cellular Localization of AID. 
eGFP-tagged AID DT40 cells were pre-treated with 10-25 ng/mL leptomycin B 
(LMB) for 2.5-5 hours prior to fluorescence microscopy. 15  l of (in PBS buffer) 
cells were incubated with or without 0.5  l/ml DRAQ5TM before mounting them 
onto poly-L-lysine coated microscope slides. The cells were investigated with 
DeltaVision  de-convolution  microscope  using  the  Softworx  3.5  software  and 
applying the following parameters: magnification=60-100x, eGFP-λEX=490 nm, 
eGFP-λEM=528 nm, DRAQ5
TM-λEX=555 nm, DRAQ5
TM-λEM=617 nm. 
 
 
3.2.4 Methods related to identification of AID-interacting 
proteins. 
 
3.2.4.1 Cross-linking antibodies to CNBr-activated Sepharose 4B. 
The cross-linking of antibodies was carried out using CNBr-activated Sepharose 
4B (GE Healthcare, UK) according to the manufacturer instructions using anti-
Myc 9E10 at 10 mg antibody per 1 ml sepharose gel.  
 
3.2.4.2 Cell fractionation in DT40. 
DT40  cells  were  harvested  at  1,200  rpm  for  10  min,  the  supernatant  was 
discarded and cell pellet washed with 50 ml cold PBS and repeated once. The 
whole procedure was carried out in the cold room (4 °C), except where indicated. 
For cytoplasmic lysis, 5 times packed cell volume (1 ul PCV = 10
6 cells) 
equivalent of Isotonic Lysis Buffer [see 3.1.15, also in (Buerstedde and Takeda, 
2006)] was added to the cell pellet, resuspended gently and then incubated for 12 
min on ice to allow the cells to swell. To the swollen cells, 10% Triton X-100   68
(made into DT40 lysis buffer) was added to a final concentration of 0.3%, mixed 
thoroughly  but  gently  and  incubated  for  3  min.  The  suspension  was  then 
centrifuged for 5 min at 1,500 rpm at 4 °C and the supernatant (cytoplasmic 
fraction)  transferred  to  a  fresh  chilled  tube.  Prior  to  IP,  the  sample  was 
centrifuged in ultracentrifuge with either a Ti 70.1 rotor for 2 min at 22,000 rpm 
at 4 °C or with a Ti 45 rotor for 2 min at 20,000 rpm at 4 °C. The supernatant was 
transferred to a pre-chilled tube, 1 x volume of cold DT40 Lysis  Buffer was 
added to the supernatant in order to compensate the salt concentration. A sample 
from the cytoplasmic fraction was taken (50-80 ul) before adding affinity beads. 
The nuclear pellet was resuspended gently with a pipette in 5 x PCV equivalent 
of Isotonic Lysis Buffer and centrifuged at 3,000 rpm for 3 min. The supernatant 
was removed.  
For nuclear lysis, nuclear pellets were resuspended in 2 x PCV DT40 Lysis 
Buffer+T (see 3.1.6) and dounce homogenized with 30-40 strokes in the cold 
room with a pre-chilled homogenizer. The samples were incubated with gentle 
agitation for 30 min at 4 °C and then centrifuged with a Ti 70.1 rotor at 22,000 
rpm for 30 min at 4 °C or with a Ti 45 rotor for 30 min at 20,000 rpm at 4 °C (the 
rotor choice depended on the volume of the sample). The supernatants (nuclear 
fraction) was subjected to IP by adding affinity beads. Prior to this, a sample (50-
80 ul) was taken.  
The pellets were dounce homogenized in 2 x PCV DT40 Lysis Buffer+TB 
or  DT40  Lysis  Buffer+TD  (if  RNA  was  to  be  kept  intact)  or  DT40  Lysis 
Buffer+TR (if RNA was to be degraded) per ml, until the pellets gave much less 
resistance. The samples were incubated at RT for 30 min until the disappearance 
of DNA fibers and centrifuged with either a Ti 70.1 rotor for 30 min at 22,000 
rpm  at  4  °C or  with  a  Ti  45  rotor  for  30  min  at  20,000 rpm  at 4  °C.  The 
supernatants (chromatin fraction) were subjected to IP by adding affinity beads. 
Prior to this, a sample (50-80 ul) was taken. 
 
3.2.4.3 Protein immunoprecipitation. 
Anti-FLAG M2 affinity gel (Sigma, UK) was prepared as follows: 50% slurry 
affinity gel was washed with 10 x gel volumes of cold PBS at 4 ºC, centrifuged   69
for 3 min at 300 x g 3 times. The resin was resuspended in lysis buffer to make 
50% slurry and added as follows for Cytoplasm - 3  l of 50% slurry beads per 
5x10
7 DT40 endogenously tagged AID; Nucleoplasm - 1  l of 50% slurry beads 
per 5x10
7 DT40 endogenously tagged AID cells; Chromatin - 1  l of 50% slurry 
beads per 5x10
7 DT40 endogenously tagged AID. Samples were incubated for 3-
4  hours  at 4 ºC  on  a  rotator,  centrifuged  for  3  min  at 300 x  g at  4  ºC  and 
supernatants collected for analysis. The beads were washed 5 times with 25 x 
bead volume of DT40 Lysis Buffer (supplemented with 0.5-1 ug/ml 1xFLAG 
peptide) at 4 ºC for 10 min (NaCl salt concentration wash increased up to 500 
mM during IP optimisation experiments for increasing stringency). Between the 
washes, the samples were centrifuged for 3 min at 300 x g at 4 ºC to pellet the 
resin. During the last wash, the supernatant with beads was transferred to a new 
tube, to remove non-specific proteins sticking to the tube walls. The beads were 
washed once more, this time  in DT40 lysis buffer lacking Triton X-100. The 
protein was eluted twice by adding 4 x bead volume of elution buffer (DT40 
Lysis Buffer + 500  g/ml 3xFLAG peptide) and incubated for 30 min at 4 ºC on a 
rotator. The samples were then centrifuged for 2 min at 2,000 rpm at 4 ºC to 
pellet the resin. The supernatants were purified through a BioRad Bio-Spin Micro 
Chromatography Columns first by gravity flow and then by spinning 15 sec at 
1,000 rpm at 4 ºC. 
For  large-scale  experiments,  tagged  AID  was  eluted  from  the  beads  in 
BioRad Bio-Spin Micro Chromatography Columns, incubating it three times with 
4 x bead volume of elution buffer for 30 min at 4 ºC and leaving the last elution 
overnight.  The  eluted  proteins  were  concentrated  with  StrataClean  Resins, 
vortexing the mixtures for 1 min, and spinning them at 2,000 rpm for 1 min, 
followed by removal of the supernatants. The samples were stored at -20 ºC. 
 
The sequences of peptides used in this study, were as follows: 
3xFLAG peptide - MDYKDHDGDYKDHDIDYKDDDDK 
1xFLAG peptide - DYDDDDK 
3xMyc peptide - MEQKLISEEDLNEMEQKLISEEDLNEMEQKLISEEDLNE 
1xMyc peptide – AEEQKLISEEDLL 
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3.2.4.4 Silver Staining. 
The samples were run on a 4-12% NuPage gel, washed for 1 min in milliQ water. 
The  gel  was  then  subjected  to  silver  staining  using  the  SilverQuest  Silver 
Staining Kit (Invitrogen Ltd, UK) according to manufacturer’s instructions. The 
gel was washed with 100 ml water for 10 min and then dried by vacuum drying at 
65 ºC for 1 hour. 
  
3.2.4.5 SYPRO Ruby Protein Gel Staining. 
The samples were run on a 4-12% NuPage gel, and washed for 1 min in milliQ 
water. Thereafter, the gel was subjected to silver staining using the SYPRO Ruby 
Protein Gel Stain (Molecular Probes, UK) according to manufacturer instructions. 
Before imaging, the gel was rinsed in ultrapure water twice for at least 5 min. The 
imaging was carried out using the Typhoon scanner or FujiFilm scanner.  
 
3.2.4.6 Mass spectrometry. 
Eluates from protein immunoprecipitation were subjected to gel electrophoresis 
by  using  4-12%  NuPage  gels  (Invitrogen,  UK),  followed  by  SYPRO  Ruby 
staining and visualization by Dark Reader under UV. Individual protein bands 
were excised from the gel, and placed into separate 96-well plate wells in 100 µl 
of DEPC-treated H2O. The samples were stored at 4 ºC until further processing. 
Peptides for analysis were generated by in situ tryptic digestion of protein/gel 
bands. Mass spectrometry  analysis of peptides was performed on a SYNAPT 
HDMS  mass  spectrometer  (Waters,  USA)  and  the  data  searched  against  a 
concatenated, non-redundant protein database (UniProt 13.6), using the Mascot 
search  engine (Matrix  Science,  USA).  Mass spectrometry was carried  out by 
Clare Hall and LRI mass spectrometry services. 
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3.2.5 Methods related to fission yeast experiments. 
 
3.2.5.1 Fission yeast strains and media. 
The genotypes of the Schizosaccharomyces pombe  (S. pombe) strains used were 
JCF108 (h- ade6-M210 his3-D1 leu1-32 ura4-D18), JCF109 (h+ wt ade6-M216 
his  3-D1  leu1-32  ura4-D18),  F1693  (h-  rec12-171::ura4+  ura4-D18  leu1-32 
arg3-D4  ade6+),  FO1694  (h+  rec12-171::ura4+  ura4-D18  leu1-32  his3-D1 
ade6-M216), FO1695 (h- rec12-167 leu1-32 his3-D1 arg3-D4 ade6-M216) and 
FO1696 (h+ rec12-169::HA6HIS-KanMX ura4-D18 leu1-32 ade6+). S. pombe 
strains were stored in 2 ml of YES medium with 15% of glycerol at -80 ºC in 
cryotubes. For growth of fission yeast strains, a small amount of frozen glycerol 
stock was scraped with a pipette tip and then transferred to a YES plate. Strains 
were grown vegetatively in liquid/solid yeast extract with supplements (YE5S) or 
liquid/solid Edinburgh minimal medium (EMM) with supplements at 30 ºC as 
described previously  (Moreno  et al., 1991). Diploids  were distinguished from 
haploid cells by adding 2.5 mg/liter phloxin B (Sigma) to the YE5S media or 
EMM+supplements. In the presence of phloxin  B, diploid colonies  stain dark 
pink whereas haploid colonies stain light pink.  
 
3.2.5.2 Fission yeast mating. 
Strains were crossed on EMM low nitrogen EMM low nitrogen supplemented 
with 225 mg/ml arginine, uracil and histidine but lacking leucine +/- thiamine 
(THIA)  at  25  ºC.  Strains  from  the  opposite  mating  types  (h+  and  h-)  were 
suspended in 50  l of water, mixed and streaked onto the plates. The plates were 
incubated 2-3 days and analysed for the formation of asci by light microscopy. 
 
3.2.5.3 Constructs for fission yeast experiments. 
Exogenous expression of the human AID in fission yeast was achieved by using 
the pREP1 (nmt1) and pREP41 (nmt41) expression vectors described previously 
(Maundrell, 1990, 1993). These vectors contain the nmt (no message in thiamine) 
promoter, allowing efficient repression of gene expression by thiamine. A final   72
concentration of 15  M thiamine was used to repress the nmt promoter. pREP41 
has a weaker promoter compared to pREP1 and therefore less protein is produced 
from this vector.  
AID, its catalytic mutant, and AID-eGFP fusion protein expression vectors 
were generated by cutting either pREP1 or pREP41 vector with Nde I and Bam 
HI restriction enzymes, run on an agarose gel and then purified from the gel. The 
same restriction sites were included in the oligonucleotides for amplifying the 
AID sequence. The inserts were cut with Nde I and Bam HI and ligated with the 
purified  and  restricted  backbone.  Apobec2  and  Apobec3C  expressing  vectors 
were generated as follows: the Apobec2 and 3C sequences were PCR amplified, 
using primers with Nde I and Xba I sites. The PCR product was restricted with 
Nde  I  and  Xba  I  sites  and  purified  with  PCR  purification  kit.  His  tag  was 
obtained separately from two oligos with 5’ Xba I and 3’ Bam HI sites, which 
were hybridized, kinated and ligated with purified and restricted pRep1 backbone 
and with either purified Apobec2 or Apobec3C through a three fragment ligation 
process. The inserts of the expression vectors were confirmed by sequencing. 
 
3.2.5.4 Lithium acetate transformation of fission yeast. 
The  protocol  for  lithium  acetate  transformation  of  fission  yeast  was  used  as 
described previously (Bahler et al., 1993). Cells were grown in 15 ml of YE4S 
liquid medium at 30 ºC shaking until OD600 0.2 – 0.5. Cells were pelleted at 
3,000 rpm 5 min and supernatant was aspirated. The pellet was suspended in 1 ml 
water and transferred to a 1.5 ml tube. Cells were spun at 13,000 rpm 30 seconds, 
supernatant  was  removed  and  pellet  was  washed  with  1  ml  lithium  acetate 
(LiAc)/TE. Cells were pelleted and resuspended in 1 ml LiAc/TE. 100  l of cells 
were mixed with 50  g boiled sonicated single stranded salmon sperm DNA. 0.5 
 g of expression vector was added to the mixture and incubated 10 min RT. 280 
 l 50% PEG LiAc/TE was added and incubated 45 min at 30 ºC. Thereafter, 43 
 l DMSO was added and cells were heat shocked 5 min at 42 ºC. Cells were 
mixed with 500  l, pelleted at 13,000 rpm 45 seconds and washed once with 1 ml 
water.  Cells  were  resuspended  in  50   l  of  water  and  plated  on  EMM  + 
supplements –Leu+THIA. Plates were incubated at 30ºC. 
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3.2.5.5 Tetrad analysis. 
Tetrad analysis was carried out as described (Moreno et al., 1991), with minor 
modifications. Asci from 3-day old matings were suspended in 0.5 ml of dH2O. A 
drop of water with asci was run down the side of YE5S plates and left to dry at 
RT. Thereafter plates were incubated at 37 ºC for 4-5 hours until the asci walls 
were nearly disrupted, with the lid of the plate partially open. Spores from either 
tetrads,  triads  or  dyads  were  individually  picked  and  segregated  with  a 
micromanipulator. YE5S plates were incubated at 30 ºC until colonies become 
visible. These were counted to estimate the viabilities of spores from tetrads, 
triads and dyads.  
Tetrad,  triad  and  dyad  frequencies  were  calculated  by  counting  ethanol 
fixed  asci  under  fluorescence  microscopy.  Mis-segregation  was  assessed  in 
mature asci by the presence of more than 4 spores, less than two spores or asci in 
which there were clearly detectable aberrances in the DNA content according to 
DAPI staining and in the relative sizes of the spores. 
 
3.2.5.6 Random spore analysis. 
Approximately 1 x 10
5 cells from 3-day old matings were suspended in 250  l of 
water containing 1500 units of β-glucuronidase (Sigma, UK) and were incubated 
overnight at 30 ºC to digest vegetative cells. Spores were pelleted for 20 seconds 
at 13,000 rpm, the supernatant aspirated and cells resuspended in 1 ml of dH2O. 
Spores were counted with a haemocytometer, 1000 spores were grown on YE5S 
or YE5S with 15  M of thiamine plates for 2-3 days at 30 ºC and corresponding 
total number of colonies was counted. 
 
3.2.5.7 Recombination assay. 
A loopfull of 3-day old yeast matings was treated with β-glucuronidase. Spores 
were  counted  with  haemocytometer  and  plated  (50,000  spores  per  plate)  on 
selective  media  EMM-Leu-Ade-Ura+Phloxin  B  with  or  without  thiamine  and 
non-selective media EMM-Leu+Ade+Ura+Phloxin B with thiamine. Plates were 
incubated at 30 ºC for 5 days. Light pink colonies representing haploid cells were 
counted, dark pink colonies representing diploid cells were excluded from the   74
counting. 
 
3.2.5.8 Analysis of GFP-AID expression during nmt promoter activation or 
repression. 
To analyse the activation of nmt promoter, cells were grown vegetatively in 4 ml 
EMM-Leu+Thiamine at 30 ºC to an OD of approximately 1.0, centrifuged at 
3000 rpm for 5 min, and the cell pellet washed with 1 ml of dH2O. Cells were 
centrifuged again and strains were mixed to start the cross. The cross was carried 
out on EMM low nitrogen plates in the absence of thiamine at 25 ºC. Analysis 
was carried out by flow cytometry as described below. 
To analyse the repression of nmt promoter by thiamine, cells were  first 
vegetatively grown in the absence of thiamine and strains mixed together in water 
containing 15  M thiamine for promoting efficient nmt repression. Thereafter, the 
cross was performed on EMM low nitrogen plates containing 15  M thiamine.  
Every hour, a loopful of cross was fixed in 1 ml of cold 70% ethanol, vortexed 
and stored at 4 ºC. Cells were spun at 13,000 rpm for 30 seconds, the cell pellet 
washed in 1 ml 50 mM sodium citrate buffer pH 7.0, then harvested in 300  l 50 
mM  sodium  citrate  buffer  pH  7.0.  Samples  were  analysed  using  a  Beckton-
Dickinson FACScan counting a total of 50,000 cells per sample. 
 
3.2.5.9 Nocodazole induced block during meiosis. 
Cells were grown vegetatively and crossed in the presence of thiamine for 24 
hours in order to promote the fusion of the cells from opposite mating types. 
Thereafter cells were treated with nocodazole (final concentration 300  M) for 24 
hours to finish DNA replication of the fused cells and to block other cells from 
entering  meiosis.  Cells  were  washed  extensively  to  remove  thiamine,  in  the 
presence  of  nocodazole,  to  induce  AID  expression  for  24  hours.  GFP-AID 
induction was confirmed by flow cytometry. Nocodazole was removed to induce 
spore  formation,  while  inhibiting  AID expression  with thiamine.  Spores  were 
freed from asci by β-glucuronidase treatment and plated on EMM media with 
thiamine lacking adenine, uracil and leucine to identify recombinants or EMM 
with thiamine lacking leucine to identify the overall numbers of live spores.   75
 
3.2.6 Methods related to nematode experiments. 
 
3.2.6.1 Worm strains and culture conditions. 
C.  elegans  strains  were  cultured  as  described  previously  (Brenner,  1974). 
Animals were cultured on MYOB plates
 seeded with E. coli and incubated at 15 
ºC or 22  ºC.  The  propagation of the animals  was  carried  out by transferring 
approximately 1 cm
2 of agarose with a clean and sterilized scalpel onto freshly 
seeded  MYOB  plates.  The  strains  wild-type  Bristol  N2  and  spo-11  (ok79) 
(Dernburg et al., 1998) were kindly provided by  the Caenorhabditis Genetics 
Centre (University of  Minnesota,  St Paul, MN). The ung-1  strain  was  kindly 
provided by Dr. Hilde Nilsen (University of Oslo) (Dengg et al., 2006). 
  
3.2.6.2 Generation of human AID expressing worm strain. 
Human AID sequence was cloned into the Gateway
 System (Invitrogen Ltd, UK) 
entry  vector,  p221,  followed  by  cloning  into  pID3  vector  generating  an 
AID::GFP fusion protein under the control of the pie-1 promoter (Tenenhaus et 
al., 1998). The AID::GFP transgenic worm
 line was generated by microparticle 
bombardment (described below) of unc-119
 (ed3) animals (Praitis et al., 2001) 
with pID3_AID::GFP. Spo-11 AID::GFP worms were generated by crossing unc-
119 AID::GFP worms with a GFP balanced spo-11 strain. The genotype of the 
worms was verified by single worm PCR, using primers for AID and spo-11 as 
described below.  
 
3.2.6.3 Bleaching worms for bombardment. 
Worms were grown on 10 plates until high density, washed off the plates with 10 
ml M9 buffer, allowed to pellet, supernatant removed and washed again with 10 
ml M9. 15 ml of bleach (1.5 ml bleach + 1 ml 5M NaOH + 12.5 ml dH2O) was 
added and shaken vigorously. After 2 min, worms were passed through a 23G 
needle, and shaken and vortexed for 6-8 minutes, until most bodies were broken 
and eggs released. Eggs were washed 4-5 x in 50 ml dH2O, spinning them down   76
at 1,500 rpm for 3 minutes between each wash. Eggs were then put into 10 ml S-
basal medium and rotated overnight at RT to hatch the eggs and obtain L1 larva. 
 
3.2.6.4 Preparing the gold beads for bombardment. 
30 mg of 1 micron gold beads were weighed into a siliconized eppendorf tube. 1 
ml of 70% ethanol was added  and  vortexed  for 5-10 minutes.  Particles were 
settled for 15 minutes and spun briefly (3-4 seconds). 1 ml of dH2O was added to 
the particles, vortexed for 1 minute, allowed to settle for 1 minute and then spun 
briefly (3-4 seconds) in microfuge, this was repeated 3 times. Supernatant was 
then removed with vacuum pump, 250  l of 50% glycerol was added, and stored 
at RT. 
 
3.2.6.5 Loading DNA onto the gold beads. 
Prepared beads were vortexed in 50% glycerol for 20 min. During vortexing, the 
following compounds per sample were added dropwise to the beads: 0.79  g of 
plasmid, 10  l 2.5 M CaCl2, 4  l 0.1 M freshly made spermidine. Between the 
addition  of  each  compound,  beads  were  vortexed  for  1  minute,  and  finally 
vortexed a further 3 minutes. Beads were left to settle for 1 min and centrifuged 
briefly (3-4 seconds) in microfuge. Supernatant was removed using a pipetman to 
avoid disturbing the pellet of beads. Pellets were resuspended in 30  l of 70% 
ethanol per bombardment and the ring of beads on the tube wall was scraped off 
with  the  pipet  tip  while  adding  the  ethanol.  Beads  were  centrifuged  briefly, 
supernatant  was  removed  and  particles  were  resuspended  in  10   l  of  100% 
ethanol  per  bombardment.  Particles  were  vortexed  at  least  3  minutes  and 
thereafter resuspending with vortexing and pipeting was continued until most of 
the large clumps of beads were broken up. 
 
3.2.6.6 Putting beads on macrocarriers. 
Macrocarriers were placed into the vacuum holders using a pen. Approximately 
10  l of the gold beads suspended in ethanol were spread over the centre of each   77
macrocarrier, avoiding the placing of beads outside the hole in the macrocarrier 
holders. Macrocarriers were allowed to dry during the preparation of worms. 
 
3.2.6.7 Preparing plates with worms for bombardment. 
Synchronized unc-119 (ed3) mutant L1 larvae were poured into 100 ml of S-
basal + Nystatin + Streptomycin + 2 g of HB101. Worms were grown at 20 ºC 
with shaking at 250 rpm. After approximately 4 days, the culture produced a 
large  number  of  L4/young  adult  worms,  which  are  the  most  effective  for 
bombarding. Worms were left to settle, washed with 40 ml of M9, and again left 
to settle for 15-20 minutes. Worms were resuspended in 5 ml of M9 and counted 
(10 x 2  l  to  estimate  the average  worm number  per   l).  The  animals were 
resuspended in M9 to 10,000 worms in 75  l. Just before each bombardment, 75 
 l  of  worms  were  added  to  the  center  of  a  seeded  10  cm  plate  for  each 
bombardment, that the target area of the plate was covered with a monolayer of 
worms. 
 
3.2.6.8 Worm bombardment and post bombardment care of the worms. 
Worm  microparticle  bombardment  was  carried  out  using  a  Biolistic  PDS-
1000/He (BioRad, UK) with 1,350 psi rupture discs. Target plates with worms 
were placed on the second shelf from the bottom and a vacuum of 25 inches Hg 
was used during bombardment. 
After bombardment, worms were left to recover for 1-2 hours, washed off 
from the plates with S-basal, allowed to settle, resuspended in 400  l of S-basal 
per bombardment, and seeded onto 4 freshly seeded 10 cm plates to isolate the 
maximum number of independent lines. Plates were incubated at RT for 2 weeks 
and then screened for transformants. The transformant are rescued for unc-119 
allowing  the  worms  to  move  on  the  starved  plates.  From  each  plate  with 
transformants, 6 individual animals were picked and placed to a separate well of 
a freshly seeded 24 well plate. These were grown and the progeny was monitored 
for unc-119  animals. Stable lines that  did not produce unc-119  animals were 
analysed further.  
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3.2.6.9 Single worm PCR. 
Five microlitres of lysis buffer [50 mM KCl, 10 mM Tris (pH 8.3), 2.5 mM 
MgCl2,  0.45%  IGEPAL  CA  630,  0.45%  Tween-20,  0.01%  Gelatin]  with 
proteinase K (1 mg/ml) was placed into 0.2 ml DNase and RNase free PCR tubes 
or a 96-well PCR plate. Single worms were washed in a drop of PBS and then 
transferred into lysis buffer and frozen at - 80 ºC or on dry ice for 20 min. Tubes 
were  then  incubated  at  65  ºC  degrees  for  90  minutes  to  lyse  the  worms. 
Proteinase K was inactivated by heating the tubes to 95 ºC for 15 min. Thereafter, 
a nested PCR reaction was performed. For the first PCR reaction, 1  l of worm 
lysate was added to a 12.5  l PCR reaction that included the primers at 0.5  M, 
1x buffer, 1 mM MgCl2, 0.2 mM dNTP’s and 1.25 U of Platinum Taq DNA 
polymerase. The PCR conditions were as follows: denaturation at 94 ºC for 30 
seconds, primer annealing at 55 ºC for 30 seconds, polymerization at 72 ºC for 90 
seconds, for 30 cycles. The second PCR reaction was performed using 1  l of the 
first PCR reaction in a 12.5  l PCR reaction mixture as indicated for the first 
reaction. The conditions for the second PCR were as follows: denaturation at 94 
ºC for 30 seconds, primer annealing at 55 ºC for 30 seconds, polymerization at 72 
ºC for 90 seconds, for 25 cycles. AID-GFP fusion construct was detected by 
nested  PCR  using  external  primer  sequences  AID-GFP1F  (5’-TAGACCCTG-
GCCGCTGCTACC-3’)  and  AID-GFP1R  (5’-CAAAAGGATGCGCCG-
AAGCTGTCTGGAG-3’)  and  nested  primers  AID-GFP2F  (5’-GAGGCAAG-
AAGACACTCTGG-3’) and AID-GFP2R (5’-GTGACATTCCTGGAAGTTGC-
3’). Spo-11 deletion was detected with nested PCR using external primers Spo11-
1F  (5’-CGTGTTTCCCAAGATGCTC-3’)  and  Spo11-1R  (5’-CGGAATGCG-
TGCAAGTG-3’)  and  nested  primers  Spo11-2F  (5’-CCGAACAGCA-
TATTGAAGAGG-3’)  and  Spo11-2R  (5’-GCGCATATAAAACACGGAGAC-
3’), as previously described (Dernburg et al., 1998). 
 
3.2.6.10 Slide preparation for immunofluorescence of C. elegans. 
Slides were washed in 70% ethanol, before smearing them with 1 mg/ml poly-L-
lysine for 5 min. Slides were left to dry at 37 ºC and then given another coat of 
poly-L-lysine.  
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3.2.6.11 Visualisation of GFP in C. elegans. 
Molten 4% agarose was placed on prewarmed (55 ˚C) slides and pressed between 
two slides to a final thickness of approximately 1 mm. The agarose was left to 
solidify before 5 worms were placed on the agar surface in 10  l of PBS. Slides 
were left to dry for 5 min before covering with a coverslip. Slides were analysed 
using a Deltavision microscope (Applied Precision, UK). 
  
3.2.6.12 Cytological preparation and immunostaining of C. elegans. 
Gravid hermaphrodites were transferred to 30 µl of PBS on poly-L-lysine-coated 
slides.  Thereafter,  worms  were  transferred  to  50  µl  of  10  mM  levamisole.
 
Germlines were extruded by removing the head and tail with
 a fine needle (27-
gauge). Levamisole was replaced with
 1% paraformaldehyde in PBS for 10 min. 
After  fixation,  the  germlines  were  permeabilised  for  5  min  in  TBSBT  (Tris-
buffered saline, 0.5%
 bovine serum albumin, 0.1% Triton X-100) and washed 
with TBSBT
 at least three times for 5 min each time, followed by blocking in 
TBSBT
  for 30  min. Primary antibodies were diluted in  TBSB  [1:50 for
 both 
4.18.1  and  4.26.1  (Aoufouchi  et  al.,  2008)  anti-AID,  1:200  for  anti-UNG 
(ab13668, Abcam, Cambridge, UK), 1:200 for anti-RAD-51 antibody (Martin et 
al., 2005)] and incubated overnight at 4°C in a humid chamber.
 Germlines were 
subsequently washed at least three times for
 5 min each time with TBSB (Tris-
buffered saline, 0.5%
 bovine serum albumin) before incubation with secondary 
antibodies conjugated with Cy3 (anti-rabbit, 1:10,000, Sigma, UK; anti-mouse, 
1:10,000; Sigma, UK)
 for 1 to 2 h at RT. Finally, the germlines were washed at 
least three
 times with TBSB for 5 min before adding ProLong Gold Antifade with 
DAPI (Molecular Probes, UK)
 and mounted with coverslips. 
 
3.2.6.13 Fluorescence microscopy. 
Delta-vision microscopy was used to examine germlines with x40 or x63, 1.4 NA 
Planapochromat lens on an Olympus inverted microscope (IX71), and images 
captured  using  SoftWorx  computer  software  (Applied  Precision,  UK).  Three-
dimensional data sets were computationally deconvolved if needed, and regions   80
of interest then projected into one dimension. Merged or single color images were 
recorded using GIMP software. 
 
3.2.6.14 Worm viability analysis. 
Single L4 stage larvae were picked into individual seeded 24 well plates. After an 
initial 12 h egg-laying period, worms were transferred to fresh plates and once 
again transferred 12 h and 24 h later, so that progeny could be scored over one 
egg-laying period per parent. Plates were examined after 48 h for the presence of 
viable  adult  progeny.  Unhatched  eggs  and  viable  progeny  were  counted  to 
estimate the viability of the offspring. 
 
3.2.6.15 Hermaphrodite / male identification. 
The percent of male progeny was determined by sex-specific counting, which 
included the rapid movement of the animal, the presence of a hook-shaped tail, 
and slim torso. Statistical analysis of worm viability was done using chi-square 
analysis, with the following addition: in the wild-type worm we arbitrarily set the 
count of dead eggs to 2, even though we did not observe any. This alteration was 
to facilitate statistical analysis (being even more conservative than the observed 
data). 
 
3.2.6.16 Preparation of PEG/DMSO competent cells. 
HT115(DE3), an RNase III-deficient E. coli stain suitable for RNAi experiments, 
was streaked on an LB plate and incubated overnight at 37 ºC. A single colony 
was inoculated in 5 ml LB and incubated overnight at 37 ºC. This starter culture 
was used to inoculate 500 ml LB culture, and grown to OD600 = 0.5-0.6 at 37 ºC. 
The cells were pelleted at 2000 rpm for 5 min at 4 ºC and gently suspended in 25 
ml cold TSB. The cells were incubated on ice for 10 min, aliquoted, frozen and 
stored at -80 ºC. 
  
3.2.6.17 Chemical transformation of bacteria for RNAi experiments. 
Ung-1  sequence  was  Gateway  cloned  into  pL4440,  a  modified  version  of   81
Bluescript vector carrying tandem T7 promoters on each side of the multi-cloning 
site, driving transcription of each DNA strand. The constructs were transferred 
(described  above)  into  HT115(DE3)  bacteria  and  plated  onto  LB  plates 
containing ampicillin. DNA (pL4440 containg ung-1 seqence or empty control 
plasmid) was mixed with 5xKCM and ddH2O to a final  volume of 100  l at 
1xKCM final  concentration. PEG/DMSO  competent  cells  were  thawn  on  ice, 
added to the mixture in an equal volume, incubation on ice for 20 min, incubated 
at RT for 10 min, 1 ml of SOC media was added and incubated at 37 ºC for 1 h, 
and plated on LB plates with ampicillin and incubating at 37 ºC overnight. 
 
3.2.6.18 RNA interference (RNAi) by feeding. 
RNAi by feeding for ung-1 (Y56A3A.29a) was performed for 24 h, as described 
previously (Boulton et al., 2002; Dengg et al., 2006; Fire et al., 1998). A colony 
with RNAi vector was grown for 6-18 hours in LB + 50  g/ml ampicillin, seeded 
onto 6 well plates with NGM Classic media and incubated overnight at RT with 4 
mM to allow RNAi production by IPTG. Then, L4 stage hermaphrodites were 
transferred onto  separate plates, while minimizing the  amount of  the  bacteria 
carried over from the MYOB plate. The plates were incubated 24-48 hours at RT 
and the offspring analysed for effects of RNAi. Empty vector (pL4440) was used 
as a control for RNAi experiments. 
 
3.2.6.19 Irradiation of worms. 
Irradiation of nematodes was performed in an 
137Cs Irradiator (IBL437, Cis Bio 
International)  with  low  dose  (15  Gy)  irradiation.  Animals  were  analysed  for 
TUNEL  staining  30  min  post-irradiation  and  for  RAD-51  staining  4  h  post-
irradiation. 
 
3.2.6.20 TUNEL assay. 
The TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end-
labelling) assay was performed as described earlier (Parusel et al., 2006), with 
minor modifications. Gravid nematodes were washed in PBS on poly-L-lysine   82
covered slides and dissected in PBS, followed by fixation in 4% formaldehyde in 
PBS at RT for 20 min. Gonads were rinsed in PTX (PBS, 0.4% Triton X-100) 
three times, incubated in 100 mM sodium-citrate, 0.1% Triton X-100 at 65 ºC for 
20 min and then washed twice in PTX. Gonads were incubated for 30 min at RT 
in 0.1M Tris/HCl (pH 7.5) containing 3% BSA and 20% bovine serum, washed 
twice with PBS at RT and excess fluid was drained off. Thereafter, the gonads 
were incubated in TUNEL reaction mixture (Roche, USA) at 37 ºC for 1.5 hours 
in the dark. The reaction was stopped by washing three times with PTX, before 
adding ProLong Gold Antifade with DAPI (Molecular Probes, UK) and mounting 
the samples with coverslips. 
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4.1 Hormonal regulation of AID. 
 
4.1.1 Introduction. 
4.1.1.1 Development of B-cells. 
The  induction  of  AID  expression  during  B-cell  activation  is  essential  for  Ig 
diversification and plays an important role in humoral immune responses. These 
immune  responses  are  initiated  when  antigen  binding  B-cells  receive  co-
stimulatory signals, which can include cytokines, direct T-cell help, complement 
or  pathogen  antigens.  B-cell  activation  can  be  mimiced  in  tissue  culture 
conditions by using various cytokines and bacterial cell wall components. In vivo, 
B-cell activation by T helper cells occurs in secondary lymphoid tissues, where 
the B-cell together with the T-cell establishes a primary focus of clonal expansion 
(Abbas, 2007). After several days, some of the proliferating B-cells differentiate 
into  antibody-synthesizing  plasma  cells. Other  B-cells migrate  into  a  primary 
lymphoid  follicle  where  they  continue  to  proliferate  and  ultimately  form  a 
germinal centre, composed mainly of proliferating B-cells and antigen-specific T-
cells.  The  early  events  in  the  primary  focus  lead  to  the  prompt  secretion  of 
specific antibody that serves as immediate protection to the infected individual. 
The germinal centre reaction, on the other hand, provides for a more effective 
later response, should the host become infected again. In germinal centers, B-
cells  undergo  several  important  processes  (McHeyzer-Williams  et  al.,  2006), 
including somatic hypermutation of V regions, affinity maturation that selects for 
survival of B-cells with high affinity for the antigen, and isotype switching that 
allows B-cells to express a variety of effector functions in the form of antibodies, 
processes described earlier (Chapter 1). 
 
4.1.1.2 Gender differences in immune responses and autoimmunity. 
During  an  infection,  the  organism  needs  to  trigger  an  immune  response  to 
eliminate the source of the infection, and at the same time, avoid harming its own 
tissues. Interestingly, there is a sexual dimorphism in the immune response in   85
humans, which was noted already several decades ago, indicating that females 
exhibit a quicker and stronger humoral  immune response upon infection than 
males  (Butterworth  et  al.,  1967).  Similarly,  after  immunization,  female  mice 
produce more antibody than male mice (Eidinger and Garrett, 1972; Weinstein et 
al., 1984). Although a component of this sexual dimorphism in immunity is likely 
due to genetic differences in mouse models, systemic sex hormone treatment or 
castration have been shown to switch the nature of immune responses to that of 
the opposite sex. This would suggest that the sex differences are due, in part, to 
differential hormone levels in vivo (Bebo et al., 2001; Bebo et al., 1999). 
There are more than 70 autoimmune diseases affecting approximately 5 % 
of  the  population  of  developed  countries,  and  in  some  of  these  pathologies, 
abnormalities in B-cells seem to play an important role (Davidson and Diamond, 
2001). An autoimmune disease occurs when a specific adaptive immune response 
is mounted against self antigens (Ermann and Fathman, 2001). When such an 
event  occurs,  the  immune  effector  mechanisms  are  unable  to  eliminate  the 
antigen  completely,  so  a  sustained  response  occurs.  This  causes  a  chronic 
inflammatory  injury  to  affected  tissues.  Cytotoxic  T-cell  responses  and 
inappropriate activation of macrophages by Th1 cells can cause extensive tissue 
damage, whereas inappropriate T-cell help to self-reactive B-cells can  initiate 
harmful  autoantibody  responses  (Davidson  and  Diamond,  2001;  Taneja  and 
David, 2001). 
The  susceptibility  to  autoimmune  diseases  is  controlled  by  both 
environmental  and  genetic  factors  (Ermann  and  Fathman,  2001;  Goodnow, 
2007). Firstly, several diseases are associated with the major histocompatibility 
complex  (MHC)  genotype.  Secondly,  in  diseases  such  as  Systemic  Lupus 
Erythematosus (SLE), the disease susceptibility genes include genes that regulate 
the thresholds for tolerance and activation of B-cells [e.g. tumor suppressor Fas 
(CD95) and Fas ligand (Rieux-Laucat et al., 1995)]. Fas is a central protein for 
inducing  apoptosis  of  autoreactive  lymphocytes  during  negative  selection  in 
lymphocyte development, and elimination of autoreactive B-cells in the periphery 
(Rieux-Laucat  et  al.,  2003;  Rieux-Laucat  et  al.,  1995). Thirdly,  an  important 
factor in disease susceptibility is the hormonal status of the patient (Christen and 
von  Herrath,  2004; Janeway,  2001;  Kamradt  and  Mitchison,  2001;  Whitacre, 
2001).   86
Female sex biases of over 80% have been reported in autoimmune diseases 
like Sjogren’s syndrome, autoimmune thyroid disease (Hashimoto’s thyroiditis 
and Graves’ disease), SLE and scleroderma (Whitacre, 2001). Other relatively 
common  diseases  including  myasthenia  gravis,  rheumatoid  arthritis  (RA)  and 
multiple sclerosis (MS) have a sex distribution of 60–75% women (Ermann and 
Fathman,  2001;  Whitacre,  2001).  The  increased  prevalence  of  autoimmune 
disease  in  women,  the  sexual  dimorphism  of  the  immune  response,  and  the 
modulatory  effects of  sex  steroids  on  immune  function  in vitro suggest  their 
involvement in mediating the sex differences in immune responses. 
 
4.1.1.3 Systemic lupus erythematosus. 
One of  the  better characterized  autoimmune diseases,  which  shows a striking 
gender bias in respect of its occurrence (90% are female), is Systemic Lupus 
Erythematosus. SLE is a polygenic autoimmune disease that is characterized by a 
breakdown of B-cell tolerance, which results in development of autoantibodies 
(Cohen-Solal  et  al.,  2006;  Grimaldi  et  al.,  2005).  In  addition  to  its  strong 
prevalence in women, it has also a characteristic age onset after menarche and 
before  menopause  (Cervera  et  al.,  1993).  Outside  the  period  of  female 
reproductive  activity,  the  onset  of  disease  is  uncommon  and  without  sex 
preference (Font et al., 1991; Tucker et al., 1995). These observations suggest 
that endogenous sex hormones may play a role in the development of the disease, 
with estrogen acting to trigger disease susceptibility. Consistent with this, women 
with SLE tend to have low levels of plasma progesterone (Arnalich et al., 1992; 
Lahita et al., 1979) and abnormal patterns of estradiol metabolism, leading to 
increased estrogenic activity (Lahita et al., 1979). Exogenous estrogen therapies, 
hormone replacement therapy (HRT), and oral contraception (OCP), have also 
been associated with SLE disease flares (Sanchez-Guerrero et al., 1995). Murine 
models  that  develop  a  syndrome  resembling  human  SLE  (NZB/NZW  mice) 
demonstrate  that  estrogen can  modulate this  disease  (Roubinian  et al., 1979). 
Female mice treated with estrogen (17β-estradiol) manifest an earlier onset of 
lupus and an earlier mortality (Roubinian et al., 1979). Conversely, when female 
mice are ovariectomized and treated with antiestrogenic drug such as tamoxifen, 
they exhibit a prolonged lifespan (Sthoeger et al., 2003).     87
Since  in  SLE,  breakdown  of  B-cell  tolerance  and  the  production  of 
autoreactive antibodies play an important pathological role, AID is a potential 
candidate  involved  in  this  process.  Interestingly,  over-expression  of  AID  in 
autoimmune prone mice leads to a more severe SLE-like phenotype (Hsu et al., 
2007), while breeding AID deficient mice with autoimmune prone MRL/lpr mice 
significantly  reduces  the  on-set  and  extent  of  disease  (Jiang  et  al.,  2007), 
indicating that alterations in AID can change the severity of B-cell autoimmunity. 
Due to a gender bias in immune responses and autoimmune pathologies, it is 
therefore possible that AID is a target for hormonal regulation. 
 
4.1.1.4 Estrogen and progesterone receptors. 
Estrogen  receptor (ER) and progesterone  receptor (PR) belong  to the  nuclear 
steroid receptor family. They mediate the effects of sex hormones estrogen and 
progesterone by binding their ligands. Estrogen and progesterone hormones are 
synthesized  from  a  cholesterol  backbone  and  produced  predominantly  in  the 
ovary. Besides having a central role in reproductive and developmental events, 
they are also involved in the modulation of the immune system (Li et al., 2004). 
ER and PR have distinct structural and functional domains: (a) an N-terminal 
region with a transactivation function, (b) a zinc finger region that mediates DNA 
binding, and (c) a C-terminal ligand-binding moiety (Sonoda et al., 2008). Two 
types of estrogen receptor, estrogen receptor α (ERα) and estrogen receptor β 
(ERβ) mediate the effects of estrogen (Bjornstrom and Sjoberg, 2005). These 
receptors are expressed not only in reproductive tissues but also in multiple other 
cell types, including cells of the immune system, such as B and T lymphocytes 
(McMurray et al., 1991; Peeva et al., 2005; Tornwall et al., 1999). However, 
there are differences in the structure and cellular distribution of ERα and β that 
suggest different biological roles for these two receptors (Gruber et al., 2002). In 
addition to intra-cellular receptors, there are also membrane-associated estrogen 
receptors that are involved in non-genomic rapid responses to hormones (Benten 
et al., 2002). Similarly to ER, PR has also 2 isoforms, PRA and PRB, which 
share several structural domains, but are distinct transcription factors that mediate 
their own response genes and physiologic effects (Leonhardt et al., 2003).   88
After estrogens bind to the ligand domain of the ER, the protein undergoes 
conformational changes that allow interactions with coactivator molecules and 
translocation into the nucleus (Tsai and O'Malley, 1994). In the classical pathway 
of estrogen action, the ER binds as a dimer to estrogen response elements (EREs) 
in  the  promoter  regions of  target genes, acting  as  an  activating  or  repressing 
transcription factor (Beato and Klug, 2000; Tsai and O'Malley, 1994). However, 
it  has  been  found  that  ER  can  regulate  genes  that  lack  a  canonical  ERE, 
suggesting additional pathways for estrogen action. For example, the ER may 
activate genes via protein tethering with c-Fos/c-Jun B (AP-1) and Sp1 (Kushner 
et al., 2000; Saville et al., 2000) or cross-talk with NFκB pathways (Ray et al., 
1994). 
The signaling pathway mediated by progesterone and its receptors resemble 
estrogen-mediated  pathways.  Upon  hormone  binding,  the  receptor  dissociates 
from  the  heat  shock  protein  complex,  dimerizes,  and  binds  to  progesterone-
responsive elements (PREs) within the regulatory regions of target genes. This 
leads to induction or silencing of target genes (Leonhardt et al., 2003). Similarly 
to ER, when bound to DNA, the PR dimer contacts components of the general 
transcription machinery, either directly (Ing et al., 1992; Kalkhoven et al., 1996) 
or indirectly via coactivators and corepressors (Onate et al., 1995; Voegel et al., 
1996). 
In addition to activated B-cells, AID expression has been reported in some 
hormone-responsive  tissues  outside the immune system  (Morgan  et al., 2004; 
Schreck  et  al.,  2006),  raising  the  possibility  that  AID  expression  might  be 
regulated  not  only  by  classical  B-cell  transcription  factors  such  as  NFκB 
(Dedeoglu et al., 2004), Pax5 (Gonda et al., 2003) and E-box proteins (Sayegh et 
al., 2003), but also by hormones such as estrogen. We therefore set forth to test, 
whether AID expression could be affected by estrogen and progesterone. 
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4.1.2 Results 
4.1.2.1 Differential effect of sex hormones on AID mRNA.  
The regulation of AID during B-cell activation is mediated by various signaling 
pathways.  To  investigate  the  effects  of  estrogen  and  progesterone  on  AID 
induction in B-cells, murine splenic B-cells were isolated by negative isolation 
and stimulated with IL4 and LPS – known to induce AID (Dedeoglu et al., 2004). 
As hormones, including estrogen and progesterone, exert their biological effects 
predominantly  through  binding  to  their  intracellular  receptors  and  act  as 
transcription factors, we examined AID mRNA levels upon B-cell stimulation 
and progesterone or estrogen treatment.  
Addition  of  physiological  amounts  of  progesterone  during  B-cell 
stimulation led to a 5-fold decrease in AID mRNA levels compared to the control 
DMSO treatment, as revealed by quantitative real time PCR (Figure 11A). In 
contrast to progesterone, physiological amounts of estrogen were able to enhance 
AID  expression  three  fold  in  these  cells  (Figure  11A).  To  confirm  that  the 
estrogen induced stimulation on AID was analogous to other known estrogen 
response genes, we observed estrogen induction of GREB1, a known estrogen-
responsive gene (Ghosh et al., 2000) (Figure 12). These results indicated that 
estrogen as well as progesterone can participate in the regulation of AID mRNA 
in activated B-cells in a stimulatory or inhibitory manner, respectively.  
To  investigate  whether  estrogen  could  up-regulate  AID  mRNA  without 
IL4/LPS stimulation, isolated B-cells were treated with estrogen in the absence of 
LPS and IL4. Surprisingly, estrogen treatment led to 7 fold up-regulation of AID 
message in mouse B-cells (Figure 11B). This induction began to plateau at 4 h, 
with the earliest indication of an increase detectable after 1-2 h (Figure 11C). 
Since it was possible to enhance AID mRNA production with estrogen after co-
treatment  with  IL4/LPS,  it  indicated  a  possible  synergy  between  these  two 
signaling pathways. 
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Figure 11. The effects of estrogen and progesterone on AID mRNA in splenic B-cells. (A) 
Changes in AID mRNA in response to estrogen and progesterone treatment in stimulated B-cells. 
Isolated  mouse  splenic  B-cells  were  stimulated  with  LPS  and  IL4  and treated  with  different 
physiological concentrations of estrogen for 8 h or progesterone for 24 h. (B) AID mRNA in 
response to estrogen treatment in un-stimulated B-cells, after 8 h treatment with physiological 
concentrations  of  estrogen.  (C)  AID  mRNA  induction  upon  different  treatments.  Cells  were 
stimulated with estrogen up to 8 h. Data is representative of three independent experiments and 
error bars indicate standard deviations from the average. DMSO is set to 1, and treatments are 
represented as relative change to DMSO. Time-lines of cell treatments are indicated next to the 
graphs. NT - not treated; Tam – tamoxifen (50 nM). Published in (Pauklin et al., 2009b). 
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Tamoxifen, a molecule that has been used as an antagonist for estrogen in 
treating breast cancer, attenuated the effects of estrogen on AID induction (Figure 
11C), but caused itself a modest increase in AID mRNA at low concentrations 
(Figure  13). Therefore,  this  structural  analogue  of  estrogen  is  not  a  clear-cut 
antagonist of estrogen, but also a partial agonist in respect to AID induction.  
 
 
 
Figure 13. The effects of tamoxifen on AID mRNA in splenic B-cells. Relative changes in AID 
mRNA  in  unstimulated  B-cells  in  response  to  8  h  treatment  with  various  concentrations  of 
tamoxifen. Published in (Pauklin et al., 2009b). 
 
 
4.1.2.2  AID  mRNA  is  regulated  by  hormones  predominantly  via 
transcription.  
Since modest effects of hormones were already observed after 2 h (Figure 11C), 
it was necessary to clarify whether these changes are due to a direct effect on 
AID or mediated via a multistep pathway. To address this, splenic B-cells were 
pre-treated  with  translational  inhibitor  (cycloheximide  -  CHX)  followed  by 
Figure 12. The effects of estrogen on GREB1 
mRNA in splenic B-cells. Unstimulated splenic 
B-cells were treated with 10 nM estrogen for 4 h  
or 24 h.  
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stimulation  with  estrogen.  This  did  not  alter  the  increase  of  AID  mRNA 
production (Figure 14A), suggesting that the effect of estrogen was exhibited on 
AID’s mRNA synthesis. qRT-PCR of cDNA is a read-out of steady state mRNA 
– therefore it was further investigated, whether the effects on AID mRNA by 
hormones were due to changes in transcription or mRNA splicing. Treatment of 
cells with transcription inhibitors α-amanitin (AMA) and actinomycin D (ACT) 
diminished the effect of estrogen, indicating that this alteration in AID’s mRNA 
was not due to message stability (Figure 14A). Since estrogen is known to affect 
pre-mRNA to mRNA processing (Auboeuf et al., 2002), qRT-PCR primers were 
designed  to  span  the  complete  transcription  unit  of  AID.  When  the  relative 
change of expression of the various exon and intron units of the pre-mRNA were 
compared  to  that  of  the  mature  mRNA,  no  major  changes  were  observed 
(Appendix Figure 1B). However, the intron between exon 3 and 4 (7538-7689 bp 
- E) showed a marginal increase in response to estrogen over that of the mature 
RNA, indicating a potential region for estrogen induced splicing of AID RNA. 
As  this  increase  was  modest,  it  was  not  analysed  further,  although  there  is 
evidence that AID can be alternatively spliced (Wu et al., 2008).  
Since the above data indicated that estrogen was likely to function on the 
level  of  transcription,  we  also  determined,  whether  progesterone  utilized  an 
analogous pathway. In order to analyse the repressive effects of progesterone, we 
stimulated B-cells with IL-4 and LPS prior to hormone treatment. In contrast to 
estrogen, progesterone treatment of stimulated splenic B-cells also resulted in a 
decrease in AID mRNA production independently of translation (Figure 14B), 
mRNA stability (Figure 14B) or pre-mRNA splicing (Appendix Figure 1C).  
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Figure 12. Estrogen and progesterone affect AID transcription directly. (A) Isolated mouse 
splenic B-cells were treated with CHX for 2 h or with ACT for 6 h and AMA for 5 h, followed by 
1 nM estrogen treatment for 4 h, and AID mRNA was analyzed by qRT-PCR. Gene expression 
was normalized to the control treatments with DMSO. Published in (Pauklin et al., 2009b). (B) 
Isolated mouse splenic B-cells were first stimulated with LPS and IL4 and then treated with CHX 
for 2 h (18 h post stimulation) or with ACT for 6 h (14 h post stimulation) and AMA for 5 h (15 h 
post stimulation), and 200 nM progesterone (20 h post stimulation) for 4 h. Time-lines of cell 
treatments are indicated next to the graphs. NT - not treated. Published in (Pauklin and Petersen-
Mahrt, 2009). 
 
4.1.2.3  Identification of hormone  response  elements  in  the AID promoter 
regions. 
The  results suggested a  direct regulation  of  AID  by  hormones.  We therefore 
identified potential EREs (estrogen response elements) and PREs (progesterone 
response elements) in the promoter of human AID and other DNA daminases, 
using bioinformatic analysis (Figure 15). This indicated potential EREs and PREs 
in  human  AID  promoter  region  and  putative  response  elements  in  mouse   94
Apobec3 and human APOBEC3F and -3G. 
 
                
Figure 13. Schematic representation  of the putative  hormone response elements in DNA 
deaminase  promoter  regions.  The  promoter  regions  were  analysed  by  bioinformatics  using 
AliBaba2.1  transcription  factor  response  element  predicting  program  and  Transfac  4.0 
transcription  factor  binding  site  database,  to  identify  potential  estrogen  response  elements 
(marked with red) and progesterone response elements (marked with yellow) in the proximity of 
DNA deaminase  promoter regions. Arrow depicts the transcription start site  and  green  boxes 
depict exons. +/-k marks the distance in kilobasepairs downstream or upstream of transcription 
start site. 
 
 
 
To examine which of these elements is functional, we dissected the AID 
promoter 1.5 kb upstream and 2 kb downstream of the ATG region and analysed 
these  fragments  for  hormone  responsiveness  in  a  heterologous  transcription 
assay.  For  this,  promoter  fragments  were  PCR  amplified,  inserted  into  a 
luciferase reporter construct containing a minimal promoter and transfected into 
SiHa cervical cancer cells (Figure 16A). Thereafter, cells were treated with the 
indicated hormones (or co-transfected with expression plasmids), and analyzed 
for luciferase activity. The results were  normalised to control treatments with 
DMSO. Estrogen responsiveness could be seen on the upstream (Fragment C) 
region (Figure 16B). Since we did not detect any changes to estrogen at the most 
ATG  proximal  ERE  (Fragment  A)  or  Fragment  E, these  fragments  were  not 
studied further. However, these results did not rule out the possibility that the 
putative ERE near the promoter is functional in other cell lines, as there can be   95
heterogeneity in the responsiveness to estrogen in different cell lines (Cerillo et 
al., 1998) or a potential cooperation between the proximal and distal putative 
EREs on Fragment C. Additionally, depending on the stimulus, a cooperative 
action between transcription factors might exist in vivo (see below).  
Aside from a putative ERE, Fragment C also harbored the two published 
NFκB binding sites (Dedeoglu et al., 2004). As already indicated by the qRT-
PCR analysis (Figure 11A), estrogen and NFκB pathway (LPS/IL4) could act 
synergistically on AID mRNA production. The co-treatment of the SiHa cells 
with estrogen and TNFα (known to activate the NFκB pathway), resulted in a 
synergistic  induction  of  the  AID  promoter,  compared  to  TNFα  or  estrogen 
treatment  alone.  Interestingly,  the  effect  was  only  detected  at  low  estrogen 
concentrations, ranging from 0.1 nM to 10 nM (Figure 16C). This effect was 
abolished  at  higher  estrogen  concentrations,  and  even  indicated  a  modest 
decrease, suggesting a complex interplay of these signals. To see whether NFκB 
and  estrogen  pathways  can  activate  AID  separately  from  each  other,  cells 
transfected with Fragment  C construct were treated with TNFα  and estrogen, 
while co-transfected with the dominant negative mutant of IκBα (S32A/S36A - 
IκBα-mt); a mutant that inhibits the release of NFκB from the cytoplasm into the 
nucleus  after  stimulation.  Although  TNFα  mediated  activaton  of  NFκB  was 
inhibited by IkBα-mt as expected, estrogen was able to independently activate 
the transcription (Figure 16D). 
To  identify  possible  PREs,  cells  were  stimulated  with  TNFα  and 
progesterone followed by the analysis of luciferase signal. TNFα was used to 
activate NFκB, because we would not be able to examine the inhibitory effects of 
progesterone without prior stimulation of AID expression. When compared to 
DMSO  treatment,  a  decrease  in  luciferase  activity  was  detected  upon 
progesterone treatment on the fragment containing the NFκB sites (Fragment C – 
Figure 16E). This indicates that the TNFα and hormone response elements in the 
AID promoter can either act in synergistically or inhibitory fashion, as for ERE 
and PRE, respectively. 
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Figure 14. Human AID promoter analysis for hormone response elements. (A) Schematic 
representation of potential ERE (square), potential PRE (triangle) and NFκB sites (circle), and 
their  locations  in  the  human  promoter.  The  indicated  promoter  regions  (marked  A-E)  were 
inserted  into  a  luciferase  reporter  construct  with  a  minimal  promoter.  The  vectors  were 
transfected  into  SiHa  cells, incubated for 24  h, treated  for  4 h  with hormones  or  TNFα  and   97
analyzed  for luciferase activity. (B) Relative luciferase activity  after estrogen treatment. Cells 
were transfected with constructs containing AID promoter fragments and treated with estrogen for 
4 h. (C) Effect of TNFα and estrogen on the human AID promoter. Expression construct with 
Fragment C (region containing NFκB sites and putative ERE and PRE) was transfected into cells 
followed by TNFα and/or estrogen treatment for 4 h. (D) Estrogen can act independently from 
NFκB. Cells were co-transfected with Fragment C and  an  IκBα dominant  mutant  expression 
vector.  After  24  h,  cells  were  treated  with  TNFα  and/or  100  nM  estrogen  for  4  h.  (E) 
Progesterone represses TNFα mediated induction of AID. Constructs were transfected into cells 
followed by TNFα treatment or TNFα and 200 nM progesterone co-treatment or for 4 h. Time-
lines of cell treatments are indicated below the graphs. NT - not treated. Published in (Pauklin et 
al., 2009b; Pauklin and Petersen-Mahrt, 2009). 
 
 
4.1.2.4 Estrogen response element binding in B-cell extracts.  
Since we observed an increase in the luciferase signal in one of the AID promoter 
fragments containing a putative ERE, we determined if this element was bound 
by the estrogen receptor in vitro. We prepared nuclear extracts from estrogen 
treated and untreated Ramos cells (estrogen treatment on AID mRNA in Ramos 
cells is shown in Appendix Figure 2A) and analysed the binding of ER (focusing 
on  the  more  widely  expressed  subtype  ERα)  to  AID  promoter  segments  by 
electromobility  shift assay (EMSA) (Pauklin et  al., 2009b). For this, a 34 bp 
fragment  containing  the  5’  most  putative  ER  binding  site  (Fragment  C)  was 
incubated with untreated and treated extract (Figure 17B lanes 2 and 3). Estrogen 
treatment induced a shift (arrow), which was not present when cells were treated 
with TNFα (lane 4). Treatment with estrogen and TNFα had the same effect as 
estrogen alone (lane 5), indicating that the two pathways act through different 
nuclear proteins. Competition experiments with an ER binding site (lanes 6 - 8) 
or a mutation of the proposed ER site (lanes 9 - 11), showed ER like binding 
kinetics. Using antibodies to the DNA binding domain of ERα strongly inhibited 
the formation of the estrogen induced band (Figure 17C lanes 2 vs. 3 - 5), but the 
shift was unaffected by a control antibody (lanes 2 vs. 6 - 8 arrow). The anti-ERα 
antibody induced the appearance of a high-molecular weight complex (triangle in 
lane  5),  which  could  be  due  either  to  the  supershift  of  a  dimerized  ERα  or 
heterodimer ERα/ERβ, but this was not analysed further.   98
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Figure 15. Identification of ER binding to human AID promoter by EMSA. (A) Schematic 
representation  of  human  AID  promoter  region  (as  in  Figure  16A).  The  position  of  the 
oligonucleotide  used  for  EMSA  is  marked  as  a  black  line.  (B)  Estrogen  (E)  induced 
oligonucleotide shift (marked with an arrow) in Ramos nuclear extracts. Cells were treated for 72 
h in hormone-depleted serum, followed by 4 h treatment with 10 nM estrogen (lanes 3, 5 - 11) 
and/or TNFα (lanes 4 and 5), and nuclear extract preparation. Different concentrations (1-, 3- and 
10-fold excess) of unlabeled competitors ER (lanes 6 – 8) and mutated ER mut (lanes 9 - 11) were 
added  to  the  binding  reaction.  (C)  Supershift  assays  with  anti-ERα  antibodies.  Increasing 
concentrations  of  anti-ERα  antibody  and  a  non-specific  antibody  were  added  to  the  binding 
reaction (see 3.2.2.22). The estrogen-induced band is marked with an arrow, and a super-shifted 
band appearing upon anti-ERα antibody addition is marked with triangles. Published in (Pauklin 
et al., 2009b). 
 
 
In order to test, whether NFκB binding to the NFκB site was affected by 
estrogen after the combined treatment, we probed the published distal NFκB site   99
(Dedeoglu et al., 2004) in our extracts. Using cold competitors (Figure 18B lanes 
4 vs. 6-11) as well as anti-NFκB antibodies (Figure 18C), the specificity of NFκB 
binding sites for binding of NFκB was shown. The specific antibody caused a 
supershift and the cold competitors induced a decrease in band intensity. As with 
the ER binding site, NFκB binding was not altered by co-treatment with estrogen 
and TNFα (Figure 18B, lanes 4 vs. 5). Thus, the respective treatments did not 
alter  the  general  binding  properties  of  ER  or  NFκB  to  the  DNA.  Since  the 
distance on the AID promoter between the ER and NFκB sites was larger than the 
EMSA  probes  (i.e.  neither  probe  contained  both  binding  sites),  cooperative 
binding of these transcription factors was studied by ChIP.  
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Figure  16.  Estrogen treatment  does  not  affect  NFκB  binding  to  its response  element in 
human  AID  promoter.  (A)  Schematic  representation  of  human  AID  promoter  region  as  in 
Figure  16A.  The  position  of  the  oligonucleotide  used  for  EMSA  containing  the  distal NFκB 
response element is depicted as a black line. (B) The appearance of two oligonucleotide shifts 
(marked with arrows) upon cell treatment with TNFα. Ramos cells were treated as in Figure 17. 
Different concentrations of cold competitors (NFκB - lanes 6-8) and mutated (NFκBmut - lanes 9-
11) competitors were used to assess the specificity of these bands for NFκB binding. (C) EMSA 
with anti-NFκB antibodies. Cells were treated as in Figure 17 using anti-NFκB antibodies. The 
disappearing  band  and  a  super-shifted  band,  which  appears  upon  anti-NFκB  p65  antibody 
addition, are marked with a black arrow/star and triangles, respectively, indicating that one of the 
shifted bands contained NFκB p65. NT - not treated. Published in (Pauklin et al., 2009b). 
 
 
4.1.2.5  Estrogen  receptor  and  progesterone  receptor  binding  to  AID 
promoter in vivo. 
In order to determine whether ER could bind to AID promoter in vivo, chromatin 
immunoprecipitation (ChIP) assays were performed on Ramos cells, followed by 
qRT-PCR.  Treated  cells  were  fixed,  lysed,  sonicated,  ERα  or  NFκB 
immunoprecipitated, and the DNA released for PCR. The results indicated that 
the  anti-ER  antibody  specifically  immunoprecipitated  AID  promoter  upon 
estrogen stimulation in a dose dependent manner, whereas a control antibody was 
unable to precipitate this region (Figure 19B). As in EMSA assay, an increase in 
ER binding to AID promoter was observed when cells were treated with estrogen 
alone or co-stimulated with TNFα and estrogen. The ERα binding to the AID 
promoter was partially abolished by co-treatment with tamoxifen (Figure 19B). 
Treatment of the cells with TNFα increased the binding of NFκB to the AID 
promoter (Figure 19C). Interestingly, co-stimulation of the cells with TNFα and 
estrogen had a synergistic effect on the NFκB binding - the binding increased 4.5 
fold above TNFα alone. This suggests that NFκB and estrogen pathways can co-
operate in the regulation of AID expression. 
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Figure 17. Identification of ER binding to human AID promoter by ChIP. (A) Schematic 
representation of human AID promoter region (as in Figure 16A). The region amplified by qRT-
PCR for ChIP is marked as a dashed line. (B) ERα binds to upstream region of human AID 
promoter.  Cells  were  treated  as  in  Figure  17B  and  data  is  represented  as  a  relative  change 
compared to  control (NT). ChIP was performed using anti-ERα or control antibodies and the 
bound DNA was subjected to qRT-PCR. Estrogen treatment is marked with E1 (E 1 nM) and E10 
(E 10 nM). (C) Estrogen can cooperate with TNFα in recruiting NFκB to AID promoter. ChIP as 
in  (B)  using  anti-NFκB  or  control antibodies.  NT  -  not  treated.  Published  in  (Pauklin  et al., 
2009b). 
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To investigate whether progesterone exerts  its effects  via PR binding to 
AID  promoter,  Ramos  cells  were  utilized  for  ChIP.  Cells  were  treated  with 
progesterone (the effects of progesterone on AID mRNA in Ramos are shown in 
Appendix Figure 2C), TNFα or with progesterone and TNFα simultaneously. 
Treatment of the cells with TNFα increased the binding of NFκB to the AID 
promoter (Figure 20E). The anti-PR antibody specifically immunoprecipitated the 
AID  promoter  upon  progesterone  treatment,  but  a  control  antibody  failed  to 
precipitate this region (Figure 20D). Interestingly, co-treatment of the cells with 
TNFα  and  progesterone  revealed  that  both  NFκB  and  progesterone  receptor 
bound to AID promoter at the same time (Figure 20D and E). This suggests a 
mechanism, where progesterone receptor binding to the AID promoter, which 
leads to a decrease in AID transcription, does not abolish NFκB binding to the 
promoter. Since gene repression can be mediated by physical alteration of the 
interactions between transcription factors and the basal transcription machinery, 
one can not rule out the possibility that progesterone receptor mediated repression 
of AID promoter utilizes this mechanism. Primers near the NFκB sites in human 
AID  promoter  were used  for qRT-PCR  on  ChIP  samples.  By  comparing  the 
relative signal increase that was amplified by these primers, the major binding 
region of PR was located to the proximity of the NFκB binding region (Figure 
20B). It remains to be determined, whether progesterone receptors might also 
engage  in  the  regulation  of  AID  expression  upon  the  activation  of  different 
signaling pathways, which rely on transcription activators other than NFκB.  
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Figure 18. Progesterone receptor is recruited to the AID promoter. (A) Schematic drawing of 
AID  promoter region.  The five qRT-PCR products tested in the ChIP  are indicated  as (I-V). 
Triangle - putative PRE, rectangle - putative ERE and circles - NFκB sites (B) ChIP of 4 h un-, 
TNFα-, progesterone-, and TNFα/progesterone-treated Ramos cells. ChIP was carried out with 
anti-PR antibody, and the de-crosslinked DNA was analysed by qRT-PCR. Each PCR fragment 
was 150 bp in length and the center position (in bp upstream of the start site) of each of the 
fragments is indicated next to the color legend. Results are normalized to input DNA. Signal 
strength is presented as in Figure 19. Standard deviations are derived from three independent 
experiments. The time line of treatments is shown at the bottom of the figure. (C) Schematic 
drawing of AID locus with emphasis on ChIP region III (from A). (D) ChIP with anti-PR and 
control antibody followed by qRT-PCR of region III. Cells were treated or for 4 h; data analyzed 
as in B. (E) As D but using an anti-NFκB antibody for ChIP. Published in (Pauklin and Petersen-
Mahrt, 2009). 
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4.1.2.6 Estrogen up-regulates whereas progesterone down-regulates AID 
protein production. 
In  order  to  determine  if  the  effect  of  estrogen  and  progesterone  on  AID 
expression would also extend to the protein level, a quantitative approach for 
measuring AID protein was developed. For this, a DT40 cell line (a chicken B-
cell lymphoma that constitutively expresses AID and undergoes immunoglobulin 
diversification; described in 4.2.1) was generated to express a 3FLAG-2TEV-
3Myc fused to the C terminal exon of endogenous AID. The modified DT40 
expresses a wt AID protein as well as an AID-FLAG-TEV-Myc fusion protein, 
both transcribed from the endogenous AID locus (the generation of the cell line is 
described in more detail in 3.2.3 and in 4.2.2.1).  
By comparing the qRT-PCR induction kinetics with that of the AID-FLAG-
TEV-Myc protein signal on a quantitative western blot, AID protein levels were 
found  to  correspond  to  mRNA  levels  when  cells  were  treated  with  estrogen 
(Figure 21A and B). By using the translation  inhibitor cycloheximide (Figure 
21C) we were able to assess AID protein degradation as published previously 
(Aoufouchi et al., 2008). Estrogen treatment did not increase tagged AID protein 
sfter cycloheximide treatment, indicating that this hormone did not affect AID 
protein stability but functioned at the gene transcription stage. On the other hand, 
proteasome  inhibitor  MG-132  treatment  increased  the  fusion  protein  levels 
compared to MG-132 alone (Figure 21C), consistent with the observations by 
(Aoufouchi  et  al.,  2008).  In  addition,  estrogen  treatment  resulted  in a  further 
increase  in  AID fusion protein at  a comparable  change  as estrogen  treatment 
alone, suggesting that estrogen was not affecting the proteasome to increase AID-
FLAG-TEV-Myc protein. 
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Figure 19. The effects of estrogen on AID protein in DT40. (A) Estrogen induces AID mRNA 
expression. DT40 cells tagged with AID-FLAG-TEV-Myc were treated with DMSO, 100 nM 
estrogen, and 10 nM estrogen with TNFα, and analyzed for AID mRNA expression with qRT-
PCR  at  various  time-points.  (B)  Estrogen  induces  AID-FLAG-TEV-Myc  fusion  protein 
expression.  Treatment  as  in  (A)  but  lysates  were  analyzed by  quantitative  Western  blot (see 
3.2.2.18). For each sample, FLAG and  Tubulin expression was quantitated. The  bar graph is 
derived from correlating the FLAG expression to Tubulin expression, and then determining the 
ratio of estrogen induced FLAG expression to untreated DMSO samples. (C) Estrogen does not 
affect AID-FLAG-TEV-Myc fusion protein stability. Cells were incubated with CHX or MG-132 
for  2  h,  prior  to  estrogen  treatment  for  4  h.  Protein  levels  were  determined  by  quantitative 
Western blot. For all experiments, cells were grown in hormone depleted media for 48 h. Results 
are normalized to control treatments as indicated on each graph. Time-lines of cell treatments are 
indicated below the graphs. Published in (Pauklin et al., 2009). 
 
Cells were also treated with TNFα or TNFα together with progesterone and 
analysed for mRNA and protein levels of AID in response to these treatments. As   106
with the effect on mRNA (Figure 22A), progesterone treatment of the modified 
DT40 cells showed a decrease in AID-FLAG-TEV-Myc production over time 
(Figure 22B). This indicated that progesterone exerted its effects on AID mRNA 
and thereby on AID protein. 
 
Figure 20. The effects of progesterone on AID protein in DT40 cells. (A) Progesterone inhibits 
AID mRNA expression in DT40. AID-FLAG-TEV-Myc tagged DT40 cells were treated with 200 
nM progesterone and/or TNFα, and then analyzed for AID mRNA expression by qRT-PCR at 
various time-points (3 samples for each treatment). (B) Progesterone inhibits tagged AID protein 
expression. Treatment as in (B) but lysates were analyzed for FLAG epitope expression using 
quantitative  Western  (pooled  analysis  from 3  samples  per treatment). Images  of  Western are 
shown above, and quantitations of bands below. Time-line of treatments is indicated below the 
figures. Published in (Pauklin and Petersen-Mahrt, 2009). 
 
 
4.1.2.7 Hormonal regulation of CSR, SHM, and translocations. 
AID is essential for triggering class switch recombination, therefore the potential 
effects of estrogen and progesterone mediated regulation of AID were analysed 
on the level of class switch recombination. B-cell stimulation with LPS, LPS and 
IL4, LPS and IFN-γ, or LPS and TGF-β causes isotype switching to IgG3, IgG1 
and IgE, IgG2a or IgG2b/ IgA, respectively. During this process, a circular DNA 
called a switch circle is formed, that contains a recombined transcription unit, 
producing a switch circle transcript (Appendix Figure 5). Using circle transcript 
analysis  combined  with  qRT-PCR  (Kinoshita  et  al.,  2001),  alterations  were   107
observed in the switching to IgG1, IgG3, IgA or IgE after hormone treatment of 
splenic  B-cells  (Figure  23A).  Similarly  to  AID  mRNA  induction,  estrogen 
enhanced switch circle formation and this increase was attenuated by tamoxifen, 
although additional effects of estrogen on circle transcript formation can not be 
ruled out. In addition to switch circle analysis, we sequenced the γ3 switch region 
in AID heterozygous mice stimulated with LPS for 6 days and found an increase 
in  mutations  in  this  locus  in  response  to estrogen  treatment  compared  to  the 
control sample (Figure 23B; Appendix Figure 3C). 
To further analyse SHM, a derivative (Ramos HS13) of the constitutive 
AID expressing and mutating Burkitt lymphoma Ramos was utilized (Sale and 
Neuberger, 1998). This cell line possesses a premature stop codon in the Ig λ 
locus within an AID target motif WRC. When AID targets this codon, it can be 
converted to a sense codon, allowing IgM surface expression, thereby giving a 
possibility to analyse SHM. In Ramos HS13 cells, AID mRNA was modestly up-
regulated upon estrogen treatment (Appendix Figure 2A). Surface IgM negative 
cells were single cell sorted and grown in the presence of hormones for 20 cell 
generations (3 weeks), followed by surface IgM expression analysis (Appendix 
Figure  2B).  In  a  similar  trend  to  AID  mRNA,  surface  IgM  expression  was 
increased by estrogen treatment. To monitor a change in mutation frequency, the 
VH  region  of  estrogen  treated  cells  was  also  sequenced,  which  showed  an 
increase in mutation frequencies (Figure 23B - ‘Ramos VH’).  
AID can be mis-targeted to non-immunoglobulin genes, causing mutations 
and subsequently oncogenesis. To determine, if estrogen induced AID can also 
lead to an alteration  in non-Ig  loci, the sequence of the pro-apoptotic tumor-
suppressor CD95/Fas was examined in Ramos HS13. This gene has been shown 
to be somatically hypermutated in human B-cells, albeit 100 to 1000 fold less 
frequently than the Ig genes (Muschen et al., 2000). The genomic DNA of the 
above treated cells were PCR amplified and sequenced in the 5’ region of the Fas 
locus. Similarly to the B-cell maturation events of SHM and CSR, estrogen was 
able to increase the mutation frequency in Fas (Figure 23B). Because of the direct 
effect  of  AID  function  on  mutations,  the  upregulation  of  AID  expression  by 
estrogen indicates a novel way in which estrogen can exert a direct mutagenic 
effect on oncogenes or tumor suppressors.   108
 
 
 
Figure 21. Hormonal effects on Ig class switching, hypermutation, and translocation. (A) 
Estrogen induces Ig class switching. Isolated mouse splenic B-cells were stimulated for 48 h with 
LPS +  IL4 for switching to IgG1 and  IgE, LPS +  TGF-β for switching to  IgA, and LPS  for 
switching  to  IgG3.  Indicated  amounts  of  estrogen  and/or  tamoxifen  were  added  to  the  cells 
together with cytokines. Relative efficiency of class switching was determined by detecting circle 
transcripts with qRT-PCR and data is normalized to the control treatment with DMSO from three 
independent experiments  (error  bars  indicate  standard  deviations).  (B)  Estrogen  increases the 
mutation frequency in VH and CD95/Fas loci of Ramos, and Sγ3 of splenic mouse cells. Ramos 
cells were grown in the presence of 100 nM estrogen for approximately 20 doublings, followed 
by sequencing of 341 bp from human VH, or 750 bp from human CD95/Fas locus. Splenic mouse 
cells were treated for 6 days with LPS and 10 nM estrogen (details in Appendix Figure 3), and 
switch Sγ3 loci  amplified  and sequenced. Mutation  frequencies are normalized to the control 
treatments with DMSO. A standard unpaired two-tailed T-test showed a significant difference in 
mutation  frequency in the Sγ3 loci of DMSO and estrogen treated spleen cells. (C) Estrogen 
enhances the c-myc/IgH translocations in splenic B-cells from p53 +/- mice. In each experiment 2 
spleens per sample were treated with or without 50 nM estrogen in the presence of LPS for 72 h. 
More  than  7x10
7  cells  were  analysed  by  long-range  PCR  (5x10
4  cells/PCR;  see  3.2.2.16). 
Frequency was determined as c-myc/IgH translocation events per cell number analysed. Statistics 
was performed on the results of the pooled experiments (two tailed, unpaired T-test: p = 0.026). 
Published in (Pauklin et al., 2009b). 
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The off-target effect of AID can also be observed in translocation events 
between  the  IgH  locus  and  c-myc  oncogene  (Ramiro  et  al.,  2004).  Using  a 
previously described assay, we found that estrogen treatment of LPS stimulated 
splenic B-cells  increased c-myc/IgH translocations in p53 +/- animals (Figure 
23C). Despite a low frequency of translocation of events, we found five (2 in one 
and  3  in  another  experiment)  translocations  in  the  LPS/estrogen  treatment, 
whereas  no  translocations  were  observed  in  the  control  LPS/DMSO  treated 
sample.  This  suggests,  that  mis-targeting  of  estrogen-induced  AID  can  cause 
translocations in thus have pathogenic consequences to the cell.  
As  for  estrogen,  we  also  analysed  the  effects  of  progesterone  on  class 
switching and somatic hypermutation. Progesterone treatment of stimulated B-
cells  resulted  in  a  decrease  in  class  switching  (Figure  24A),  mimicking  the 
attenuation  of  AID  mRNA  induction  upon  B-cell  stimulation  (Figure  11A). 
Surface  IgM  analysis  in  Ramos  HS13  cells  indicated  a  decrease  in  SHM 
Figure  24.  Progesterone  inhibits  CSR  and  SHM.  (A)  Progesterone  inhibits  isotype 
switching.  Isolated  mouse  splenic  B-cells  were  stimulated  for  48  h  with  LPS  +  IL-4  for 
switching to IgG1 and IgE, LPS + TGF-β for switching to IgA, and LPS for switching to IgG3. 
Indicated amounts of progesterone were added to the cells together with cytokines. Relative 
efficiency of class switching was determined by detecting circle transcripts with qRT-PCR and 
data is normalized to the control treatment with DMSO from three independent experiments 
(error bars indicate standard deviations). (B) Progesterone decreases the mutation frequency. 
Using a cell culture surface IgM reversion assay, human Ramos cells were grown as indicated 
in Appendix Figure 4A and B, followed by sequencing of 341 bp from the rearranged VH 
(VH186) or 750 bp from human CD95/Fas locus. Mouse splenic B-cells were treated for 6 
days with LPS and 200 nM progesterone. Genomic DNA was amplified and 750 bp of the Sγ3 
region  sequenced  (details  provided  in  Appendix  Figure  4C).  Mutation  frequencies  are 
normalized to the control treatments with DMSO. Published in (Pauklin and Petersen-Mahrt, 
2009). 
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(Appendix  Figure  2D  and  E).  In  addition,  there  was  a  decrease  in  mutation 
frequencies  in  the  VH  region  and  CD95/Fas  locus  in  Ramos  HS13,  and  a 
decrease in mutations in γ3 switch region in mouse splenic B-cells (Figure 24B 
and Appendix Figure 4).  
 
4.1.2.8 AID induction by estrogen is not limited to B-cells. 
AID  expression  has  been  detected  in  tissues  outside  B-cells  such  as  oocytes 
(Morgan et al., 2004). We therefore analysed whether the increase in AID mRNA 
production by estrogen would also be detectable in dissected tissues. The analysis 
showed, significant AID responsiveness to hormones in ovarian tissue and to a 
lesser extent in breast tissue, even though the signal was much lower compared to 
B-cells (Figure 25 and 26). Since the relative increase in AID mRNA was higher 
Figure 25. Estrogen induces AID and Apobec3 transcription in mouse tissue. The red and 
blue colors indicate the results for mApobec3 and mAID, respectively. Tissues were treated 
with DMSO, 1 nM estrogen (E1), or 10 nM estrogen (E10). Gene expression is normalized to 
the control treatments with DMSO. The tissue expression profiles represent pooled data for the 
respective tissues from two experiments. Time-lines of cell treatments are indicated below the 
graphs. Published in (Pauklin et al., 2009b). 
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in oocytes (reaching approximately 25 fold) than in other tissues, it is likely that 
this  increase  was  predominantly  due  to  ovarian  derived  tissue  and  not 
contaminating B-cells.  
 
 
 
Figure 22. Absolute values of AID and Apobec3 mRNA in mouse tissues. Absolute qRT-PCR 
values as compared to GAPDH expression from Apobec3 data (light red) and AID data (blue) of 
Figure 25. In the upper panels, values are plotted on a linear scale, and in the lower panels, values 
are plotted on a logarithmic scale. Published in (Pauklin et al., 2009b). 
 
 
4.1.2.9 Estrogen activates APOBEC3B, 3F and 3G mRNA transcription. 
The  regulation  of  AID  by  estrogen  raised  the  question  whether  a  similar 
regulation is conserved among other AID/APOBEC family members. qRT-PCR 
primers to detect APOBEC family member mRNAs in mouse and human cells 
were designed and the expression of APOBEC genes examined upon estrogen 
treatment  (Figure  25  and  26).  Estrogen  treatment  led  to  an  increase  in 
transcription  of  the  mouse  Apobec3  in  ovaries,  spleen,  and  splenic  B-cells. 
Expression  of  human  APOBEC3B,  3F  and  3G  family  members  were  also 
enhanced upon estrogen treatment in several different cell lines (including: T-
cell, ovarian, placental, and cervical  origin)  (Table  10).  APOBEC2, a related   112
member  of  the  DNA  deaminases  without  any  apparent  catalytic  activity 
(Conticello et al., 2005), was not affected by estrogen treatment. Since AID is 
considered as the ancestor to APOBEC3 genes, the regulation of estrogen of AID 
and  other  family  members  suggests  that  this  might  be  conserved  mechanism 
among these genes. 
 
 
Table 10. Estrogen induces the transcription of AID and some APOBEC3 family members 
in various hormone-responsive human cell lines. The indicated human cell lines were treated 
with 1 nM or 10 nM estrogen (E1, E10) or 50 nM tamoxifen (T50) for 4 h, followed by gene 
expression analysis by qRT-PCR. Results are normalized to control treated cells. Small numbers 
below the fold induction indicate standard deviations for three independent experiments. Yellow, 
orange and red rectangles indicate the extent of fold induction in response to these treatments. 
Time-line of cell treatments are indicated below the table. Published in (Pauklin et al., 2009b).  
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4.1.3 Discussion 
The inactivation of AID abolishes SHM and CSR, as has been observed in AID 
knockout  mice  (Muramatsu  et al., 2000)  and human  patients with the type  2 
hyper  IgM  (HIGM)  syndrome  (Revy  et  al.,  2000).  On  the  other  hand,  if 
overexpressed  or  misregulated,  AID  can  act  as  a  mutator  and  lead  to 
translocations  and  mutations  in  several  oncogenes  and  tumorsuppressors. 
Therefore, AID expression needs to be regulated, to allow for efficient immune 
responses, and at the same time, to avoid the harmful genotoxic effects. In this 
study, I have identified steroid hormones estrogen and progesterone as regulators 
of AID. The regulation of AID by estrogen and progesterone seems to be direct, 
since estrogen receptor and progesterone receptor are able to bind AID promoter 
(Figure 19 and 20). Estrogen is able to increase the transcription of AID, thereby 
resulting  in an upregulation of AID mRNA (Figure 11A) and protein (Figure 
21B). Progesterone, on the other hand, decreases AID mRNA (Figure 11A) and 
protein  production  (Figure  22B).  In  addition,  these  ER  and  PR  engage  in 
crosstalk  with  factors  that  participate  in  AID  regulation,  including  the  NFκB 
pathway (Figure 16). The interaction between estrogen and NFκB is complex, 
since the co-activation of these factors can result in synergistic induction of AID 
expression  at  low  estrogen  concentrations,  but  looses  this  effect  at  highes 
estrogen concentrations (Figure 16C). On the other hand, progesterone represses 
NFκB mediated induction of AID expression (Figure 16E). 
Although  hormones  are  involved  in  many  aspects  of  development,  the 
extent of their functioning, as well as their exact molecular effector mechanisms, 
are  not  well  understood.  There  is  a  correlation  between  the  expression  of 
hormones  or  their  cognitive  receptors  and  the  development  of  some  gender 
related  cancers  and  autoimmune  diseases.  Estrogen  and  its  biological  and 
synthetic derivates are considered oncogenic for at least breast and ovarian tissue 
(Roy  and  Liehr,  1999;  Yager  and  Davidson,  2006).  Early  menarche,  late 
menopause and length of reproductive life, and factors consistent with prolonged 
exposure to  endogenous  estrogens,  have  consistently  been  associated  with an 
increased  risk  of  breast  cancer  in  post-menopausal  women.  This  is  at  least 
partially caused by the stimulation of cell proliferation, changes in differentiation 
and  DNA  repair  and  repression  of  apoptosis  (Yager  and  Davidson,  2006).   114
However,  my  results  suggest  an  additional  possibility  how  estrogen  might 
promote cancer – that is via upregulating AID expression. These results indicate 
that  AID  expression  is  increased  by  estrogen  (Figure  11A),  which  casuses 
stimulation  of  its  downstream  processes,  somatic hypermutation  (Figure 23B) 
and class switch recombination (Figure 23A). Besides the Ig locus, there seems to 
be an increase in AID mediated mutations also in non-Ig loci, since the mutation 
frequency in tumorsuppressor Fas was increased upon estrogen treatment (Figure 
23B). This imposes a threat to the cell that expresses AID, since mutations in 
tumor suppressors or oncogenes can result in the deregulation of apoptosis or 
constitutive  cell  growth,  ultimately  leading  to  malignancies.  Indeed,  previous 
work has shown that somatic hypermutation can result in mutations in various 
non-Ig loci such as BCL-6, Fas, p53, or c-myc (Kuppers and Dalla-Favera, 2001; 
Muschen  et  al.,  2000;  Pasqualucci  et  al.,  2001).  Furthermore,  forced  AID 
expression outside the immune system can cause tumor formation (Okazaki et al., 
2003). This is relevant for ovarian tissue, since I observed approximately 25-fold 
induction of AID in mouse ovaries (Figure 25 and 26). The treatment of the cells 
with estrogen also led to an increase in c-myc translocations (Figure 23C). These 
translocations  are  frequently  identified  in  lymphomas,  but  analogous 
translocations could potentially occur in some hormone-responsive tissues upon 
estrogen mediated induction of AID.  
In addition to oncogenesis, defects in apoptosis are also attributed to some 
B-cell  mediated  autoimmune  pathologies.  Since  estrogen  is  involved  in  the 
gender bias in some autoimmune diseases such as SLE, the regulation of AID by 
this  hormone  could  mechanistically  link  gender  related  malignancies  and 
autoimmune pathologies. Over-expression of AID  in  autoimmune prone mice 
induced a more severe SLE-like disease (Hsu et al., 2007), while breeding AID 
deficient  mice  with  autoimmune  prone MRL/lpr mice reduced the on-set  and 
extent  of  disease  (Jiang  et  al.,  2007),  suggesting  that  alterations  in  AID  can 
change the severity of B-cell autoimmunity. Future studies could address the role 
of estrogen induced AID in mouse models of these diseases. 
In contrast to the effects of estrogen on AID expression and downstream 
effects, progesterone represses AID function in somatic hypermutation (Figure 
24B)  (both  in  the  Ig  locus  and  CD95/Fas  gene)  as  well  as  class  switch 
recombination  (Figure  24A).  The  attenuating  effect  of  progesterone  on  AID-  115
induced  processes  could  therefore  decrease  some  immune  responses,  which 
might be relevant during pregnancy, helping to avoid the destruction of the fetus 
by mother’s immune system (Druckmann and Druckmann, 2005). The decrease 
in  mutation  frequencies  outside  the  Ig  locus  indicates,  that  this  regulatory 
mechanism  could  in  some  instances  result  in  fewer  off-target  pathological 
mutations due to progesterone. 
Interestingly, the hormonal regulation of DNA deaminases was not limited 
to  AID, but  was  also  evident  (to  a  varying  extent)  for  murine  Apobec3  and 
several human APOBEC3 family members, especially for APOBEC3B, -3G and 
-3F (Figure 25 and Table 10). These proteins are essential anti-viral factors in 
higher  mammals,  inhibiting  the  movement  of  retro-transposable  elements  and 
retroviral infections (Harris and Liddament, 2004). Therefore, it is possible that 
the upregulation of APOBEC3 genes by estrogen  in some cell types, such as 
oocytes, might have a physiological role in inhibiting the movement of retro-
transposable elements.  
In  conclusion,  I  have  identified  estrogen  and  progesterone  as  novel 
regulators for AID that influence AID expression and its down-stream processes 
that could contribute to the regulation of immune responses but also be involved 
in pathological conditions such as cancer and autoimmunity.  
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4.2 Identification of AID-interacting proteins. 
 
 
4.2.1 Introduction. 
When AID was discovered, it was proposed to work on RNA as an RNA-editing 
enzyme  (Muramatsu  et  al.,  2000;  Muramatsu  et  al.,  1999).  This  notion  was 
indirectly  supported  when  AID  was  identified  to reside  predominantly  in  the 
cytoplasm (Rada et al., 2002). However, subsequent studies have shown that AID 
can enter the nucleus and initiate Ig diversification by deaminating cytosines in 
ssDNA [Reviewed in (Di Noia and Neuberger, 2007; Petersen-Mahrt, 2005)]. 
Since accessibility of DNA to the enzymatic activity of AID can potentially result 
in harmful mutations outside the Ig locus, it is likely that sub-cellular localization 
is  an  important  level  for  regulating  AID  protein  in  vivo.  Even  though  the 
localization of AID has been addressed in some studies (Aoufouchi et al., 2008; 
Ito et al., 2004; McBride et al., 2004; Patenaude et al., 2009; Rada et al., 2002), it 
is essential to study the regulation of the sub-cellular distribution of AID protein 
at its endogenous levels in B-cells that accurately recapitulates in vivo conditions.  
An important mechanism for regulating AID activity is via interacting with 
other proteins that influence AID’s localization, post-translational modifications, 
and targeting to the V and switch regions. Even though the identification of AID-
interacting  proteins  in  an  unbiased  setting  is  largely  missing,  several  AID-
interacting  proteins  have  already  been  found.  AID  can  be phosphorylated by 
PKA and interact with RPA in a phosphorylation dependent manner (Basu et al., 
2005; Chaudhuri et al., 2004). The nuclear import of AID seems to be mediated 
by its binding  to  importin  α  (Patenaude et  al., 2009).  Further potential  AID-
interacting proteins include, Mdm2 (MacDuff et al., 2006) and DNA-PKcs (Wu 
et al., 2005), both can bind to the C-terminus of AID protein. In addition, AID 
co-immunoprecipitates with RNA polymerase II (Nambu et al., 2003) and binds 
directly to CTNNBL1, a protein involved  in RNA splicing (Conticello et  al., 
2008). 
Once AID accesses the Ig locus, the distribution of AID-induced mutations 
in  this  gene  is  not  uniform  (Figure  27).  The  first  100-200  bp  from  the   117
transcription initiation site are spared from mutations, and most of the mutations 
occur after this initial region, followed by an exponential decrease during the next 
1.5-2 kb (Both et al., 1990; Lebecque and Gearhart, 1990; Longerich et al., 2006; 
Rada and Milstein, 2001). The frequency of mutations is highest in the V(D)J 
region, but it is unknown what causes this pattern of mutations. Since AID can 
interact with RNA polymerase II (Nambu et al., 2003), it is possible that the 
transcription  machinery  may  be  involved  in  establishing  this  characteristic 
mutation distribution found in the Ig loci. The lack of mechanistic understanding 
of AID mediated DNA deamination comes from the absence of data investigating 
AID-interacting  proteins  that  modulate  DNA  deamination  in  vivo.  The 
identification of AID-interacting proteins is difficult due to the lack of a suitable 
system: 1) AID is expressed in activated B-cells, restricting the choice of cells, 2) 
AID protein is predominantly localized in the cytoplasm, making it difficult to 
identify  proteins  that  form  a  complex  with  AID  in  the  nucleoplasm  and 
chromatin, and 3) there is a lack of antibodies that would immunoprecipitate AID 
protein and thus allow biochemical studies of AID in large enough quantities for 
complex analysis.  
The avian DT40 cell line has several favourable characteristics (Buerstedde 
and Takeda, 2006), which make it a suitable system for studying the biochemistry 
of  AID and for identifying  its  interaction partners:  1)  it  is a  B-cell  line  that 
expresses  endogenous  AID;  2)  it  undergoes  immunoglobulin  diversification, 
Figure 27. Schematic depiction of mutation distribution in the IgH locus. The variable region 
V(D)J is most heavily  mutated whereas the constant region (C, green) is not  mutated. SHM 
(blue) are delimited by the variable region promoter (P), appear 100-200 bp after transcription 
start  site,  peak  in  the  variable  region  and  exponentially  decrease  1.5-2  kb  3’  from  the 
transcription start site. L marks leader sequence. 
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mainly  via  gene  conversion,  making  it  possible  to  analyse  AID-mediated 
processes;  3)  it  has  a  high  rate  of  homologous  recombination,  enabling  the 
targeting of endogenous loci; and 4) it has a relatively short doubling time (10-12 
hours),  allowing  for  the  growth  of  these  cells  in  large  quantities  for  protein 
interaction studies. These features of DT40 prompted us to generate DT40 cell 
lines with tagged AID, to study the localization of endogenous AID and identify 
AID-interacting proteins in an unbiased manner. 
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4.2.2 Results. 
 
4.2.2.1 Generation of endogenously tagged DT40 cell lines. 
4.2.2.1.1 Generating Tagged AID Constructs. 
In order to generate chicken DT40 cells lines with endogenously tagged AID, we 
first constructed vectors with a partial genomic sequence of AID with various 3’ 
tags.  For  this,  AID  genomic  sequence  was  placed  into  a  pBluescript  vector, 
followed by the construction of different tags:  FLAG, Myc, FLAG-TEV-Myc 
and eGFP, and their ligation in frame with exon 5 at the 3’ end of the AID coding 
sequence  (Figure 28 and see 3.2.3).  
 
 
 
 
 
 
Figure 23. Schematic drawing of the construction of the tagged AID vectors. Different tags 
were  ligated  at  the  3’  end  of  a  chicken  AID  gene  in  a  Spe  I  and  EcoR  I  double  digested 
pBluescript plasmid. loxP sites, depicted as blue triangles, are located at the 5’- and 3’-end of a 
puromycin selection marker. 5’arm is 1 kb of the intron between exon one and exon two in the 
chicken gene and 3’arm stands for approximately 1 kb of the sequence downstream of the AID 
gene in the chicken genome. Exons are depicted as light blue, numbered squares.  Tag marks 
either FLAG, Myc, FLAG-TEV-Myc or eGFP. Stop codon is depicted as a dark yellow square. 
Not drawn to scale. 
 
 
FLAG  and  Myc  tags  were  obtained  by  hybridizing  two  complementary 
oligos, followed by ligation into the expression vector containing AID genomic 
sequence.  For  generating  FLAG-TEV-Myc,  the  tag  was  produced  from  6 
oligonucleotides with partially overlapping sequences at their ends to facilitate 
their ligation. eGFP was derived by PCR amplification from an eGFP expressing   120
plasmid (for details see 3.2.3.1). The vectors with inserts were verified both by 
digestion and by sequencing. The sequenced constructs were linearized with Not 
I before transfecting DT40 cells.  
 
 
4.2.2.1.2 Transfecting DT40 for endogenous tagging of AID locus. 
Since  the  initial  transfection  attempts  with  linearized  constructs  were  not 
successful,  indicated  by  the  absence  of  puromycin  resistant  clones,  the 
transfection  procedure  was  modified.  The  DNA  concentration  used  for  the 
transfection was decreased from 50 µg to 25 µg, the final concentration of β-
mercaptoethanol in the culture media was increased from 50 µM to 75 µM, and 
the cells were electroporated once instead of two short interval electroporations. 
This new transfection procedure generated 75, 70, 98 and 40 puromycin resistant 
clones for FLAG, Myc, FLAG-TEV-Myc and eGFP, respectively. Since some of 
the selection marker resistant clones were expected to have random integrations 
of the constructs into the genome, the clones were analyzed by southern blot. A 
southern blot probe was designed to anneal to exon 3 and intron 3 in the AID 
gene. The results from southern blot analysis of Spe I digested genomic DNA 
from puromycin resistant clones are shown in Figure 29. 
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The wild-type AID allele digested with Spe I yields a ~12 kb fragment, and 
the  tagged AID  allele  yields a  4  kb fragment, as  a  Spe  I  restriction  site  lies 
immediately upstream of the tags. Therefore, samples with bands approximately 
4  kb  indicate  targeted  integration.  Although  a  few  samples  reveal  random 
integration, many of the samples contain a 4 kb band, e.g seven out of the eight 
eGFP  and  FLAG-tagged  clones  have  a  4  kb band.  Eight  targeted  integration 
(marked with ‘*’ in Figure 29) were confirmed with a second southern blot. Here, 
the genomic DNA was digested with Mph1103I endonuclease, generating a 4.6 
kb fragment for the wild-type allele and a 7.2-8.1 kb fragment for the tagged AID 
allele.  The  second  southern  blot  verified  that  all  of  the  chosen  clones  had  a 
targeted integration (Figure 30).  
Figure  29.  Southern  blot  analysis  of  puromycin  resistant  DT40  clones  cut  with  Spe  I. 
Schematic presentation of AID genomic locus. Grey boxes mark exons 1 to 5, red box depicts the 
tag, white box marks puromycin resistance cassette, yellow box marks the location of southern 
blot probe. Genomic DNA from puromycin resistant clones from transfections with AID-FLAG, 
-Myc, -FLAG-TEV-Myc and -eGFP were digested with Spe I and analyzed on a southern blot. 
Genomic  DNA  from  wt  cells  is  included  as  a  control.  Samples  marked  with  ‘*’  were  later 
analyzed with a second southern blot. 
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Figure  24.  Southern  blot  analysis  of  selected  puromycin  resistant  DT40  clones  with 
Mph1103I.  Genomic  DNA  from  selected  puromycin  resistant  clones  were  digested  with 
Mph1103I and analyzed on a southern blot. Genomic DNA from wt cells is included as a control. 
 
 
4.2.2.1.3 Transient transfection of DT40 Cells with Cre Recombinase. 
Eight  clones  confirmed  to  contain  targeted  integration  of  tagged  AID,  were 
transiently transfected (Amaxa electroporation) with a plasmid expressing  Cre 
recombinase under the control of a CMV promoter. Expressed Cre recombines 
the  two  loxP  sites,  thereby  removing  the  puromycin  cassette.  Cells  were 
simultaneously  transfected  with  a  plasmid  containing  GFP  under  the  same 
promoter and monitored for transfection efficiency after 30 hours. Despite a low 
transfection efficiency of the cells (< 10% GFP positive), clones were  grown 
until sufficient density, and tested for puromycin sensitivity. The results from this 
test indicated a poor transfection efficiency, as we obtained 2/393 (puromycin 
sensitive clones/total number of clones) FLAG, 6/335 for Myc, 1/334 for eGFP, 
and no puromycin sensitive clones (0/323) for FLAG-TEV-Myc. The transfection 
method  was  therefore  optimized,  by  using  varying  concentrations  of  plasmid 
DNA  and  a  number  of  transfection  programs  as  recommended  by  the 
manufacturer.  The  results  of  this  optimization  experiment  indicated,  that  the 
program B023 and a plasmid amount of 3 µg should be used in the future for 
DT40  Cre  transfection  (other  conditions  indicated  more  than  2-fold  lower 
transfection efficiencies). Southern blot analysis was carried out on the selection 
marker sensitive clones, to verify that the puromycin gene has been excised out 
of  the  genome.  Two  southern  blot  investigations  of  the  puromycin  sensitive   123
clones were carried out, using either Kpn I cleaved genomic DNA (Figure 31B) 
or Mfe I cleaved DNA (Figure 31C).  
 
A) 
 
 
 
B) 
 
 
 
 
 
 
 
 
C) 
 
 
 
 
Figure 25. Southern blot analysis of puromycin sensitive clones. (A) Schematic representation 
of the AID locus in wt, targeted or Cre treated cells. Grey boxes indicated exons 1 to 5, red box 
marks  the  tag,  white  box  marks  puromycin  cassette,  yellow  box  depicts  the  location  of  the 
southern blot probe.  Genomic DNA from puromycin sensitive clones was digested with either 
(B) Kpn I or (C) Mfe I and analyzed by a southern blot. Genomic DNA from wt cells is included 
as a control. The tag-controls are samples with digested genomic DNA from clones that still carry 
the puromycin gene. Sample in which the puromycin cassette was not excised, is indicated with 
“*”. 
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Kpn I digestion of an AID allele containing a puromycin selection marker 
yields a 5.5 kb fragment, whereas an excised allele results in 3.1 kb. From Figure 
31 we can deduce that 1/2 FLAG; 6/6 Myc; 1/1 GFP and 6/6 FLAG-TEV-Myc 
clones  had  excised  the  puromycin cassette.  Mfe I  digestion  of  an  AID  allele 
containing a puromycin selection marker yields a 4.4 kb fragment, whereas an 
excised allele results in 5.7 kb. Southern blot of Mfe I cleaved samples indicated 
that the selection marker had not been excised in one of the clones with a FLAG-
tagged  AID,  confirming  the  findings  of  the  Kpn  I  southern  blot  analysis. 
Therefore, 14 clones carrying tagged AID were derived - 6 with a Myc tag, 1 
with an eGFP, 1 with a FLAG and 6 with a FLAG-TEV-Myc tag.  
The eGFP signal from the clone carrying eGFP-tagged AID was compared 
to  wild-type  cells  by  flow  cytometry,  to  confirm  that  the  fusion  protein  is 
functional and expressed. The cells were stained with propidium iodide (PI), to 
exclude dead cells from the analysis (Figure 32). The FACS analysis confirmed 
the expression of eGFP from the endogenously tagged AID allele, due to an eight 
times higher than the background signal from wild-type cells.  
 
 
 
Figure 26. Analysis of eGFP-tagged AID DT40 by flow cytometry. Number of cells (y-axis) as 
a function of the GFP signal (x-axis, logarithmic scale). Results from wild-type cells are shown 
with a purple color whereas results from cells carrying eGFP-tagged AID are shown with a green 
color. Dead cells are excluded from the analysis by PI gating. 
 
 
The FLAG, Myc and FLAG-TEV-Myc tagged cell lines were subjected to 
western blot analysis, to investigate whether the cells express the FLAG and Myc 
tagged AID. As an anti-Myc 9E11 antibody failed to detect the endogenously   125
tagged AID-Myc fusion protein, an anti-myc 9E10 antibody was used instead 
(Figure 33). 
 
 
 
Figure 27. Western blot  analysis  of endogenously tagged AID in DT40 cells. (Left  panel) 
DT40 cell lysates from control cell line (CL18-), FLAG, Myc or FLAG-TEV-Myc tagged cell 
lines, detected with anti-FLAG antibody. (Right panel) DT40 cell lysates from control cell line 
(CL18-), FLAG, Myc or FLAG-TEV-Myc tagged cell lines, detected with anti-Myc antibody. 
Triangles mark the presence of the tagged AID protein. 
 
 
 
The results indicated that all three DT40 cell lines contained a functional 
tag  and  were  expressed  in  these  cells  in  comparable  levels  to  each  other. 
Furthermore, neither FLAG antibody nor Myc antibody cross-reacted with each 
other on AID. In conclusion, AID-tag DT40 cell lines were generated, that can be 
used for detecting endogenous AID protein and for investigating AID-interacting 
proteins. 
 
4.2.2.1.4 Analysis of AID-eGFP localization in DT40. 
In  order  to  verify  that  the  detected  GFP  signal  was  specific  for  AID-eGFP 
expression, we analysed the GFP signal under a fluorescence microscope. Wild-
type  cells  and  cells  expressing  AID  tagged  with  eGFP  were  mixed  in  equal 
numbers and stained with the DNA specific fluorescent dye DRAQ5TM (Figure 
34). 
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  A) DRAQ5                      B) GFP                           C) Merge 
 
Figure 28. Endogenous expression of AID-eGFP fusion protein in DT40. Confocal images of 
eGFP and DRAG5TM signal from living wild-type cells mixed with cells expressing AID-eGFP. 
Equal numbers of wild-type and AID-eGFP DT40 cells were mixed and stained with DRAG5TM, 
followed by fluorescence microscopy.  
 
 
 
Fluorescence  microscopy confirmed  that  the  detected GFP signal  comes 
from the AID-eGFP allele, since a GFP signal was observed in approximately 
50% of the cells (Figure 34). The cellular localisation of the fusion protein was 
investigated  in the  presence of  leptomycin  B  (LMB), an  inhibitor of CRM1-
mediated nuclear export that has been reported to affect the cellular localization 
of overexpressed AID (Figure 35) (McBride et al., 2004). 
 
 
 
Figure 29. AID localization in AID-eGFP DT40 cells after Leptomycin B treatment. Live 
AID-eGFP  DT40  cells  were  analyzed  by  fluorescence  microscopy  in  the  A)  absence  or  B) 
presence of LMB. Cells were treated with 25 ng/mL LMB for 5 hours. White arrows indicate 
cells that have a significant redistribution of the eGFP signal.  
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Endogenously expressed C-terminally tagged AID resides predominantly in 
the cytoplasm as indicated by the eGFP signal (Figure 35A). After treating the 
cells  with  LMB,  the  eGFP  signal  partially  relocates  into  the  nucleus  (Figure 
35B). Even though the AID-eGFP fusion protein remains to be confirmed by 
western blotting, our results already suggest that endogenously tagged AID enters 
the  nucleus and is actively exported from the nucleus by a CRM1-dependent 
nuclear export pathway. However, the translocation of the signal into the nucleus 
was not complete, because a significant proportion of the GFP signal remained in 
the cytoplasm. Therefore, the eGFP signal 
 
4.2.2.2 Identification of AID-interacting proteins. 
DT40 cells that contain AID tagged with FLAG, Myc or FLAG-TEV-Myc, can 
be  used  for  biochemical  studies  of  AID  and  for  identifying  its  interaction 
partners. As the knowledge of proteins that interact with AID in a physiological 
environment  is  scarce,  we  aimed  to  use  the  cells  in  unbiased 
coimmunoprecipitation studies for identifying factors that form a complex with 
AID. 
 
4.2.2.2.1 Optimization of AID immunoprecipitation conditions in DT40 cells. 
In order to use our tagged AID cell lines for identifying AID-interacting proteins, 
it  was  necessary  to  optimize  the  experimental  conditions.  This  comprised  of 
various parameters, including cell lysis, number of cells per volume lysate, the 
volume of beads per volume lysate and washing conditions.   
First, cell lysis was tested using either 0.3% Triton X-100 or 0.3% NP40 as 
a detergent  in the  lysis buffer (Figure 36). The cell  lysates from DT40 AID-
FLAG-TEV-Myc  were  subjected  to  immunoprecipitation  (see  3.2.4.3),  using 
commercial anti-FLAG antibody crosslinked to agarose. Following the binding 
step, the beads were washed and the protein was eluted with a 3xFLAG peptide 
using  a  concentration  recommended  by  the  manufacturer.  The  comparison  of 
AID-tag protein signal from total cell lysates (Figure 36 lane 1-4) and from the 
flow-through (Figure 36 lane 5-6) of the pull-down indicated that AID-tag fusion 
protein  was  efficiently  bound  to  the  anti-FLAG  affinity  beads.  The  protein   128
elution fractions showed that less than 50% of the protein remained bound to the 
beads (Figure 36 lane 7-8 vs 9-10). There was also some contamination of the Ig 
heavy and light chains from anti-FLAG affinity beads, seen as a slower and faster 
migrating band compared to AID-tag protein (Figure 36 lane 7), indicating that 
bead removal conditions needed optimization. Nevertheless, the results indicated 
that both lysis conditions worked with a similar efficiency.  
 
 
 
Figure 30. Optimization of DT40 lysis conditions for AID pull-down. Cells were lysed with 
lysis buffer containing either 0.3% NP40 or 0.3% Triton-X, subjected to immunoprecipitation 
with anti-FLAG affinity beads and detected with anti-Myc antibody. The corresponding fractions 
of the pull-down experiment were compared to each other in order to estimate the efficiency of 
each step in the experiment. !/100 of total was loaded on lane (1-6), 1/4 of total was loaded (7-
10). The triangle marks AID-FLAG-TEV-Myc fusion protein. The asterisks mark Ig heavy and 
light chain contaminants from the anti-FLAG affinity beads. The film was exposed shorter for 
lanes 7-10 compared to lanes 1-6, since the signal was too strong at longer time of exposure. 
 
 
Even  though,  silver  stain  analysis  of  the  eluates  from  the  pull-downs 
confirmed that both lysis conditions were compatible with AID-FLAG-TEV-Myc 
immunoprecipitation, we  chose to  proceed  with  0.3% Triton X-100 in  future 
experiments,  because  Triton  X-100  can  be  used  in  broader  ranger  of 
concentrations without affecting the functionality of anti-FLAG beads.   129
Next, we optimized the bead volume per cell number. By using decreasing 
volumes of anti-FLAG beads during the pull-downs, we determined that 2.5  l of 
anti-FLAG affinity beads was optimal per 5 x 10
7 cells (data not shown), thus 
allowing for the scaling of the experiment while keeping the bead to cell number 
ratio. In order to use the Myc epitope for immunoprecipitation of AID in AID-
Myc  and  AID-FLAG-TEV-Myc  cell  lines,  anti-Myc  affinity  gel  had  to  be 
generated. The 9E10 anti-Myc antibody was cross-linked to cyanogen bromide 
activated sepharose, and the remaining active groups were then blocked. To test 
bead volume to cell number, various volumes of anti-Myc affinity beads were 
used for AID pull-down from AID-FLAG-TEV-Myc DT40 cell line (data not 
shown). Based on this experiment, we decided to use 15  l of anti-myc beads per 
5 x 10
7 cells. The relative difference of the optimal volumes for anti-FLAG and 
anti-Myc affinity beads  might  be due  to both,  the  lower affinity of anti-Myc 
antibody towards its epitope, as well as small differences  in the cross-linking 
efficiency of the antibodies to the beads. For determining the efficiency of anti-
Myc  affinity  beads,  we  compared  the  protein  signal  intensities  for  total  cell 
lysates, flow-through after binding to the beads, the percentage of protein eluted 
from the beads and the percentage  which remained  bound  to  the  beads  after 
elution, on a western blot (Figure 37). In parallel, we tested 1xMyc (Figure 37 
lanes 2, 5, 7, 9) and 3xMyc peptides (Figure 37 lanes 4, 6, 8, 10) for their ability 
to elute (Figure 37 lane 7 vs 8) our protein. 
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Figure 31. Optimization of AID pull-down from DT40 with anti-Myc affinity beads. Protein 
pull-downs were carried out from DT40 extracts using anti-myc affinity beads. Pull-down was 
carried  out  using  either  a  1xMyc  peptide  (odd  lane  numbers)  or  3xMyc  peptide  (even  lane 
numbers) for protein elution from the beads. The efficiency of these pull-downs was estimated 
with a western blot using anti-FLAG antibody for detecting the protein. CL18- DT40 cell line was 
used as a control. The triangle marks AID-FLAG-TEV-Myc fusion protein. 
 
 
 
Comparing anti-FLAG and anti-Myc affinity gels to each other (Figure 36 
vs Figure 37) led us to conclude: 85-90% of the total AID-FLAG-TEV-Myc pool 
was  bound  to  the  anti-FLAG beads  and approximately  50-60% of  the  bound 
molecules were eluted by the 3xFLAG peptide. On the other hand, the anti-Myc 
affinity gel indicated that 40-50% of the total AID-FLAG-TEV-Myc pool was 
bound to the beads and approximately 20% of the bound molecules were eluted 
by  the  Myc  peptide.  Thus,  the  elution  efficiency  was  not  as  high  as  for  the 
3xFLAG peptide, and did not improve when 3xMyc peptide was used for elution. 
Having  established  the  optimal bead volumes  for both  affinity  gels  and 
elution  conditions,  we  continued  with  improving  other  pull-down  parameters 
such  as  the  signal  to  noise  ratio.  To  decrease  the  background  binding  of 
unspecific proteins to the beads, higher salt concentrations, addition of 1xFLAG 
peptide in  the  washes,  pre-clearing  and post-clearing with  anti-Ig affinity  gel 
were tested (data not shown). The results indicated that the addition of 1xFLAG 
peptide in the washes improves the results, as it removed non-specific sticking of 
proteins to the beads, at the same time not eluting AID-FLAG from the beads. On   131
the other hand, pre-clearing of the samples with an anti-Ig affinity gel had only 
minor effects on the non-specific binding. This might be due to a strong excess of 
proteins in the lysate, which are not removed by pre-clearing and therefore stick 
to the anti-FLAG beads. Post-clearing of the eluates (data not shown) indicated 
that  the  signal  for  AID-FLAG  fusion  decreased  together  with  non-specific 
proteins.  Therefore,  both  pre-clearing  and  post-clearing  in  general,  did  not 
significantly improve the signal to noise ratio during the pull-down experiments. 
By increasing the salt concentration in the bead washes, it was possible to remove 
background  sticking,  but  it  also  led  a  loss  in  AID-tag  binding  to  the  beads. 
Furthermore, as high salt concentrations might  disrupt the binding of specific 
interaction partners to AID, we chose to continue using 150 mM NaCl in the 
washes.  
In order to use the AID-FLAG-TEV-Myc cell line for two-step pull-downs 
(first  IP  with  anti-Myc,  followed by  anti-FLAG  IP),  it  was  necessary  to  test 
whether the TEV cleavage sites in the double tag are functional. Therefore, pull-
downs were carried out, using anti-Myc affinity gels to bind the protein and then 
cleave with various amounts of TEV protease (Figure 38).  
 
 
Figure 32. Optimization of TEV cleavage. Tagged DT40 cells were subjected to protein pull-
downs using anti-Myc affinity beads and analyzed by western blot. The resin bound AID-FLAG-
TEV-Myc proteins were treated with various concentrations of TEV protease at 3 h and 24 h 
time-points. Immunoprecipitated  proteins  were  detected  with  anti-FLAG  antibody  in  order  to 
visualize both the non-cleaved and cleaved (marked with arrows) fractions of AID on the beads. 
The CL18- DT40 cell line was used as a control. 
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Incubating with TEV protease resulted in the appearance of an additional 
lower-migrating  band  and  the  simultaneous  disappearance  of  the  higher-
migrating non-cleaved band. The efficiency of the cleavage was already maximal 
at 1  g TEV, and the subsequent experiments revealed that a 0.1  g of TEV per 5 
x 10
7 cells for 3 h is suitable for efficient elution of the tagged AID protein. 
In  conclusion,  by  optimizing  the  immunoprecipitation  conditions,  we 
determined suitable parameters for identifying AID-interacting proteins in large-
scale experiments. 
 
4.2.2.2.2 Mass spectrometry. 
By analyzing the disribution of AID protein in the cytoplasm, nucleoplasm and 
chromatin, we found that the majority of the total AID pool is localized in the 
cytoplasm  (approximately  80-90%), 5-10%  nucleoplasm  and  5-10%  is  in  the 
chromatin fraction (Figure 39). This  is in agreement with our observations  in 
DT40  AID-eGFP  cell  line  as  well  as  earlier  studies  which  also  found  AID 
predominantly in the cytoplasm (Aoufouchi et al., 2008; McBride et al., 2004; 
Rada et al., 2002). 
 
Figure  33.  Sub-cellular  localization  of  AID  in  DT40.  Cytoplasmic,  nuclear  and  chromatin 
fractions (see 3.2.4.2) were isolated from  DT40 AID-FLAG-TEV-Myc cells and analysed  for 
relative AID signal by using anti-FLAG antibodies. Lanes contain equivalent loadings. Tubulin 
and  histone  H3  were  included  as  internal  controls  to  assess  the  purity  of  the  corresponding 
fractions.  
 
 
In order to identify proteins in complex with AID, cells were grown to large 
volumes (20L), followed by the isolation from cytoplasmic fraction, nucleoplasm 
and chromatin. AID was immunoprecipitated from these sub-cellular fractions 
and the proteins binding to AID were identified by mass spectrometry (Figure 40   133
and 41). In parallel, samples were treated with RNAse prior to IP to degrade 
RNA and thus abolish interactions mediated by RNA. Proteins identified from 
the CL18- control IP were considered as nonspecific and disregarded.  
 
 
Figure  34.  Identification  of  AID-interacting  proteins.  Cytoplasmic,  nuclear  and  chromatin 
fractions were isolated (see 3.2.4.2) from DT40 AID-FLAG-TEV-Myc cells, immunoprecipitated 
by anti-FLAG beads (see 3.2.4.3) and visualized on a 4-12% gradient gel by Sypro Ruby staining 
(see 3.2.4.5). Left panel indicates samples not treated with RNAse A, whereas right panel shows 
samples treated with RNAse A prior to immunoprecipitation. C marks CL18- cells that were used 
as a control; F marks AID-FLAG-TEV-Myc cells. 
 
Of  the  proteins  identified,  I  will  discuss  briefly  some  interesting,  albeit 
unverified proteins (Figure 41 and Appendix Table 1). Proteins identified in the 
cytoplasm in the absence of RNAse treatment indicated various factors involved 
in  translation,  including  several  ribosomal  proteins.  We  also  found  factors 
involved in nucleo-cytoplasmic transport, such as importin subunit beta-1 and 
GTP binding protein Ran, suggesting that these proteins might be involved in the 
transport of AID into the nucleus. In addition, exportin 5 was identified as an 
AID-binding candidate, suggesting its involvement in the export of AID from the 
nucleus.  However,  its  interaction  with  AID  requires  confirmation  in  future 
studies. Mass spectrometry also revealed several proteins known as components 
of various signaling pathways such as RACK1, which binds activated Protein 
kinase C (PKC) and the substrates of PKC, thereby acting as an adaptor for PKC 
mediated phosphorylation; or 14-3-3 protein, involved in a number of signaling 
pathways.  
In  the  nucleoplasm  (in  RNAse  treated  sample),  we  identified  several 
signaling  proteins  such  as  nuclear  calmodulin-binding  protein,  interleuking   134
enhancer binding protein; a few DNA repair proteins such as RAD54-like 2 and 
Mre11, however these interaction candidates gave a relatively  low number of 
identified peptides and thus a weak signal. As for the cytoplasmic fraction, a 
number of  RNA  binding  proteins  were  identified,  such  as  splicing  factor  3B 
subunit  1,  3  and  4,  pre-mRNA-processing  factor  6,  pre-mRNA-processing-
splicing factor 8 and DEK oncogene that binds both DNA and RNA.  
In  chromatin  fraction  (RNAse  treated  sample),  we  found  a  significant 
number of proteins known to be part of the transcription elongation machinery. 
These include RNA polymerase II-associated factor 1, transcription elongation 
factors SPT5 and SPT6, FACT complex subunits and splicing factor 3B subunits 
1, 3 and 4. In addition, mass spectrometry also revealed some DNA repair factors 
such as Rad16 and Topoisomerase I.  
 
 
Figure 35. AID-interacting protein candidates identified by mass spectrometry. The listed 
proteins were identified from cytoplasm (-RNAse), nucleoplasm (+/-RNAse) or chromatin (+/-
RNase). The colour of the letters represents the known function of these candidates as indicated in 
the legend. + or – behind each candidate indicates, whether it was identified in RNAse treated 
sample or not treated sample, respectively. Candidates found in both samples are marked as +/-. 
 
 
By  comparing  the  proteins  from  all  three  cellular  fractions,  we  found 
significant  differences  between  the  cytoplasm,  nucleoplasm  and  chromatin   135
(Figure  41  and 42). On the other  hand,  nucleoplasm and chromatin  fractions 
showed more resemblance to each other than to the cytoplasm. These results form 
the basis for further studies that address the question, which of the  identified 
factors are direct binding partners  for AID and how they are involved in the 
process of AID-mediated DNA deamination. 
 
 
Figure  36.  The  intracellular  distribution  of  AID-interacting  candidates.  Cytoplasm, 
nucleoplasm and chromatin are depicted as coloured circles. AID-interacting candidates identified 
by mass spectrometry are marked as in the figure legend and their place in the circle depends on 
the cellular fractions where these candidates were identified. 
 
 
4.2.2.2.3 Confirmation of AID-interaction candidates. 
In  order  to  confirm  the  interaction  of  AID  with  some  of  the  candidates,  we 
performed  cell  fractionations,  followed  by  immunoprecipitation  of  AID  and 
subsequent detection of the interaction candidate by western blot (Figure 43). 
Western blot indicated the immunoprecipitation of Poly(ADP)-ribose polymerase 
(PARP) in the chromatin fraction (Figure 43A), however this interaction seemed 
to be RNAse sensitive since the signal was lost in the sample that was treated   136
with  RNAse  A  prior  to  immunoprecipitation.  Using  an  antibody  against 
Poly(ADP)-ribose  chains  (Figure  43B),  we  observed  several  bands  in  the 
cytoplasmic fraction of the AID pull-down and a distinct band in the chromatin 
fraction, which was moving at the  same molecular weight as PARP  and was 
absent in RNAse A treated sample. This suggested that at least a proportion of 
PARP molecules in a complex with AID is Poly(ADP)-ribosylated.  
In contrast, the signal of RACK1 indicated an interaction with AID in the 
cytoplasm and this seemed to be resistant to RNAse A treatment, suggesting that 
this  might  be  a  direct  protein-protein  interaction  (Figure  43C).  Using  this 
approach, other candidates identified in a complex with AID will be investigated, 
determining interactions that are mediated via RNA or proteins.       
 
A 
 
B 
 
 
                                     C 
 
Figure 37. Confirmation of AID-interacting proteins. AID-FLAG-TEV-Myc and CL18- DT40 
cells were subjected to the isolation of cytoplasm, nucleoplasm and chromatin. The samples were 
either threated with RNAse A or not, followed by immunoprecipitation of AID with anti-FLAG 
affinity beads.  The eluates were analysed  by western blot, using either anti-Poly(ADP)-ribose 
polymerase antibodies (A), anti-Poly(ADP)-ribose antibodies (B) or anti-RACK1 antibodies (C). 
C marks CL18- as a control pull-down for each fraction, F marks AID-FLAG-TEV-Myc pull-
down. 
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4.2.3 Discussion. 
By constructing four vectors with partial AID locus and a tag sequence, followed 
by  introducing  the  vector  in  the  endogenous  AID  locus  via  homologous 
recombination, we generated four DT40 cell lines – an AID-eGFP, AID-3FLAG, 
AID-3Myc and AID-3FLAG-2TEV-3Myc. These cell lines were confirmed by 
southern blot analysis (Figure 31), FACS analysis (Figure 32) and western blot 
(Figure 33). Thus, new DT40 cell lines were obtained in which one AID allele is 
tagged,  leaving  the  fusion  protein  under  the  regulation  of  its  endogenous 
promoter.  
Fluorescence  microscopy  showed  that  AID with an eGFP  tag  at the C-
terminus localizes predominantly in the cytoplasm (Figure 34). A similar AID 
distribution was found in AID-FLAG-TEV-Myc cells (Figure 39). These findings 
partially  confirm  earlier  observations  (Ito  et  al.,  2004),  which  analyzed 
overexpressed C-terminally GFP tagged AID in mouse fibroblast, as well as the 
recent  (McBride  et  al.,  2004)  investigation  of  the  sub-cellular  distribution  of 
overexpressed  C-  and  N-terminally  GFP  tagged  AID  in  mouse  B-cells.  Both 
studies also reported, that treating the cells with LMB, a specific inhibitor of 
CRM1, results in nearly complete nuclear accumulation of the GFP-tagged AID. 
However, LMB treatment of our cell line indicated a more modest retention of 
AID  in  the  nucleus,  since  the  GFP  signal  intensity  was  still  higher  in  the 
cytoplasm than in the nucleus (Figure 35). Furthermore, the cells did not respond 
in a homogeneous manner to LMB treatment, suggesting a complex regulation of 
AID  localization.  This  discrepancy  is  likely  to  be  a  result  of  analyzing 
overexpressed  versus  endogenously  expressed  AID,  and  underlines  the 
importance of our DT40 cell  lines that possess  endogenously expressed AID, 
representing a more physiological condition compared to overexpression.  
The fact that most of AID is located in the cytoplasm and a small fraction is 
present in the nucleoplasm and on chromatin, makes it difficult to identify AID-
interacting proteins in the nucleoplasm and chromatin fractions. However, this 
was overcome in our study by using large volumes of cells (e.g. 20 Litres). Using 
co-immunoprecipitation and subsequent mass-spectrometry, we have identified 
proteins that form a complex with AID in the cytoplasm, nucleoplasm and on 
chromatin (Figure 41 and Appendix Table 1). Proteins found to be in a complex   138
with  AID  include  factors  that  participate  in  nucleo-cytoplasmic  transport, 
intracellular signaling and DNA repair. In the cytoplasm, a number of factors 
(components  of  translation  machinery  and  RNA-binding  factors,  including 
ribosomal  proteins)  overlap  with  proteins  identified  in  a  complex  with 
APOBEC3G (Kozak et al., 2006), a member of the AID/APOBEC family of 
proteins. The identification of these mRNA binding proteins and components of 
the  translation  machinery  is  also  indirectly  supported  by  a  recent  finding, 
suggesting that AID can bind to mRNA (Nonaka et al., 2009), as reported earlier 
for APOBEC3G (Kozak et al., 2006).  
Strikingly, in the chromatin fraction, AID resides in a complex containing a 
significant number of RNA-binding proteins involved in transcription elongation 
and splicing (Figure 41). This suggests, that transcription elongation and/or RNA 
processing  might  be  important  for  the  targeting  and  execution  of  DNA 
deamination.  Although,  the  participation  of  transcription  in  AID-induced 
deamination  has  been  suggested  earlier  (Nambu  et  al.,  2003),  an  unbiased 
approach using endogenously expressed AID for identifying its binding partners, 
as our DT40 system, has been missing so far. Interestingly, the mutation pattern 
in AID-targeted Ig loci starts approximately 150 bp downstream of transcription 
initiation site, is highest after this region and gradually decreases over the next 
1.5 kilobase (Both et al., 1990; Lebecque and Gearhart, 1990; Longerich et al., 
2006; Rada and Milstein, 2001). This resembles the general occupancy of RNA 
polymerase II on a transcribed locus, since a proportion of RNA polymerase II is 
known to fall off the chromatin during transcription, mainly due to nucleosomes 
that interfere with the movement of elongating RNA polymerase (Kristjuhan and 
Svejstrup, 2004).  
Using  Ingenuity  Pathway  Analysis  software  and  analyzing  proteins 
identified specifically in the chromatin fraction of AID IP (RNAse treated), we 
were able to build a protein  interaction network, based on protein interaction 
databases (Figure 44). Many of the factors identified in our study, are known to 
bind each other, suggesting the presence of a large complex. In the future, it will 
be important to analyse AID-interacting candidates further – to examine which 
residues in AID mediate a particular protein-protein interaction. This would be 
particularly interesting with the factors found on chromatin, since AID-binding 
candidates identified in this fraction suggest a complex involved in transcription   139
elongation and RNA processing and might give a mechanistic view of the process 
of AID-mediated DNA deamination.  
 
 
 
Figure 38. Protein-protein interaction network for AID-interacting candidates in the RNAse 
treated chromatin fraction. Proteins identified by mass spectrometry (see also Appendix Table 
1) were searched for known interactions using information from protein interaction databases. 
Each line depicts a previously identified interaction between the candidates. The proteins in red 
mark the candidates identified in our mass spectrometry analysis. White marks proteins not found 
in our samples  but previously identified to interact with red candidates. Light blue highlights 
components of elongating RNA polymerase. 
 
 
Recently,  it  has  been  found  that  the  V-region  and  switch  regions,  both 
targeted by AID, are being transcribed in sense and anti-sense direction (Perlot et 
al., 2008; Ronai et al., 2007). It is possible that this might help to explain the lack 
of  strand  biases  in  AID-mediated  mutations  since  transcription  bubble  would 
make  the  ssDNA  accessible  for  DNA  deamination  (Figure  45).  Future 
experiments  will  hopefully  clarify  how  transcription  of  a  locus  affects  AID-
mediated DNA deamination. In addition, AID has been shown to directly interact 
with CTNNBL1 (Conticello et al., 2008), a protein known to bind other splicing   140
factors. Since my study found a number of splicing factors in a complex with 
AID in the nucleus, it is possible that RNA processing might also play a role in 
the DNA deamination process.  
 
A)                                                                                   B) 
 
 
 
 
Figure 39. A model for AID-mediated DNA deamination. A) A schematic depiction of AID-
mediated DNA deamination, where AID  binds to elongating RNA polymerase  II during  both 
sense and anti-sense transcription in the Ig locus. This opens the chromatin and makes ssDNA 
accessible for cytosine deamination by AID. AID is depicted in red. B) Schematic depiction of 
AID-mediated DNA deamination pathway. AID induced cytosine deamination results in uracil, 
which can initiate SHM, iGC or CSR. 
 
 
In conclusion, the unbiased identification of AID-interacting proteins by 
mass spectrometry forms the basis for future analysis of the identified factors and 
the investigation of their role in the process of AID-mediated DNA deamination. 
It also forms the basis of a mechanistic view of AID-mediated deamination and 
opens up new possibilities to tackle the process of enzymatic DNA deamination. 
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4.3  Dissecting  downstream  DNA  repair  pathways  of  AID-
mediated deamination. 
 
 
 
4.3.1 Introduction. 
4.3.1.1 DNA repair. 
The  repair  of  DNA  damage  is  essential  for  the  survival  of  an  organism. 
Genotoxic  factors  can  stem  from  exogenous  as  well  as  endogenous  sources. 
These  include  chemical  agents  (oxygen,  radicals,  or  alkylating  molecules), 
physical agents (e.g. UV- or gamma-radiation) and enzymes such as AID. DNA 
damage itself comes in different forms and includes base damage, inter and intra-
strand DNA cross-links and single- and double-strand DNA breaks [Reviewed in 
(Lindahl, 1993)]. Depending on the cellular context as well as the location of the 
lesion, AID-induced uracils can initiate various DNA repair pathways, however, 
the choice of which DNA repair pathway is used, is still poorly understood. If 
AID deaminates cytosines in switch regions in activated B-cells, it induces class 
switch recombination via NHEJ. On the other hand, if AID targets the variable 
region, U lesions can be processed either by BER or MMR, followed by repair 
via an error free or error prone manner (Neuberger et al., 2003; Odegard and 
Schatz, 2006; Rada et al., 2004; Rada et al., 2002). In DT40, AID induces lesions 
in V-region that are preferentially repaired via gene conversion (Arakawa et al., 
2002; Harris et al., 2002b). These differences in downstream processing of AID 
lesions are at least partially dependent on the genomic loci, since some genes 
targeted by AID readily accumulate mutations whereas other AID-targeted loci 
undergo error-free  DNA  repair (Liu  et al., 2008). This  also suggests  that  the 
repair of deaminated cytosines generated by spontaneous DNA deamination, can 
have different outcomes depending on the cellular context and genomic location 
of the lesion.  
We therefore aimed to study the fate of dU lesions in meiotic cells, by using 
AID as a source for uracils in DNA. We chose to utilize cells undergoing meiosis 
in  two  model  organisms,  the  fission  yeast  (S.  pombe)  and  the  nematode  (C. 
elegans) (described below). Both organisms do not contain endogenous DNA   142
deaminases (Conticello et al., 2005), allowing us to detect changes caused by 
AID expression. We aimed to express AID during meiosis in a Spo-11 deficient 
background (Rec12 in S. pombe), which is devoid of meiotic DSBs (described 
below  in  more  detail).  Since  Spo-11  deficiency  leads  to  a  lack  of  meiotic 
recombination  (De  Veaux  et  al.,  1992;  Dernburg  et  al.,  1998),  chromosome 
segregation defects, and loss in viability in both organisms, it is possible to detect 
effects  of  AID-induced  U:G  mismatches  on  meiosis  and  to dissect  the  DNA 
repair pathways involved in the process. 
 
4.3.1.2 Base excision repair. 
Base  excision  repair  mechanism  recognizes,  excises,  and  accurately  replaces 
specific forms of base modifications [Reviewed in (Barnes and Lindahl, 2004)]. 
The  first  step  of  BER  typically  involves  the  recognition  and  excision  of  an 
inappropriate  base,  such  as  uracil,  3-methyladenine,  8-OH-dG,  or 
formamidopyrimidines, with each particular lesion being recognized by a specific 
DNA glycosylase (Lindahl and Wood, 1999). They catalyze hydrolysis of the N-
glycosylic bond, resulting in an abasic site with an intact DNA phosphodiester 
backbone. Next, apurinic endonuclease 1 (APE1) both incises immediately 5′ to 
an AP site and removes 3′-obstructive termini (Demple and Sung, 2005; Wilson 
and Barsky, 2001). DNA polymerase β (POLβ) replaces the excised damaged 
nucleotide  and  removes  the  5′-terminal  abasic  fragment  left behind  by  APE1 
incision (Bennett et al., 1997; Mol et al., 2000). Once the DNA terminal ends 
have been processed to contain a 3′-hydroxyl group and a 5′-phosphate moiety, 
the remaining nick is sealed by either a complex of X-ray cross-complementing 1 
(XRCC1) protein and DNA ligase 3α (LIG3α), or the individual protein DNA 
ligase  1  (LIG1)  (McKinnon  and  Caldecott,  2007).  Even  though  it  is  well 
established that BER is important in somatic cells, including Ig diversification in 
B-cells, its role in fixing base lesions in meiotic cells is less well studied. 
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4.3.1.3 Meiosis. 
Meiosis is a cell division process in sexually reproducing organisms that results 
in the generation of gametes. It is characterized by two consecutive cell divisions 
that  give  rise  to  four  haploid  cells  from  a  diploid  zygote.  After  meiotic 
recombination  and  during  the  first  reductional  division,  paired  homologous 
chromosomes are separated. The second meiotic division is similar to mitosis, 
where sister chromatids are passed to daughter cells, ultimately resulting in four 
cells that are genetically different from each other. Meiotic recombination plays 
an important role in the establishment of genetic differences of daughter cells 
[Reviewed in (Page and Hawley, 2003)] – it shuffles alleles between homologous 
chromosomes, exerting a profound effect on genetic diversity. At the same time, 
meiotic  recombination  provides  physical  contacts  (chiasmata)  between 
homologous  chromosomes,  thereby  facilitating  the  proper  segregation  of 
chromosomes at the first meiotic division [Reviewed in (Kauppi et al., 2004)].  
Meiotic  recombination  is  initiated  by  the  formation  DNA  double-strand 
breaks (DSBs) and subsequent utilization of DSB repair. DSBs are  generated 
directly  through  a  topoisomerase-like  transesterase  reaction  by  Spo-11,  a 
meiotically  induced protein that has  sequence  similarity  to  an  archeal  type  II 
topoisomerase (Keeney et al., 1997; Klapholz et al., 1985; Lin and Smith, 1994). 
Meiotic recombination also involves eukaryotic Rad51 – a functional homolog of 
the  Escherichia  coli  strand  transfer  enzyme  RecA  (Shinohara  et  al.,  1997; 
Shinohara  et  al.,  1992).  Spo-11  mutants  are  unable  to  accomplish  meiotic 
recombination  and  exhibit  defects  in  chromosome  segregation,  leading  to 
aneuploid gametes, causing infertility in mammals, and a decrease in viability of 
spores in fission yeast (Keeney et al., 1997; Klapholz et al., 1985; Lin and Smith, 
1994;  Whitby,  2005).  Because  Spo-11  homologs  are  widely  conserved  in 
eukaryotes and are essential for meiotic recombination, DSB formation is most 
likely a universal mechanism for initiating meiotic recombination (Baudat et al., 
2000; Romanienko and Camerini-Otero, 2000).  
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4.3.1.4  Schizosaccharomyces pombe and  Caenorhabditis  elegans as  model 
organisms. 
The fission yeast Schizosaccharomyces pombe is a unicellular eukaryote with a 
genome divided among three chromosomes [Reviewed in (Forsburg and Rhind, 
2006)]. Comparison of gene sequences suggests that S. pombe is more similar to 
mammalian  cells  than  S.  cerevisiae.  Also,  its  cell  cycle  and  chromosome 
structure are in general more analogous to mammalian cells compared to budding 
yeast (Moreno et al., 1991). S. pombe divides by medial fission, producing two 
identical daughter cells. The nuclear cell cycle is divided into distinct G1 (10%), 
S  (10%),  G2 (70%)  and M (10%) phases  and the  generation time  in  normal 
minimal or complex media is between 2 and 4 hours. S. pombe cells prefer a 
vegetative  growth  as  haploid  and  may  be  of  two  mating  types:  h+  and  h− 
(Moreno et al., 1991). Starving induces the haploid cells of opposite mating types 
to mate in pairs, forming diploid zygotes, which then undergo meiosis to form 
four haploid spores in a linear tetrad ascus (Forsburg and Rhind, 2006). As in 
other  organisms,  meiotic  recombination  in  fission  yeast  is  initiated  by  Spo-
11/Rec12 (De Veaux et al., 1992; Keeney et al., 1997). 
The soil nematode Caenorhabditis elegans is a widely used model organism 
for animal development, because of its simplicity as a multicellular organism, its 
rapid  (3-day)  life  cycle,  and  ease  to  knock  down  gene  expression  by  RNA 
interference (Riddle, 1997). Furthermore, it  has a well characterized  germline 
development, where different stages of meiosis can be visualized and compared 
in  the  same  organism  simultaneously.  The  two  sexes  of  C.  elegans, 
hermaphrodites and males, are of similar length but differ in appearance as adults 
- males have a slim torso, move rapidly and have a characteristic hook-shaped tail 
(Riddle,  1997).  Hermaphrodites  produce  both  oocytes  and  sperm  and  can 
reproduce by self-fertilisation. Each worm lays up to 300 eggs which hatch in 12 
hours, producing larvae (Brenner, 1974). The nuclear genome of C. elegans is 
organized into six chromosomes (Brenner, 1974). The karyotype of C. elegans 
consists of 12 chromosomes in hermaphrodites, five pairs of autosomes and two 
sex  chromosomes,  and  11  chromosomes  in  males,  which  have  a  single  sex 
chromosome. In C. elegans, X0 males arise spontaneously in XX hermaphrodite 
populations by means of X chromosome nondisjunction at a frequency of about   145
0.1% (Riddle, 1997). The males mate with hermaphrodites to produce a 1:1 ratio 
of  male  and  hermaphrodite  cross-progeny.  The  chromosomes  of  C.  elegans 
undergo all of the classically described stages of meiotic prophase, culminating in 
a reductional division at meiosis I and equational division at meiosis II. As in S. 
pombe,  homologous  chromosomes  in  C.  elegans  rely  on  the  formation  of 
crossovers  to  ensure  their  proper  disjunction  at  meiosis  I,  however  in  the 
nematode, due to crossover interference, these are limited to one crossover per 
chromosome pair (Villeneuve, 1994). 
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4.3.2 Results. 
 
4.3.2.1 Generation of expression vectors for fission yeast studies.   
For analysis of base mismatches in fission yeast meiosis, we generated vectors 
expressing the indicated DNA deaminases and an AID catalytic mutant (Figure 
46. For details see 3.2.5.3). AID catalytic mutatant possesses a mutation in the 
zinc  co-ordinating  amino  acid  histidine  56  (H56L)  (Chaudhuri  et  al.,  2003; 
Morgan et al., 2004; Papavasiliou and Schatz, 2002; Pham et al., 2003).  
 
Figure 40. Schematic representation of the constructs used in fission yeast study. Proteins 
were expressed under the control of thiamine-repressible nmt1 or nmt41 promoter - expression is 
driven in the absence of thiamine. Amino acids essential for the formation of the catalytic domain 
(blue) are indicated as well as the substitution of His56 with Leu56 in human AID (AID). 
 
 
4.3.2.2 Induction of base mismatches rescues tetrad formation in S. pombe 
rec12∆. 
In S. pombe, meiotic recombination is initiated by the formation of DSBs induced 
by  the  Spo-11  equivalent  in  fission  yeast  -  Rec12  (De  Veaux  et  al.,  1992). 
Rec12∆  mutants  are  deficient  in  tetrad  formation  (Figure  47A)  and  therefore 
meiosis yields only approximately 50 % of tetrads (compared to 94 % in wt) and 
30 % dyads (1-2 % dyads in wt), indicative of impaired meiotic recombination. 
The expression of AID during meiosis in the rec12∆ strain significantly rescued 
tetrad  formation  and  decreased  dyads  (Figure  47B).  Tetrad  formation  was   147
increased from 50 % to 73 %, while dyad formation decreased from 30 % to 12 
%,  indicating  that  AID  or  its  dU  product  can  compensate  for  some  of  the 
functions of Rec12 (Pauklin et al., 2009a). If AID expression was repressed in 
these strains by addition of thiamine, the tetrad rescue was abolished (Table 11). 
To determine, if the catalytic activity of AID is required for rec12∆ rescue, we 
expressed  a  catalytically  inactive  mutant  of  AID  during  meiosis  (Figure  46). 
Expression  of  AID  H56L  in  the  rec12∆  background  failed  to  rescue  the 
deficiency in tetrad formation (Figure 47C). To follow protein expression in vivo, 
we used a GFP-AID fusion protein (Figure 46). Similarly to functional AID, this 
fusion protein was also able to partially rescue tetrad formation, at the same time 
lowering the number of dyads (Figure 47D and Table 11). 
 
 
Figure 41. DNA deaminases partially restore tetrad formation in rec12∆ S. pombe. (A - F) 
Relative distribution of tetrads, triads, dyads and mis-segregations, that are formed during meiosis 
in rec12∆ background transfected with an empty vector (A), with human AID (B), with a H56L 
human  AID  (C),  with  GFP-human  AID  (D),  with  human  APOBEC2  (E),  and  with  human 
APOBEC3C (F). Cells were transfected, grown in the presence of thiamine for 24 hours, washed, 
grown in the absence  of thiamine for 6 hours, and crossed for 2 days  on thiamine (-) plates.  
Tetrads,  triads,  dyads  and  mis-segregations  were  quantitated  by  microscopy.  Modified  from 
(Pauklin et al., 2009a). 
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Table  11.  Asci  analysis  in  S. pombe.  All  vectors  were  expressed  in  rec12∆  S.  pombe.  The 
concentration of thiamine was 15 µM. The numbers highlighted in red correspond to the tetrad 
and dyad percentages in AID-expressing cells. n = number of asci. Published in (Pauklin et al., 
2009a). 
 
 
 
 
4.3.2.3 AID expression in rec12∆ increases spore viability. 
DNA deaminases generate uracil in DNA, followed by the processing of these 
lesions by BER to abasic sites or ssDNA nicks, which in turn can be processed to 
DSBs. In our tetrad analysis, this could have increased DSB lesions to an extent 
that started decreasing spore viabilities. We addressed this by dissecting tetrads, 
triads, and dyads into individual spores, to analyse spore viabilities. The average 
spore viability from a tetrad of rec12∆ was 22 %, but when catalytically active 
AID  was  expressed  during  meiosis,  viability  increased  by  more  than  2  fold 
(Figure  48A).  An  increase  in  viability  was  also  observed  when  spores  were 
picked from dyads or triads (Figure 48A), or when a random spore analysis from 
cultures  was  preformed  (Figure  48B).  As  in  the  tetrad  formation  assay,  the 
catalytically inactive AID mutant was unable to rescue the viability.   149
 
Figure 42. Deaminases increase spore viability after meiosis. (A) Relative spore viability by 
ascus dissection analysis. Viabilities of rec12∆ single spores from tetrads, triads and dyads in 
control-transfected  cells  (white),  in  AID  catalytic  mutant  expressing  cells  (light  blue)  and  in 
catalytically active AID expressing cells (dark blue). The numbers of the spores that were isolated 
are indicated at the bottom of each column, and the viability of vector only rec12∆ strain set to 
one.  (B)  Percent  viability  of  random  spore  analysis,  from  rec12∆  cells  expressing  different 
deaminases during meiosis. Published in (Pauklin et al., 2009a). 
 
 
4.3.2.4 AID expression induces meiotic recombination. 
DNA DSBs generated by Spo-11/Rec12 induce inter-homologue recombination 
that promotes proper chromosome segregation by inducing chiasmata (Bahler et 
al., 1993; Gerton and Hawley, 2005; Whitby, 2005). To investigate whether AID 
expression  and  the  formation  of  dU  could  lead to  meiotic recombination,  we 
analysed the recombination frequency between ade6 and ura4, two auxotrophic 
markers on chromosome III. In rec12∆ strain, meiotic recombination frequency 
between these markers is approximately 0.1 - 0.2 %, a value derived from the 
number of viable spores growing on plates lacking uracil and adenine versus the   150
total spore count. Expression of AID during meiosis in rec12∆ strains induced a 
15-fold increase in recombination (Figure 49B) (Pauklin et al., 2009a). This was 
dependent on the expression of AID as no recombination was detected in the 
presence of thiamine, as well as AID’s catalytic activity, because AID H56L did 
not significantly increase recombination (Table 12). 
 
Table 12. Initiation of meiotic recombination by DNA deaminases. 
 
 
Next, we analysed whether recombination derived from dU can be initiated 
after DNA replication. Cells were synchronized at the post-replicative stage of 
meiosis by using nocodazole (known to depolymerise microtubules). To monitor 
the efficacy of the treatment (completion of S phase) we used propidium-iodide 
staining  and  FACS  analysis  (Appendix  Figure  6).  Yeast  were  grown  in  the 
presence of thiamine (time-line  in Figure 49C), induced to mate at time 0 h, 
nocodazole was added after 24 h, a further 24 h later AID was expressed by 
removing  thiamine  [expression  was  monitored  via  GFP-AID  (see  Appendix 
Figure 6)] while the cells were still in nocodazole. By 72 h post mating initiation, 
cells were released from the nocodazole block by extensive washing and AID 
expression inhibited with thiamine. After 24 h, cells were plated and incubated 
until  colonies  were  visible  to  score  for  meiotic  recombination.  If  AID  was 
induced after the nocodazole block, a significant increase  in the frequency of 
meiotic recombination between the two loci was still observed (Pauklin et al., 
2009a).  As  expected,  this  effect  required  AID  expression  and  AID  catalysis 
(Figure  49D). These  results  suggest that a  significant  proportion of  the  AID-
mediated  meiotic  recombination  events  occur  independently  from  DNA 
replication. 
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Figure 43. Meiotic recombination initiated by AID. (A) Representative  plates showing the 
increase in recombinants after meiosis of rec12∆ cells transfected with empty vector (left plate) or 
with AID (right plate). Cells auxotrophic for either adenine (ade6) or uracil (ura4) were crossed 
on EMM low N and spores plated  on EMM media supplemented with phloxin B, and in the 
absence or presence of both adenine and uracil, to assess the relative number of recombinants 
compared to the total number of viable spores. (B) Fold increase in ade6 ura4 recombinants after 
the  expression  of  either  AID  catalytic  mutant,  functional  AID,  GFP-AID,  APOBEC2  or 
APOBEC3C during meiosis compared to empty vector (set to one) transfectants. (C) Timeline of 
post-replicative induction of AID-induced recombination. Time points on the figure represent the 
relative timing of changing the media or the addition of the indicated compounds nocodazole 
(noco),  leucine  (leu),  and  thiamine  (thia);  +  and  –  indicate  the  presence  or  absence  of  the 
compounds  starting  from  the  corresponding  time  point.  (D)  DNA  deaminase  mediated 
recombination events are initiated after DNA replication. Cells were treated as indicated in the 
timeline (C). The graph shows the recombinants obtained when AID, mutant (H56L) AID and the 
APOBEC  proteins  were  expressed  after  removal  of  thiamine  (-  thia)  at  48  hour  time  point 
compared to the results when deaminase expression is repressed during meiosis by thiamine (+ 
thia).  For details see 3.2.5.9. Published in (Pauklin et al., 2009a). 
   
 
It is thought that the sub-cellular localization of AID and other APOBEC 
family members may be a means of regulating the function of DNA deaminases 
(Coker and Petersen-Mahrt, 2007). AID is known to enter and function in the 
nucleus, whereas the APOBEC3 family members (except for APOBEC3B) are 
usually confined to the cytoplasm (Mangeat et al., 2003; Marin et al., 2003). We 
therefore tested if other DNA deaminases besides AID, could be used to induce 
dU:dG mismatches during meiosis leading to rescue of the rec12∆ phenotype as 
well as homologous recombination. Expression vectors for APOBEC3C (a DNA 
deaminase known to inhibit SIV and Line1 retrotransposon (Dutko et al., 2005; 
Harris et al., 2002a; Muckenfuss et al., 2006; Yu et al., 2004b) and APOBEC2 
(Conticello et al., 2005; Harris et al., 2002a; Jarmuz et al., 2002; Mikl et al., 
2005)] were transformed into fission yeast. Expression of APOBEC2 failed to 
rescue tetrad formation (Figure 47E), increase viability (Figure 48B), or increase 
meiotic recombination (Table 12). On the other hand, expression of APOBEC3C 
did increase tetrad  formation  (Figure  47F),  viability  (Figure 48B), as well  as 
meiotic  recombination  (Table  12),  indicating  that  dU  from  other  DNA 
deaminases can also induce meiotic recombination events. 
 
 
4.3.2.5 Generating an AID expressing spo-11 deficient nematode.  
Results from the single cell fission yeast meiosis suggested, that a base mismatch   153
generated  by AID’s  enzymatic  activity results  in  the  processing of the  lesion 
leading to homologous recombination. To study the effects of AID expression in 
a  genetically  tractable  multicellular  organism,  we  generated  a  nematode  that 
expresses AID in meiotic cells.  
AID was fused to GFP and placed under the control of the pie-1 promoter, 
limiting its expression to germline and early embryogenesis. Pie-1 promoter was 
originally derived from a nematode gene known to express specifically in the 
germ line and during early embryogenesis (Tenenhaus et al., 1998). The pie-1 
AID vector was used for worm microparticle bombardment (described in 3.2.6), 
using  an  unc-119  (UNCoordinated)  mutant  worm  strain.  Vector  integration 
confers movement to the worm due to unc-119 protein expression. Upon stable 
integration, the progeny of this worm maintains the ability to move. Two weeks 
post-bombardment, plates were analysed under a light microscope, showing 10 
positive plates out of 120 plates. From each of these positive plates, 6 moving 
worms were picked and transferred to a 24-well plate. Progeny of the worms 
were visually analysed under light microscopy. Animals from 8 out of 10 plates 
gave predominantly moving progeny, indicative of stable integration of the AID 
expression vector. The integration of AID sequence was confirmed on individual 
animals by nested PCR (Figure 50; see also 3.2.6.9), using primers for amplifying 
AID sequence and analysing on average 9 animals per plate.  
 
 
 
Figure 44. Confirmation of the stable integration of AID in the nematode. Moving progeny of 
bombarded worms were used in single worm PCR to detect the genomic integration of AID. 
Numbers indicate different plates from which worms were picked for analysis. Arrows mark the 
PCR product corresponding to AID sequence. 
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In addition, live worms were also analysed for GFP signal with Deltavision 
microscope in high magnification, indicating a weak GFP signal predominantly 
in the cytoplasm of germline cells. This cytoplasmic staining was confirmed with 
monoclonal  antibodies  against  AID  protein  (Figure  52).  Immunocytological 
staining  of  the  animals  indicated  the  presence  of  AID protein  throughout  the 
germline from meiosis I leptotene through diplotene. As predicted, AID signal 
was absent from spo-11 worms. 
In  order to  obtain  a  spo-11 deficient  nematode  expressing AID,  several 
consecutive  crosses  were  carried  out  as  schematically  depicted  in  Figure  51. 
Firstly, spo-11 males were crossed with a GFP balancing strain that harbours a 
GFP ORF very close to the genomic locus of spo-11 gene. Since the spo-11 gene 
Figure 51. A schematic representation of nematode crossing. The strategy for obtaining a 
spo-11 deficient nematode stably expressing AID in its germ line. Spo-11 marks the deficient 
allele, GFP marks the balanced allele, “+” marks the wt spo-11 alleele, “-“ marks the absence of 
AID.  Female and male are depicted with red and blue symbols, respectively.  
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and  GFP  loci  are  in  physical  proximity,  the  GFP  signal  (exclusively  in  the 
pharynx of the animal) can be considered as a genetic marker for this spo-11 
allele, allowing to trace its segregation among the progeny. GFP positive male 
progeny (a total of 5 animals) from this cross were crossed with the above AID 
unc-119 hermaphrodites (2 animals). Thereafter, GFP expressing hermaphrodites 
that arose from the cross, were further cross with non-GFP males from the same 
brood. Hermaphrodites from the resulting brood were then individually grown to 
give self progeny. These worms were placed in individual wells of a 24-well 
plate and allowed to reproduce. The animals were subjected to nested PCR to 
detect both AID and the deletion of spo-11 gene. Nested PCR results allowed for 
the identification of PCR double-positive homozygous AID expressing spo-11 
deficient  animals.  These  animals  were  propagated  and  used  for  subsequent 
studies.  
 
 
 
Figure 45. Expression of AID during oogenesis.  AID was detected with anti-AID antibodies 
(red) in (A) spo-11 worm and (B) AID expressing spo-11 worm. Nuclei were counter stained with 
DAPI. Published in (Pauklin et al., 2009a). 
 
 
4.3.2.6  AID expression rescues  RAD-51 focus  formation and bivalency  in 
spo-11 mutant C. elegans. 
In C. elegans, each chromosome pair has a single crossover event (Villeneuve, 
1994).  Animals  deficient  in  Spo-11  are  devoid  of  meiotic  RAD-51  focus 
formation  and  fail  to  generate  the  obligate  crossover  per  homolog  pair. 
Cytologically, this manifests as chromosome univalency at diakinesis, that can be   156
visualized as separate DAPI staining bodies inside the nucleus (Dernburg et al., 
1998). To determine if ectopic expression of AID in the C. elegans germline is 
capable of inducing meiotic recombination, spo-11 deficient worms expressing 
AID  were  examined  for  RAD-51  focus  formation  as  a  measure  for  meiotic 
recombination (Figure 53). Wild-type worms exhibit the normal distribution of 
Spo-11 induced RAD-51 foci, which are located predominantly in late leptotene 
to pachytene (Figure 53A and G). As expected, the spo-11 mutants are deficient 
in the induction of meiotic DSBs and therefore lack RAD-51 foci (Figure 53B). 
Ectopic germline expression of AID induces meiotic RAD-51 foci (Figure 53C). 
The distribution of these foci is broader and less numerous than in wild-type 
organism, but interestingly are most abundant near the leptotene and zygotene 
zone (Figure 53C and G). Importantly, AID-induced RAD-51 foci were absent 
from the pre-meiotic zone, which contains the only actively proliferating nuclei 
in  the  adult  animal,  indicating  that  lesions  induced by  AID  are  mostly  post-
replicative.  Our  work  in  S.  pombe  (Figure  49D)  is  in  agreement  with  this, 
indicating  that  DNA  replication  is  dispensable  for  the  AID  induced  meiotic 
recombination. Previous studies have used ionising radiation to artificially induce 
DSBs  in  spo-11  deficient  worm  in  order  to  rescue  the  spo-11  phenotype 
(Dernburg et al., 1998). Gamma radiation induced RAD-51 focus formation in 
spo-11  worms  are  distributed  randomly  throughout  meiotic  prophase  (Figure 
53E),  which  is  in  contrast  to  the  AID-induced  lesions,  which  peaked  around 
zygotene (Figure 53C and G), suggesting differences between these sources of 
DNA lesions. 
 
   157
 
Figure 46. AID induces RAD-51 foci during meiosis in spo-11 worm. Representative pictures 
of germlines visualized for RAD-51 foci, using anti-RAD-51 antibodies (red) as well as DAPI 
staining to visualise the nuclei: (A) wild-type animals, (B) spo-11, (C) spo-11 worm expressing 
AID,  (D)  spo-11  worm  expressing  AID  with  RNAi  treatment  for  ung-1,  (E)  spo-11  worm 
irradiated with 15 Grays (Gy) and analysed after 4 hours, and (F) ung-1 defective nematode. 
Dashed squares represent the proposed location of zygotene stage in the germline. The germlines 
were  divided  into  six  zones  according  to  the  developmental  stage  of  the  germline.  (G)  The 
number of RAD-51 foci per nuclei was counted in worm germlines with respective genotypes (A-
F)  in  the  six  developmental  zones  (30  nuclei  per  zone  per  worm,  analyzing  3  worms  per 
genotype). Published in (Pauklin et al., 2009a). 
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During meiosis, a condensed homologous chromosome pair held physically 
together by a single chiasma, known as a bivalent. In a spo-11 worm, there is no 
manifestation  of  bivalency,  leading  to  the  formation  of  12  univalent 
chromosomes  (Figure  54B).  In  wild-type  nematode,  DAPI  staining  reveals  6 
bivalents in oocyte nuclei at diakinesis (Figure 54A). Upon AID expression in 
spo-11 deficient animals, some of the AID induced mismatches are processed to 
induce  meiotic  recombination  leading  to  a  substantial  recovery  of  bivalency 
(Figure  54C  and  E),  indicating  that  AID  is  able  to  influence  chromosome 
segregation.  
 
 
 
Figure 47. AID alters the chromosome morphology during diakinesis. Representative pictures 
of DAPI stained chromosomes during diakinesis from (A) wild-type, (B) spo-11, (C) two nuclei 
of AID expressing spo-11 worm, and (D) AID expressing spo-11 worm after treatment with ung-1 
(RNAi). (E) The numbers of DAPI staining bodies per nuclei were counted for each genotype 
from the indicated number of cells. Different shadings for the columns represent the numbers of 
DAPI stained bodies as indicated on the top of the graph. Published in (Pauklin et al., 2009a). 
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4.3.2.7  AID  expression  increases  viability  and  decreases  males  in  spo-11 
nematode. 
Since the formation of RAD-51 foci and chromosomal bivalency in response to 
AID expression indicated changes in the molecular events taking place during 
meiosis compared to spo-11 worms, we investigated if AID could also increase 
the  viability  of  the  spo-11  mutant  worms.  Due  to  aberrant  chromosome 
segregation, spo-11 worms produce less than 1% viable offspring, compared to 
wild-type N2 worms (Figure 55A; Table 13). Chromosomal non-dysjunction in 
these animals  also results  in  increased  frequency of male offspring,  which  is 
increased from ~ 0.1% in wild-type N2 to above 40 % in spo-11 mutants (Figure 
55B and Table 12) (Dernburg et al., 1998). C. elegans spo-11 expressing AID 
exhibit a more than 10 fold increase in viable brood size (Figure 55A) and a 2.5 
fold decrease in males (Figure 55B and Table 13). These results indicate that the 
induction of meiotic recombination events by expressing AID in spo-11 mutants 
is  sufficient  to  increase  viability  of  the  progeny  and  proper  chromosome 
segregation. 
 
 
 
 
Figure 48. AID increases viability and hermaphrodite frequency in spo-11 worms. (A) Worm 
viabilities for the indicated genotypes were assessed by counting viable offspring and dead eggs 
in a brood  from  young adults. (B) The  frequencies  of males among  viable  progeny  from the 
sample in (A) were assessed by microscopic analysis of tail morphology and movement. A total 
of at least 2000 worms were counted per genotype (for extended data see Table 12). Published in 
(Pauklin et al., 2009a). 
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Table 13. Viability and male frequency in the nematode. Viability (% Viability) is based on 
the number of viable offspring/ (dead eggs + viable offspring); % Lethality = 100 - Viability; 
Male frequency (% Male) is based on the numbers of animals with a male phenotype (hook-
sphaped  tail,  slim  torso,  more  active  movement)  among  at  least  170  viable  offspring; 
Hermaphrodite frequency (% Hermaph.) = 100 - % Male; wt - N2 or unc-119; si-UNG - siRNA 
UNG treated worms; 15 Gy - 15 Grey units of ionizing radiation; †p<0.01 (to wt);††p<0.05 (to 
spo-11); *p<0.001 (to spo-11); **p<0.01 (to wt si-UNG);*†p<0.01 (to spo-11 + AID). Published 
in (Pauklin et al., 2009a). 
 
 
 
 
4.3.2.8 Rescue of spo-11 by AID is dependent on UNG. 
To investigate which DNA repair pathways may be involved in processing the 
AID-induced  dU:dG  lesion,  we  inactivated  UNG-1  [the  only  Uracil  DNA 
glycosylase in nematode (Dengg et al., 2006)] by RNAi in AID expressing spo-
11 worms. UNG-1 depletion by RNAi completely inhibited AID induced RAD-
51 focus formation in spo-11 mutants (Figure 53D and G). Similarly to RAD-51 
foci formation, AID induced bivalency and the decrease in male frequency was 
dependent on the presence of UNG, since RNAi for UNG abrogated these effects 
(Figure 54D and E). Furthermore, analysis of ung-1 (RNAi) treated wt worms 
indicated a  minor  but  significant  increase  in  dead  eggs  and male frequencies 
(Table 13). These effects were even larger in the ung-1 worm (knock-out), and 
also detectable in Spo-11 deficient background in which ung-1 was depleted by 
RNAi (Table  13),  altogether  indicating  that BER  proteins  can affect meiosis. 
According to these results, AID induced dU lesions seem to be predominantly 
processed via the  BER pathway  to generate abasic sites that are sufficient to 
generate HR substrates in meiosis. 
Since AID expression resulted in RAD-51 foci that peaked around zygotene 
(Figure 53C), we investigated the expression of UNG-1 in the germline using   161
specific antibodies (Figure 56). Even though there were minor differences in the 
distribution of UNG-1 compared to AID expression (Figure 52 vs 56), there is no 
clear  indication that the relative  distribution  of  AID  induced  RAD-51 foci is 
solely caused by the expression pattern of UNG. Therefore, the distribution of 
these  foci  might  be  caused  by  other  features  of  the  meiotic  recombination 
pathway or differences in cell stage throughout oogenesis. 
 
 
Figure 49. Expression of UNG during oogenesis. UNG was detected with anti-UNG antibody 
(red) in (A) wild-type worm germline and (B) wild-type worm treated with ung-1 (RNAi). Nuclei 
were counterstained with DAPI. Published in (Pauklin et al., 2009a). 
 
 
4.3.2.9 Differences in AID and gamma radiation induced rescue of spo-11 
phenotype. 
Gamma  radiation  induced  RAD-51  focus  formation  in  spo-11  worms  were 
distributed randomly throughout meiotic prophase (Figure 53E), whereas AID-
induced lesions peaked around zygotene (Figure 53C). It was possible there are 
differences  in  the  processing  of  irradiation  induced  lesions  and  AID-induced 
lesions. To directly visualize the formation of DSBs and accessible DNA ends, 
we  employed  a  previously  published  TUNEL  assay  (Parusel  et  al.,  2006). 
Although we could observe a large number of TUNEL positive cells after gamma 
radiation treatment (sub-lethal dose), we did not detect foci in the AID expressing 
worms (Figure 57B and C). This demonstrated, that AID did not induce a large 
number of DSBs or accessible DNA ends unlike the ionizing radiation treatment 
and  therefore  AID  induced  lesions  differ  from  lesions  generated  by  gamma 
irradiation.   162
 
 
 
 
Figure  50.  TUNEL  staining  of  C.  elegans  germline.  Worms  were  treated  as  described  in 
3.2.6.19 and 3.2.6.20. One representative germline from wt (A), wt (IR 15 Gy) (B), spo-11 + AID 
(C), and spo-11 (IR 15 Gy) (D) is shown for TUNEL staining (I - upper) and merged with DAPI 
(II - lower) fluorescence. Published in (Pauklin et al., 2009a). 
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4.3.3 Discussion. 
The genome is under constant threat by chemical or physical sources of DNA 
damage. These lesions need to be removed by DNA repair mechanisms in order 
to maintain the integrity of the genome. A common single base altering lesion in 
non-replicative  DNA  is  deaminated  cytosine,  resulting  in  the  formation  of  a 
dU:dG mismatch. In the Ig locus, different DNA repair pathways can process the 
dU:dG lesion leading to various phases of SHM, iGC, and CSR (Chaudhuri and 
Alt,  2004;  Maizels,  2005;  Neuberger  et  al.,  2005;  Neuberger  et  al.,  2003; 
Petersen-Mahrt et al., 2002). The repair of a dU:dG mismatch leading to class 
switching  is  mediated  by  BER  (UNG)  as  well  as  MMR  (MLH1-PMS2, 
Msh2/Msh6 and MSH5) (Larson et al., 2005b; Rada et al., 2004; Sekine et al., 
2007), followed by NHEJ (Ku70/Ku80 DNA PKs) that completes the process 
(Manis et al., 1998; Rooney et al., 2004). In my study, I was interested in the fate 
of dU:dG lesions in meiotic cells, using AID as a source for these lesions. To 
date,  it  is  not  known  if  AID  can  function  in  a  meiotic  nucleus,  if  dU:dG 
mismatches are repaired in meiotic cells and if so, which DNA repair pathways 
are responsible for it. Since it has been hypothesized that DNA lesions other than 
Spo-11 induced DSBs might be involved in meiotic recombination (Cromie et al., 
2006; Farah et al., 2005), we speculated that AID-induced deamination could 
affect these recombination events. 
Expression of DNA deaminases in the rec12∆ strains of S. pombe lead to a 
rescue of tetrad formation (Figure 47), increased spore viability (Figure 48), and 
increased meiotic recombination (Figure 49). The partial rescue of C. elegans 
spo-11 by AID demonstrates that in multi-cellular organisms the meiotic nucleus 
is  also  capable  of  processing  a  dU  lesion.  The  formation  of  RAD-51  foci 
indicates that AID induced dU lesions can be processed by the post-replicative 
meiotic  nucleus  to  HR  substrates  (Figure  53C).  Furthermore,  the  increased 
chromosomal bivalency (Figure 54C), viable offspring (Figure 55A) and decrease 
in males (Figure 55B), suggests that AID induced base mismatches can give rise 
to crossovers that are capable of guiding chromosomal segregation at the first 
meiotic  division.  Our  RNAi  experiments  in  the  nematode  indicated  that  the 
processing  of  dU  lesions  into  recombination  events  in  meiotic  cells  was 
dependent on UNG-1, suggesting that BER influences AID-induced DNA repair   164
processes during meiosis. 
The rescue of Spo-11 deficiency by AID in both fission yeast and nematode 
is important, considering the difference of the lesions that are generated by AID 
(dU)  and  Spo-11  (DSB).  Since  Spo-11  may  have  auxiliary  functions  during 
meiosis, it might explain the partial rescue of spo-11 phenotype by AID. AID 
expression in the nematode germline led to RAD-51 foci, which were in modestly 
lower  numbers  than  in  wt,  however  the  viability  and  male  rescue  was  not 
complete  nor  to  the  extent  to  which  the  RAD-51  foci  would  have  indicated 
(Figure  53C  and  Figure  55).  As  each  chromosome  pair  has  to  acquire  one 
recombination event (visualized by a RAD-51 focus), AID induced lesions may 
not have allowed for sufficient HR substrate formation. This might have only 
partially  restored  proper  chromosomal  segregation  or  even  cause  some 
chromosomal  instability,  as  indicated  by  irregular  bivalency  numbers  (Figure 
54C). Future work could address whether AID lacks some auxiliary function as 
Spo-11 or whether the lesions generated by AID and Spo-11 undergo different 
processing in these cells. 
Importantly, AID expression in germline did not induce RAD-51 foci in the 
pre-meiotic zone of the germline (Figure 53C and G), which contains the only 
cells in the germline that replicate their DNA. This suggests, that the majority of 
RAD-51 foci induced by AID in spo-11 mutants occur in post-replicative cells. 
This  is  supported  by  the  results  in  fission  yeast,  which  also  indicated  that 
replication  is  not  essential  for  AID-induced  recombination  (Figure  49D).  It 
remains to be determined, if this is due to differences in the accessibility of AID 
to ssDNA or a difference in DNA repair between the pre-meiotic and meiotic 
phases. It can not be attributed to UNG-1 expression, which is expressed in both 
stages (Figure 56A).  
In B-cells, the processing of AID induced mismatches and the formation of 
DSBs seem to be dependent on the genetic loci, the cell state, the chromatin 
status and AID co-factors, as DSBs are limited to the highly repetitive switch 
regions during class switch recombination, but are less likely to occur during 
somatic hypermutation of the variable regions (Petersen et al., 2001; Stavnezer et 
al., 2008; Wuerffel et al., 1997). By using TUNEL assay we analysed free DNA 
ends  indicative  of  DSBs  in  gamma  irradiated  (sub-lethal  dose),  wt  and  AID 
expressing worms. In gamma irradiated worms, we observed extensive TUNEL   165
staining throughout the germline but no TUNEL staining in wt animals. Though 
the TUNEL assay has a detection limit, it is not clear if this lack of signal is due 
to the threshold of detection, or if the Spo-11 induced DSBs are inaccessible. 
Since  Spo-11  is  temporarily  covalently-bound  to  the  DSB  during  meiosis 
(Keeney et al., 1997), and can co-localise with the lesion to recruit downstream 
processing pathways, it might result in “hiding” the available DSB until other 
repair factors are present. From the TUNEL staining, there did not appear to be a 
large number of AID induced DSBs or free ends during meiosis. This implies, 
that  although  base  mismatches  are  processed  into  recombination  events  as 
indicated by RAD-51 foci and chromosome bivalency, the lesions seem to be 
different  in their accessibility to TUNEL  staining.  Thus, the  lack  of TUNEL 
staining and the enhanced efficiency of the rescued viability of AID-induced base 
mismatches over IR (Table 13), indicate that random DNA DSB generation is not 
as efficient in rescuing the spo-11 phenotype, compared to AID induced base 
lesions. 
My results show for the first time that DNA lesions other than DSB such as 
dU, abasic site, or ssDNA nicks, can initiate meiotic recombination in yeast and 
the multi-cellular organism C. elegans independently from DNA replication. This 
suggests an evolutionary conserved mechanism of DNA repair for dU lesions in 
the meiotic nucleus of organisms as diverse as fission yeast and the nematode. 
Since AID and some other DNA deaminases are expressed in oocytes (Morgan et 
al., 2004) and during spermatogenesis (Schreck et al., 2006), it is possible that 
protein  induced  DNA  deamination  can  affect  meiotic  recombination  also  in 
vertebrates.  
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5. Conclusions and prospects. 
5.1 Hormonal regulation of AID. 
AID is essential for antibody diversification by deaminating cytosines to uracils. 
Due to hormonal effects on immune responses and the expression of AID in some 
hormone-responsive tissues, I investigated whether AID could be regulated by 
estrogen and progesterone.  Estrogen  treatment resulted in  an  increase in  AID 
transcription via the binding of ER to AID promoter. In addition, estrogen could 
cooperate  with  the  NFκB  pathway  in  the  regulation  of  AID  expression. 
Importantly, up-regulation of AID mRNA resulted in an increase in SHM and 
CSR.  This  not  only  has  implications  for  the  efficiency  of  humoral  immune 
responses, but also autoimmune pathologies and malignancies caused by estrogen 
induced AID-mediated genomic instability. In addition to the Ig loci, we found 
increases  in  mutation  frequencies  in  the  tumor suppressor  CD95/Fas loci  and 
translocations between Ig and c-myc loci. 
Since estrogen resulted in an increase in AID mRNA also in ovarian tissue, 
future  work  should  address  the  role  AID  plays  in  this  tissue.  One  possible 
function could be inhibiting the movement of retro-transposable elements. This 
possibility in supported by our data on estrogen induced increase in Apobec3, its 
primary  function  being  to  inhibit  retro-transposable  elements  and  retroviral 
infections. Since there are considerable fluctuations in the levels of estrogen in 
females during the reproductive cycle (Smith et al., 2000), peaking close to the 
timing of fertilisation, one can speculate that estrogen mediated up-regulation of 
some APOBEC3 family members could provide an additional mechanism  for 
fighting off retroviral infections. 
In  contrast  to  estrogen,  progesterone  resulted  in  a  decrease  in  AID 
expression in stimulated B-cells. This was mediated by the binding of PR to AID 
promoter, resulting in the attenuation of SHM and CSR. These results place AID 
in the regulatory pathways of estrogen and progesterone that modulate the down-
stream processes of AID by regulating its transcription. 
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5.2 Identification of AID-interacting proteins. 
By generating four DT40 cell lines with endogenously tagged AID, I established 
a system that allowed me to investigate AID localisation and to identify novel 
proteins that form a complex with AID in the cytoplasm, nucleoplasm and on 
chromatin.  My  investigation  of  the  sub-cellular  distribution  of  AID  is  in 
agreement with earlier studies that most of the total AID protein pool is localised 
in the  cytoplasm, and a small fraction resides  in the nucleoplasm and on the 
chromatin. This distribution could be explained by the need of keeping AID out 
of the  nucleus to avoid potentially  harmful mutations in the  genome. Indeed, 
using an AID-eGFP DT40 cell line, I found that the endogenous AID protein is 
actively exported from the nucleus via a CRM1-dependent export mechanism, 
correlating  with  other  studies.  However,  it  is  likely  that  this  is  not  the  only 
mechanism regulating the intracellular distribution of AID.  
By using large scale IP and subsequent mass spectrometry, I was able to 
identify a number of proteins interacting with AID. Since this approach indicated 
several  proteins  in  the  cytoplasmic  fraction  and  nucleoplasm  that  could 
potentially be involved in the nucleo-cytoplasmic transport of AID, it would be 
important  to  study,  whether  these  proteins  bind  AID  directly.  AID  has  been 
suggested to be regulated by post-translational modifications. Since AID has been 
shown to be phosphorylated by PKC, future studies should address the question, 
whether PKC adaptor protein RACK1 or other signaling proteins identified in my 
study, regulate AID phosphorylation and its function.  
My mass spectrometry results in the chromatin fraction suggest that AID 
resides  in  a  complex  with  elongating  RNA polymerase. This  could modulate 
AID-mediated cytosine deamination and help to explain the distribution of SHM 
in  Ig  loci. Since AID  has been shown  to bind  directly  to the  splicing  factor 
CTNNBL1, it would be useful to identify the transcripts that are bound to AID 
complex in the chromatin fraction, to find out whether these RNA species are 
spliced in a specific way or contain specific sequence motifs. This might explain, 
why only a fraction of transcribed loci are targeted by AID.  
The DT40 cell lines generated in this study will be useful for analysing the 
regulation  of  AID  and  post-translational  modifications  in  the  future.  My 
investigation provides an essential framework for understanding the process of   169
DNA  deamination  in  vivo  and  for  investigating  these  novel  AID-interacting 
proteins in more detail. 
 
5.3 Dissecting DNA repair pathways downstream of AID-induced 
deamination. 
AID  expression  during  meiosis  in  spo-11/rec12  deficient  fission  yeast  and 
nematode  was  able  to  partially  rescue  a  meiotic  defect  phenotype.  The 
appearance of RAD-51 foci in AID expressing spo-11 nematode suggested that 
lesions generated by AID were processed into meiotic recombination events. This 
was confirmed by increased meiotic crossovers and the visualisation of bivalent 
homologous  chromosomes.  Interestingly,  AID  expression  also  resulted  in 
abnormal chromosomal structures in some nuclei, suggesting that AID can cause 
chromosomal re-arrangements. Importantly, in both yeast and worm, AID was 
able  to  initiate  meiotic  recombination  independently  from  DNA  replication. 
Therefore, uracils in DNA can be processed by the meiotic nucleus to give rise to 
meiotic recombination. In worm, this was mediated by BER since knockdown of 
UNG  by  RNAi  abolished  AID-induced  spo-11 rescue.  These results  raise  the 
possibility,  that  recombination  triggered  by  U  lesions  might  also  occur  in 
mammalian germ cells.  
Since  errors  in  chromosomal  segregation  are  correlated  with  unusual 
crossover positions in many cases of maternally derived trisomy 21 (Lamb et al., 
1997; Lamb et al., 1996), it is possible that spontaneous DNA deamination or 
AID-induced uracils can interfere with Spo-11 induced crossovers, or give rise to 
crossovers outside of normal recombination “hot-spots”. Analogously, increased 
aneuploidy has been noted for irradiation (Neel, 1998). In the light of my finding 
that AID mRNA is up-regulated in the ovarian tissue in response to estrogen and 
present  in  oocytes,  future  studies  could  address  the  question,  whether  AID 
expression in germ cells can affect the frequency of chromosomal abnormalities 
and aneuploidy. This could be addressed in AID knockout and wt mice treated 
with estrogen, and analysed for the frequencies of aneuploidy.  
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The deamination of cytosine to uracil is central for the biological function 
of AID. This deamination event is not only essential for humoral immunity, but it 
is  involved  in  pathologies  –  autoimmunity  and  oncogenesis.  Therefore  it  is 
important  to  understand,  how  AID  is  regulated,  both  on  the  level  of  gene 
expression, and its binding partners in the cell. Once AID has generated the dU 
lesion,  it  is  essential  to  delineate,  what  are  the  mechanisms  that  determine, 
whether this lesion undergoes error free repair or is utilized for the distinct DNA 
repair  pathways  involved  in  SHM,  iGC  or  CSR.  The  results  from  the  three 
diverse approaches described in my thesis, have all addressed questions that are 
central  for  understanding  AID-mediated  DNA  deamination:  1)  how  is  AID 
expression regulated in the cell?  2) which factors interact with AID in different 
subcellular compartments, and modulate AID function? 3) what determines the 
fate  of  the  dU  lesion  generated  by  AID?  The  results  of  my  studies  have 
significantly furthered the general understanding of the process of AID-mediated 
DNA deamination, and opened up new ways for addressing these important and 
exciting questions in the future.  
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Appendix Figure 1. 
 
 
 
Appendix Figure 1. AID pre-mRNA processing in estrogen and progesterone treated cells. 
(A)  Schematic  depiction  of  AID locus.  Exons  (blue)  with  corresponding  numbers  and  UTRs 
(green) are indicated as boxes. Red lines with capital letters indicate the relative positions of the 
PCR  products  (A-G)  along  the  AID  locus.  (B)  The  effects  of  estrogen  on  AID  pre-mRNA. 
Unstimulated mouse splenic B-cells were treated with 1 nM (E 1) for 4 h, followed by analysis of 
AID  pre-mRNA  by  qRT-PCR.  Results  are  normalized  to  DMSO-treated  cells  for  each  PCR 
product.  (B)  The  effects  of  progesterone  on  AID  pre-mRNA.  Mouse  splenic  B-cells  were 
stimulated with LPS/IL4 as in Figure 11, followed by DMSO or progesterone treatment for 4 h. 
cDNA was synthesized, and analysed by qRT-PCR. Results are normalized to DMSO-treated 
cells for each PCR product. Data represents results from three independent experiments and error 
bars indicate standard deviations from the average. Time-lines of cell treatments are indicated 
beside the graph. Published in (Pauklin et al., 2009b) and (Pauklin and Petersen-Mahrt, 2009). 
 
   188
Appendix Figure 2. 
 
 
 
 
 
 
Appendix Figure 2. Hormonal effects on AID mRNA and sIgM in Ramos. (A) The effect of 
estrogen on AID mRNA in Ramos HS13 cells. Cells were hormone depleted for 72 h prior to 
treatment with 1 nM estrogen (marked as E 1), 10 nM estrogen (E 10) or 100 nM estrogen (E 
100) for 4 h. Data is represented as in Figure 11. Time-line of cell treatment is indicated beside 
the graph. Published in (Pauklin et al., 2009b). (B) The effects of estrogen on sIgM expression in 
Ramos. Sorted individual sIgM negative cells were grown in the presence of indicated amounts of 
estrogen for 3 weeks. Clones were analyzed for sIgM expression by flow cytometry. Each colored 
dot represents the relative  proportion  of sIgM  positive cells per clone. (C)  Inhibition  of AID 
mRNA  in  RamosHS13  by  progesterone  treatment.  Ramos  cells  were  treated  with  2  µM 
progesterone for 4 h and AID mRNA was analyzed by qRT-PCR. (D) Hormonal effects on sIgM 
expression  in  Ramos.  Sorted  individual  sIgM  negative  cells  were  grown  in  the  presence  of 
indicated amounts of progesterone for 3 weeks. Clones were analyzed for sIgM expression by 
flow cytometry. Each colored dot represents the relative proportion of sIgM positive cells per 
clone.  (E)  The  data  from  (D)  expressed  as  fold  inhibition  on  the  median surface  expression 
(DMSO set to 1). Cell growth analysis indicated that progesterone only had a marginal influence 
on cell replication, and results analysed on the number of cell duplications were not different 
(data not shown). NT - not treated. Published in (Pauklin and Petersen-Mahrt, 2009) 
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Appendix Figure 3. 
 
 
 
 
 
Appendix Figure 3. Estrogen increases the mutation frequency in Ig and non-Ig loci. (A and 
B) Ramos HS13 cell line was grown in the presence of indicated amounts of estrogen for 20 
doublings, followed by cloning and sequencing of individual human VH (A) or human CD95/Fas 
(B) loci. The number of sequences analyzed (Seq), total base pairs (BP), number of mutations 
(Mut), mutation frequency per base pair (Mut/bp), overall percentage of mutations at C:G base 
pairs  (%  C:G),  percentage  of  transitions  (%  Ts)  and  pie  charts  (mutations  per  sequence) are 
indicated for each of the treatments. As the overall mutations and percentage of transitions are 
already  intrinsically  very  high  in  Ramos,  estrogen  treatment  only  modestly  increases  these 
percentages. (B) From single cell sorted clones in (A), genomic DNA was isolated and ~750 bp of 
the 5’ CD95/Fas locus sequenced. The number of mutations in CD95/Fas locus in Ramos and 
does not allow  for  meaningful statistical analysis  of  mutations at C:G base pairs (% C:G) or 
percentage  of  transitions  (%  Ts).  (C)  Mouse  splenic  B-cells  from  AID+/-  were  isolated  and 
stimulated with LPS and co-treated with DMSO or 10 nM estrogen for 72 h. Genomic DNA was 
amplified and 750 bp of the γ3 switch region sequenced. Table was generated as indicated in (A). 
The difference between the two samples 'mutation per base pair' was significant to p < 0.02 (two-
tailed unpaired T-test). Published in (Pauklin et al., 2009b).  
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Appendix Figure 4. The effect of progesterone on SMH in RAMOS HS13 cells and splenic 
B-cells.  (A  and  B)  Progesterone  decreases  the  mutation  frequency  in  the  VH  locus  and  the 
CD95/Fas locus. Ramos cells were grown in the presence of indicated amounts of progesterone 
for 3 weeks, followed by PCR amplification, cloning and sequencing of individual human VH (A) 
or human CD95/Fas (B) loci. The number of sequences analyzed (Seq), total base pairs (BP), 
number of mutations (Mut), mutation frequency per base pair (Mut/bp), overall percentage of 
mutations at C:G base pairs (% C:G), percentage of transitions (% Ts) and pie charts (mutations 
per sequence) are indicated for each treatment. Statistical significance was tested using a two-
tailed unpaired T-test. (C) Progesterone inhibits SHM in the Sγ3 of mouse splenic cells. Mouse 
splenic  cells  were  treated  for  6  d  with  LPS  and  200  nM  progesterone.  Genomic  DNA  was 
amplified and 750 bp of the Sγ3 region sequenced. Mutation frequencies are normalized to the 
control treatments with DMSO. The difference in mutation frequency in the Sγ3 loci of DMSO 
and progesterone treated spleen cells is significant, according to standard unpaired two-tailed T-
test. Published in (Pauklin and Petersen-Mahrt, 2009). 
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Appendix Figure 51 Schematic depiction of class switching. The formation of switch circles 
and production of ‘circle’ transcripts. The combinations of cytokines and LPS that lead to the 
switching of Ig isotypes are indicated in the top panel. Ovals indicate switch regions, arrows mark 
the promoters and rectangles are different constant region exons (C , Cγ3, Cγ1). Class-switching 
can result in the formation switch circle, from which a hybrid transcript (switch circle transcript - 
wavy line) is expressed (Kinoshita et al., 2001). These transcripts can be reverse-transcribed for 
cDNA, and using specific primers (e.g. arrows marked with C and A for detecting the switching 
to Cγ1 isotype), quantitate switch circle formation  by qRT-PCR. Published in (Pauklin et al., 
2009b). 
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Appendix Figure 6. 
 
 
 
Appendix Figure 52 FACS analysis of nocodazole treatment. Yeast cells (see Figure 49) were 
analysed for eGFP-AID expression and DNA content with propidium-iodide by FACS analysis. 
Published in (Pauklin et al., 2009a). 
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Appendix Table 1. 
 
Appendix Table 1. Identification of AID-interacting proteins. List of proteins identified by 
mass spectrometry in Figure 40. Cytoplasmic, nuclear and chromatin fractions were isolated from 
DT40 AID-FLAG-TEV-Myc DT40 cells, immunoprecipitated by anti-FLAG beads, visualized on 
a 4-12% gradient gel, cut out of the gel with a scalpel and analysed by mass spectrometry (see 
3.2.4.6). Samples not treated with RNAse A prior to immunoprecipitation are marked with as      
(-)RNAse, samples treated with RNAse A are marked with (+)RNAse. Numbers in columons 
CL18- IP and AID IP mark the number of individual peptides identified for each protein in CL18- 
and AID-FLAG-TEV-Myc pulldown, respectively. Ribosomal proteins were not included in this 
table. Names in brackets and highlighted with Bold mark factors shown in the network of AID-
interacting proteins (Figure 44).  
  
Cytoplasm (-)RNAse         
Protein ID  Accession 
number 
Mw 
(kDa) 
CL18-  
IP 
AID 
IP 
poly(A) binding protein, cytoplasmic 
1 (Gallus gallus) 
gi|71896197  71 kDa  1  11 
Heterogeneous nuclear 
ribonucleoprotein K - Gallus gallus 
(Chicken) 
HNRPK_CHICK  47 kDa  0  6 
Guanine nucleotide-binding protein 
subunit beta-2-like 1 - Gallus gallus 
(Chicken) [RACK1] 
GBLP_CHICK 
(+18) 
35 kDa  1  4 
Nucleophosmin - Gallus gallus 
(Chicken) 
NPM_CHICK  33 kDa  1  4 
14-3-3 protein beta/alpha - Gallus 
gallus (Chicken) 
1433B_CHICK  28 kDa  0  2 
Survival motor neuron protein - 
Gallus gallus (Chicken) 
Q98SU9_CHIC
K  29 kDa  0  2 
Cellular tumor antigen p53 - Gallus 
gallus (Chicken) 
P53_CHICK  40 kDa  0  1 
Importin subunit beta-1 - Homo 
sapiens (Human) 
IMB1_HUMAN 
(+8) 
97 kDa  0  1 
Poly(rC)-binding protein 2 - Homo 
sapiens (Human) 
PCBP2_HUMA
N (+18) 
39 kDa  0  1 
GTP-binding nuclear protein Ran - 
Gallus gallus (Chicken) 
RAN_CHICK 
(+128) 
24 kDa  0  1 
PREDICTED: similar to RAD54-like 2 
(Macaca mulatta) 
gi|109039362 
(+138) 
163 kDa  0  1 
PREDICTED: similar to exportin 5 
(Gallus gallus) 
gi|118088066 
(+5) 
137 kDa  0  1 
         
         
Nucleoplasm (-)RNAse         
         
DEK oncogene (DNA binding) 
(Gallus gallus), hypothetical protein 
(Gallus gallus) 
gi|60302770  42 kDa  0  9 
Nuclease-sensitive element-binding 
protein 1 - Gallus gallus (Chicken) 
YBOX1_CHICK 
(+2) 
36 kDa  0  3 
Lamin-B2 – Gallus gallus (Chicken)  LMNB2_CHICK  68 kDa  1  14 
Nucleolin - Gallus gallus (Chicken)  NUCL_CHICK  76 kDa  0  10 
Nuclear calmodulin-binding protein - 
Gallus gallus (Chicken) 
Q9YHD2_CHIC
K  84 kDa  0  5 
ATP-dependent RNA helicase DDX1 -  DDX1_CHICK  82 kDa  0  5   194
Gallus gallus (Chicken) 
RuvB-like 2 - Xenopus tropicalis 
(Western clawed frog) (Silurana 
tropicalis) 
Q28GB7_XENT
R  51 kDa  0  3 
Cytoplasmic activation-proliferation-
associated protein 1 - Gallus gallus 
(Chicken) 
Q5XNV3_CHIC
K (+6) 
78 kDa  0  2 
Nuclear protein matrin 3 - Gallus 
gallus (Chicken) 
Q8UWC5_CHI
CK 
101 kDa  0  2 
Pre-mRNA-processing-splicing factor 
8 - Homo sapiens (Human) 
PRP8_HUMAN 
(+22)  274 kDa  0  2 
DNA topoisomerase I - Gallus gallus 
(Chicken) 
P79994_CHIC
K 
91 kDa  0  2 
Cellular tumor antigen p53 - Gallus 
gallus (Chicken) 
P53_CHICK  40 kDa  0  1 
Importin subunit beta-1 - Homo 
sapiens (Human) 
IMB1_HUMAN 
(+8) 
97 kDa  0  1 
Interleukin enhancer-binding factor 
2 - Homo sapiens (Human) 
ILF2_HUMAN 
(+16) 
43 kDa  0  1 
Splicing factor 3B subunit 4 - Homo 
sapiens (Human) 
SF3B4_HUMA
N (+10) 
44 kDa  0  1 
Histone H1.01 - Gallus gallus 
(Chicken) 
H101_CHICK 
(+14) 
22 kDa  0  1 
PREDICTED: similar to 
endo/exonuclease Mre11 (Nasonia 
vitripennis) 
gi|156554359  52 kDa  0  1 
PREDICTED: similar to RAD54-like 2 
(Macaca mulatta) 
gi|109039362 
(+138) 
163 kDa  0  1 
poly(A) binding protein, cytoplasmic 
1 (Gallus gallus)  gi|71896197  71 kDa  0  1 
         
         
Chromatin (-)RNAse         
         
Lamin-B2 – Gallus gallus (Chicken)  LMNB2_CHICK  68 kDa  0  4 
poly(A) binding protein, cytoplasmic 
1 (Gallus gallus) 
gi|71896197  71 kDa  0  3 
Nucleophosmin - Gallus gallus 
(Chicken)  NPM_CHICK  33 kDa  0  2 
Nucleolin - Gallus gallus (Chicken)  NUCL_CHICK  76 kDa  0  2 
RuvB-like 2 - Xenopus tropicalis 
(Western clawed frog) (Silurana 
tropicalis) 
Q28GB7_XENT
R 
51 kDa  0  1 
Splicing factor 3a subunit 2 - Gallus 
gallus (Chicken) 
Q66VY4_CHIC
K (+11) 
35 kDa  0  1 
Splicing factor 3B subunit 2 - Homo 
sapiens (Human) 
SF3B2_HUMA
N (+4) 
98 kDa  0  1 
Nuclear calmodulin-binding protein - 
Gallus gallus (Chicken) 
Q9YHD2_CHIC
K 
84 kDa  0  1 
Cytoplasmic activation-proliferation-
associated protein 1 - Gallus gallus 
(Chicken) 
Q5XNV3_CHIC
K (+6) 
78 kDa  0  1 
Nuclear protein matrin 3 - Gallus 
gallus (Chicken) 
Q8UWC5_CHI
CK 
101 kDa  0  1 
Heterogeneous nuclear 
ribonucleoprotein A3 - Homo 
sapiens (Human) 
ROA3_HUMAN 
(+16) 
40 kDa  0  1   195
DNA-directed RNA polymerase II 
subunit RPB3 - Bos taurus (Bovine) 
RPB3_BOVIN 
(+6) 
31 kDa  0  1 
Spliceosome RNA helicase BAT1 - 
Gallus gallus (Chicken) 
UAP56_CHICK 
(+63) 
49 kDa  0  1 
FACT complex subunit SPT16 
(Facilitates chromatin transcription 
complex subunit spt16) 
gi|110287969 
(+21) 
118 kDa  0  1 
DNA excision repair protein Rad16, 
putative 
gi|119482550  111 kDa  0  1 
         
         
Nucleoplasm (+)RNAse 
treatment 
       
         
matrin 3 (Gallus gallus), nuclear 
protein matrin 3 (Gallus gallus) 
gi|45383822  101 kDa  1  9 
PREDICTED: interleukin enhancer 
binding factor 3 isoform 7 (Pan 
troglodytes) 
gi|114675397 
(+18) 
96 kDa  0  3 
nuclear calmodulin-binding protein 
(Gallus gallus) 
gi|3822553  84 kDa  1  4 
DEK oncogene (DNA binding) 
(Gallus gallus), hypothetical protein 
(Gallus gallus) 
gi|60302770  42 kDa  0  4 
Splicing factor 3B subunit 3 - Bos 
taurus (Bovine) 
SF3B3_BOVIN 
(+4) 
136 kDa  2  9 
Splicing factor 3B subunit 1 - Homo 
sapiens (Human) 
SF3B1_HUMA
N (+2) 
146 kDa  0  4 
Nuclease-sensitive element-binding 
protein 1 - Gallus gallus (Chicken) 
YBOX1_CHICK 
(+28)  36 kDa  0  1 
Nuclear protein matrin 3 - Gallus 
gallus (Chicken) 
Q8UWC5_CHI
CK 
101 kDa  0  6 
Nuclear cap-binding protein subunit 
1 - Gallus gallus (Chicken) 
NCBP1_CHICK  93 kDa  0  3 
Pre-mRNA-processing factor 6 - 
Homo sapiens (Human) 
PRP6_HUMAN 
(+12)  107 kDa  0  1 
NIK- and IKBKB-binding protein - 
Bos taurus (Bovine) 
NIBP_BOVIN 
(+6) 
127 kDa  0  1 
Putative uncharacterized protein - 
Gallus gallus (Chicken) 
Q5ZIR3_CHIC
K (+11) 
155 kDa  0  1 
Nuclear calmodulin-binding protein - 
Gallus gallus (Chicken) 
Q9YHD2_CHIC
K  84 kDa  0  1 
Transport protein particle subunit 
TMEM1 - Homo sapiens (Human) 
TMEM1_HUMA
N (+13) 
142 kDa  0  1 
         
         
Chromatin (+)RNAse treatment         
         
RNA polymerase II-associated factor 
1 homolog - Bos taurus (Bovine)  
[PAF1] 
PAF1_BOVIN 
(+5)  60 kDa  0  4 
DNA-directed RNA polymerase II 
subunit RPB1 - Homo sapiens 
(Human) [POLR2A] 
RPB1_HUMAN 
(+6)  217 kDa  0  1 
DNA-directed RNA polymerase II 
subunit RPB2 - Homo sapiens 
(Human)  
RPB2_HUMAN 
(+5) 
134 kDa  0  5   196
[POLR2B] 
Pre-mRNA-processing factor 19 – 
Gallus gallus (Chicken)  
[PRPF19] 
PRP19_CHICK  55 kDa  0  6 
Pre-mRNA-processing factor 6 - 
Homo sapiens (Human) 
[PRPF6] 
PRP6_HUMAN 
(+12) 
107 kDa  0  1 
Lamin-B1 - Gallus gallus (Chicken) 
[LMNB1] 
LMNB1_CHICK  67 kDa  0  1 
Transcription elongation factor SPT5 
- Gallus gallus (Chicken) 
[SUPT5H] 
SPT5H_CHICK  120 kDa  0  11 
Transcription elongation factor SPT6 
- Homo sapiens (Human) 
[SUPT6H] 
SPT6H_HUMA
N (+2) 
199 kDa  0  4 
Transcription elongation factor SPT6 
- Homo sapiens (Human) 
[SUPT6H] 
SPT6H_HUMA
N (+2)  199 kDa  0  4 
DNA topoisomerase I - Gallus gallus 
(Chicken) 
[TOP1] 
P79994_CHIC
K 
91 kDa  0  2 
FACT complex subunit SPT16 - 
Homo sapiens (Human) 
[SUPT16H] 
SP16H_HUMA
N (+6) 
120 kDa  0  1 
FACT complex subunit SSRP1 - 
Gallus gallus (Chicken) 
[SSRP1] 
SSRP1_CHICK 
(+13) 
80 kDa  0  1 
ATP-dependent RNA helicase DDX1 - 
Gallus gallus (Chicken) 
[DDX1] 
DDX1_CHICK 
(+15) 
82 kDa  0  1 
Nucleolin - Gallus gallus (Chicken) 
[NCL] 
NUCL_CHICK  76 kDa  3  9 
PREDICTED: interleukin enhancer 
binding factor 3 isoform 7 (Pan 
troglodytes) 
gi|114675397 
(+18) 
96 kDa  0  4 
nuclear calmodulin-binding protein 
(Gallus gallus) 
gi|3822553  84 kDa  0  0 
DEK oncogene (DNA binding) 
(Gallus gallus), hypothetical protein 
(Gallus gallus) 
gi|60302770  42 kDa  1  2 
Highly divergent homeobox - Gallus 
gallus (Chicken)  HDX_CHICK  77 kDa  0  3 
U5 small nuclear ribonucleoprotein 
200 kDa helicase - Homo sapiens 
(Human) 
U520_HUMAN 
(+1)  245 kDa  1  7 
Elongation factor 2 - Gallus gallus 
(Chicken) 
EF2_CHICK  95 kDa  0  6 
Splicing factor 3B subunit 1 - Homo 
sapiens (Human) 
SF3B1_HUMA
N (+2) 
146 kDa  1  3 
Nuclease-sensitive element-binding 
protein 1 - Gallus gallus (Chicken) 
YBOX1_CHICK 
(+28) 
36 kDa  0  1 
RNA polymerase II-associated factor 
1 homolog - Bos taurus (Bovine) 
PAF1_BOVIN 
(+5) 
60 kDa  0  4 
Lamin-B2 – Gallus gallus (Chicken)  LMNB2_CHICK  68 kDa  0  4 
Pre-mRNA-processing factor 6 - 
Homo sapiens (Human) 
PRP6_HUMAN 
(+12) 
107 kDa  0  1 
Lamin-B1 - Gallus gallus (Chicken)  LMNB1_CHICK  67 kDa  0  1   197
 
 